ࡱ> =?89:;<BCDEFWj  bjbj .^xxs&      8A Uq:"xzzzzzzGz,,,zf&3&3&3,Vx&3,x&3&3^4_? B/hd`UL/44H#&3^&<(Rzz1U,,,, :  EMBED MSPhotoEd.3   EMBED MSPhotoEd.3  Required and Elective Educational Outcomes, Goals, Objectives and Instructional Objectives for Postgraduate Year One (PGY1) Community Pharmacy Residency Programs  Explanation of the Contents of This Document: The educational outcomes, goals, and objectives below are to be used in conjunction with the Accreditation Standard for Postgraduate Year One (PGY1) Community Pharmacy Residency Programs. Users of this document will want to refer to the accompanying glossary to assure a shared understanding of terms. Each of the documents objectives has been classified according to educational taxonomy (cognitive, affective, or psychomotor) and level of learning. An explanation of the taxonomies is available elsewhere. The educational outcomes are divided into those that are required and those that are elective. The required outcomes, including all of the goals and objectives falling under them, must be included in the design of all programs. The elective outcomes are provided for those programs that wish to add to the required outcomes. Programs selecting an elective outcome are not required to include all of the goals and objectives falling under that outcome. In addition to the potential elective outcomes contained in this document, programs are free to create their own elective outcomes with associated goals and objectives. Each of the goals falling under the programs selection of program outcomes (required and elective) must be evaluated at least once during the residents year. Educational Outcomes (Outcome): Educational outcomes are statements of broad categories of residency graduates capabilities. Educational Goals (Goal): Educational goals listed under each educational outcome are broad sweeping statements of abilities. Educational Objectives (OBJ): Resident achievement of educational goals is determined by assessment of the residents ability to perform the associated educational objectives below each educational goal. Instructional Objectives (IO): Instructional objectives are the result of a learning analysis of each of the educational objectives. They are offered as a resource for preceptors encountering difficulty in helping residents achieve a particular educational objective. The instructional objectives falling below the educational objectives suggest knowledge and skills required for successful performance of the educational objective that the resident may not possess upon entering the residency year. Instructional objectives are teaching tools only. They are not required in any way nor are they meant to be evaluated. The required educational outcomes for PGY1 Community Pharmacy Practice Residencies are as follows: Outcome R1: Manage and improve the medication-use process. Outcome R2: Provide evidence-based, patient-centered care and collaborate with other healthcare professionals to optimize patient care. Outcome R3: Exercise leadership and practice management skills. Outcome R4: Demonstrate project management skills. Outcome R5: Provide medication and practice-related information, education, and/or training. Outcome R6: Utilize medical informatics. Each of the educational outcomes, goals, and objectives in this document is numbered with a prefix of R if it is required and E if it is not. Educational Outcomes, Required for Postgraduate Year One (PGY1) Community Pharmacy Practice Residencies Outcome R1: Manage and improve the medication-use process. Goal R1.1: Demonstrate ownership of and responsibility for the welfare of the patient by performing all necessary aspects of the medication-use system. OBJ R1.1.1: (Characterization) Display initiative in preventing, identifying, and resolving pharmacy-related medication-use system problems. Actively works to identify the potential for significant medication-related problems Correctly identifies the problem to be solved Takes initiative and seeks information to solve the problem Accurately identifies appropriate sources of information needed to solve the problem Explores logical alternative approaches to solving the problem Chooses most appropriate plan for solving the problem Appropriately assesses the results of the action taken to solve the problem Initiates alternative plan if the problem is not solved Actively pursues all significant existing and potential medication-related problems until satisfactory resolution is obtained Suggested assessment activity: Cumulative direct observation of practice IO Explain the role of the pharmacist in preventing, identifying, and resolving pharmacy-related patient-care problems. IO Explain the importance of contacting the appropriate parties when a problem is identified. IO Explain the role of assertiveness in presenting pharmacy concerns, solutions, and interests. IO Explain the pharmacists obligation for absolute attention to detail in the preparation/distribution process. IO Explain the interdependent relationship between operational tasks and clinical activities. IO Explain the importance of follow-through of medication-use system activities. Goal R1.2: Identify, design, and implement quality improvement changes to the organizations (e.g., community pharmacy, corporation, health-system) medication-use system. OBJ R1.2.1: (Comprehension) Explain the organizations medication-use system and its vulnerabilities to adverse drug events (ADEs). Explanation accurately describes organizations policies and procedures regarding the medication-use system. Explanation provides accurate definition of terms associated with adverse drug events Explanation of organizations medication-use system is clear and accurate Explanation reflects understanding of the organizations medication-use process as a system Accurately states sources of information on the design, implementation, and maintenance of safe medication-use systems Explanation reflects understanding of system error Explanation reflects understanding of human factors error Cites the potential contribution of automation and technology to preventing medication misadventures at the pharmacy and at the organizational levels Cites the potential contribution of automation and technology to the occurrence of medication misadventures at the pharmacy and organizational levels Accurately explains the meaning of the term culture of safety Suggested assessment activity: Resident discussion of the organizations medication-use system and its vulnerabilities to adverse drug events IO Explain the organizations policies and procedures related to the medication-use system. IO Explain the central concepts of systems theory. IO Explain the concept of system error. IO Explain the definitions of the various terms associated with adverse drug events (e.g., medication misadventure, medication error, adverse drug reaction, error, accident, systems error, individual error, latent error). IO State sources of information on the design, implementation, and maintenance of safe medication-use systems. IO Explain the potential for contribution to the occurrence of adverse drug events by the use of automation and information technology. IO Explain the role that automation and information technology play in preventing adverse drug events. IO Explain the potential for contribution to the occurrence of adverse drug events by things such as the pharmacys workflow and staff training issues. IO Explain the meaning of the term culture of safety. OBJ R1.2.2: (Analysis) Analyze the structure (resources, equipment, staff, technology, workspace, etc.), analyze the process (procedures, methods, steps for providing services/products), and measure outcomes of the organizations medication-use system. Analyses and measurements reflect clear understanding of the differences between structure, process, and outcomes Choices of techniques and tools for analyzing structure and process and measuring outcomes are appropriate Structure, process, and outcomes are accurately analyzed Suggested assessment activity: Examination of residents analysis of the organizations medication-use system IO Explain methods for analyzing a medication-use systems structure. IO Explain how inputs to the medication-use system such as patients, staff, and environment make up its structure. IO Explain methods for analyzing processes within a medication-use system (e.g., root cause analysis, failure mode and effect analysis). IO Explain how the interactions between pharmacists, other health care providers, and patients constitute processes in the medication-use system. IO Exercise skill in process-mapping, a type of flowchart depicting the steps in a process, with identification of responsibility for each step and the key measures. IO Exercise skill in cause-and-effect diagramming. IO Explain the organizations policies and procedures for handling a drug recall. IO Explain methods for measuring outcomes of the medication-use system. IO Explain the characteristics of a clinically significant ADE. IO Explain various methods, including decision trees, for determining the significance of adverse drug events. IO Explain how to categorize medication errors using ones own organizations categorization methodology. IO When a clinically significant ADE is identified, report the event following the organizations policies and procedures. OBJ R1.2.3: (Evaluation) Identify opportunities for improvement in the organizations medication-use system by comparing the medication-use system to relevant best practices. Best practices selected for comparison are relevant Ideas for improvement have potential to result in significant improvements to the existing process Suggested assessment activity: Evaluation of residents identification of opportunities for improvement in the organizations medication-use system from comparison with best practice IO State sources of quality measures for pharmacies and pharmacists. IO Explain reporting processes for quality measures. IO Explain how key stakeholders, including health plans, interface with pharmacists and pharmacies to impact quality performance. IO When a clinically significant ADE is identified, participate in determining the presence of any similar potential ADEs. IO Participate in the community pharmacys ongoing process for tracking and trending ADEs. IO Explain how basic safety design principles such as standardization, simplification, and the employment of human factors training can minimize the incidence of error in the medication-use process. IO Explain safe practices for the storage, dispensing, administration, and security of pharmaceuticals IO Explain how to use information on how to design, implement, and maintain safe medication-use systems from external sources to identify opportunities for improvement in the organizations medication-use system. OBJ R1.2.4: (Synthesis) Participate in the process by which the organization identifies the need for, develops, implements, and evaluates evidence-based treatment guidelines/protocols for specific patient populations. The need identified is an important one for care of the organizations patient population Treatment guideline reflects careful consideration of systematically developed best evidence as described in Clinical Practice Guidelines: Directions for a New Program published by the Institute of Medicine Treatment guideline reflects consideration of new and emerging data Treatment guideline reflects consideration of the culture of the organization Guideline/protocol is fully implemented Outcome information is provided to the prescribers/providers Judgment of outcome information is accurate Judgment of outcome information gives appropriate weighting to humanistic as well as clinical and economic outcomes Suggested assessment activity: Review of a treatment guideline/protocol for which the resident identified the need, made significant contributions to its development, and participated directly in its assessment IO Define treatment guidelines and protocols. IO Explain the indications/rationale for using guidelines and protocols. IO Explain guidelines/protocols as they relate to: patient care activities, provider networks, provider incentives, cost effectiveness, utilization management, quality measurement, consumer incentive, accreditation, and benefit analysis (if applicable). IO Explain the use of evidence-based medicine in the development of treatment guidelines/protocols. IO Explain the process by which criteria for treatment guidelines/protocols are developed. IO Explain effective strategies for gaining necessary commitment and approval for use of a treatment guideline/protocol. IO Explain the importance of providing outcome information to the prescriber/provider as support for evaluative decisions on program continuance or revision. IO Explain methods for assessing the effectiveness/impact of guidelines and protocols. IO Explain the importance of assessing the clinical, economic and humanistic outcomes of treatment guidelines/protocols related to patient care. OBJ R1.2.5: (Synthesis) Design and implement pilot interventions to change problematic or potentially problematic aspects of the organizations medication-use system with the objective of improving quality. Problem identified for improvement has potential significance to the quality of the medication-use system Design of intervention is practical to implement As designed, the intervention offers an approach that can be expected to remedy or minimize the problem Plan for implementation is well thought out and includes meeting the concerns of all stakeholders Assessment of outcomes of implementation accurately reflects measurement of quality indicators Suggested assessment activity: Review of resident design and implementation of a medication-use system quality improvement pilot intervention IO Explain the importance of continually reassessing medication-use policies. IO Exercise skill in the revision of a policy or procedure when necessitated by the implementation of a change in a medication-use process. Goal R1.3: Prepare and dispense medications following existing standards of practice and the organizations policies and procedures. OBJ R1.3.1: (Synthesis) Effectively utilize technology and information systems to support preparation and dispensing of medications. Follows established policies and procedures Effectively operates existing technology and information systems, including pharmacy dispensing software Utilizes appropriate sources of information Utilizes appropriate reports to assess quality of dispensing Identifies potential areas of improvement for the technology and information systems, both for technician and pharmacist users Suggested assessment activity: Observation of residents use of technology and information systems while participating in the medication distribution process. OBJ R1.3.2: (Application) Prepare medications using appropriate techniques and following the organizations policies and procedures. When required, accurately calibrates equipment Prepares medications using appropriate technique according to the organizations policies and procedures and applicable professional standards Prepares medications so they are appropriately concentrated, stable, and stored and without incompatibilities Adheres to appropriate safety and quality assurance practices Prepares labels that conform to the organizations policies and procedures Medication contains all necessary and/or appropriate ancillary labels Inspects the final medication before dispensing Suggested assessment activity: Observation of preparation of a specific medication using a skills checklist specific to the preparation technique for the product being prepared that details the criteria listed IO State the elements of a complete medication prescription and the essentials of legibility and accuracy. IO Use effective prescriber communication techniques to secure agreement on modifications to medication prescriptions. IO Document modifications to medication prescriptions according to the organization's policies and procedures. . IO Explain standards of practice for the preparation of medications. IO Explain the organization's quality assurance standards for the preparation of medications. IO If applicable, prepare non-sterile compounded products using appropriate techniques and guidelines. IO If applicable, prepare sterile compounded products using aseptic technique and observing applicable guidelines. IO If applicable, prepare chemotherapeutic agents observing rules for safe handling of cytotoxic and hazardous medications. IO If applicable, appraise compounded products for appropriate concentrations, rate, compatibilities, stability, clarity, coring, and storage. IO Label medication products following the organizations policies and procedures. IO Explain the organizations policies and procedures for maintaining the accuracy of the patients profile. OBJ R1.3.3: (Application) Dispense medication products following the organizations policies and procedures. The patient receives the appropriate medication(s) as ordered Ensures the integrity of medication dispensed Provides any necessary written and/or verbal counseling Patient receives medication on time Follows HIPAA requirements Documentation of dispensing and consultation follows the organizations policies and procedures Suggested assessment activity: Observation of dispensing process and review of documentation for dispensing of a specific medication IO Compare and contrast the procedures used to dispense medications across the continuum of care settings. IO Follow a systematic procedure for checking the accuracy of medications dispensed, including correct patient identification, correct medication, correct dosage form, correct dose, correct number of doses, correct prescriber, expiration dates, and properly repackaged and relabeled medications. IO Follow procedures and standards of practice to insure the integrity of medication dispensed. IO Follow appropriate policies and procedures to document patients' medication refill histories. OBJ R1.3.4: (Application) Provide necessary medication-use counseling to the patient or caregiver at the time of dispensing. Session appropriately reflects the designed plan for patient counseling Clearly conveys the purpose of the counseling session Demonstrates skill in execution of each teaching method employed during the counseling session During the session, adjusts the instruction to appropriately accommodate the patient's or caregiver's previous knowledge of the medication literacy level and cultural factors During the session, adjusts the instruction to appropriately accommodate the patient's or caregiver's responses Assures the required information as specified in the organizations policy and procedures and/or statutory requirements is conveyed to the patient or caregiver. Assures the information or skills required are learned by the patient or caregiver before ending the session Uses appropriate clinical decision-making skills if the need for interventions and/or referrals are discovered during the counseling session Suggested assessment activity: Direct observation of resident counseling session with a specific patient and/or caregiver OBJ R1.3.5: (Analysis) At the time of dispensing, recommend other appropriate patient care services to help improve patient outcomes. Identifies appropriate patient care services (e.g. internal and external referrals, wellness/preventive care services) Conveys the need for/benefit of the patient care service(s) Accurately conveys information about the patient care service(s) As appropriate, implements the organizations procedure for follow-up with the patient Accurately assesses the appropriateness for patient care services based on the needs, desires and preferences of patients Suggested assessment activity: Direct observation of resident recommendation of other appropriate patient care services. Outcome R2: Provide evidence-based, patient-centered care and collaborate with other healthcare professionals to optimize patient care. (This outcome involves a series of integrated, interrelated steps. These steps describe the decision processes of a novice practitioner and are presented in this way in order to facilitate teaching and evaluation.) R2.1: Establish collaborative professional relationships with other healthcare professionals ( R2.2: Establish collaborative pharmacist-patient relationships ( R2.3: Collect and analyze patient information to identify problems ( R2.4 Design a comprehensive evidence-based regimen ( R2.5 Design evidence-based monitoring plan ( R2.6 Design patient education ( R2.7: Recommend or communicate regimen and monitoring plan ( R2.8: Implement regimen, monitoring plan, and provide patient education ( R2.9: Evaluate patient progress and redesign as necessary ( R2.10: Communicate ongoing patient information to other healthcare professionals ( R2.11: Document patient care activities  Goal R2.1: Establish collaborative professional relationships with other healthcare professionals involved in the care of patients. OBJ R2.1.1: (Comprehension) Explain the process by which collaborative practice agreements are developed and implemented. Accurately explains the role of collaborative practice agreements in defining the scope of a community pharmacys practice Accurately explains the legal/regulatory environment in which collaborative practice agreements are possible For a given situation, accurately identifies the stakeholders in the formation of a collaborative practice agreement Accurately explains strategies for establishing a collaborative practice agreement. Accurately explains the collaborative relationships that are necessary for successful fulfillment of the pharmacists role in a collaborative practice. Suggested assessment activity: Resident discussion of the development and implementation of collaborative practice agreements IO Explain the role of collaborative practice agreements in defining the scope of a community pharmacys practice. IO Explain the legal/regulatory environment in which collaborative practice agreements are possible. IO For a given situation, identify the stakeholders in the formation of a collaborative practice agreement. IO Explain strategies for establishing a collaborative practice agreement. IO Explain the collaborative relationships that are necessary for successful fulfillment of the pharmacists role in a collaborative practice. OBJ R2.1.2: (Synthesis) Develop a collaborative practice agreement (may be hypothetical) that could be used in the community pharmacy. Agreement reflects an understanding of the purpose of collaborate practice agreements Agreement is written in a manner that complies with state regulations Agreement is based on evidence-based treatment guidelines Agreement reflects a mutual understanding of the stakeholders Agreement reflects an understanding of appropriate strategies for establishing a collaborative practice agreement Agreement reflects an understanding of the collaborative relationships required for a collaborative practice agreement Agreement incorporates a practical timeline for implementation Suggested assessment activity: Review of residents written practice collaborative agreement. OBJ R2.1.3: (Synthesis) Implement a strategy that effectively establishes cooperative, collaborative, and communicative working relationships with other healthcare professionals involved in the care of patients. The relationship reflects mutual respect for the others professional expertise The relationship reflects mutual respect for appropriate delegation of professional responsibilities in providing care for patients The relationship reflects appropriate integration of the pharmacists care with the contributions of other members of the interdisciplinary team The pharmacists work within the team reflects skillful application of group process skills such as negotiation, time management, conflict management, communication, and consensus building Suggested assessment activities: Examination of the individual relationship between the resident and a particular physician or health care provider with whom he or she interacts when fulfilling practice responsibilities through a combination of direct observation, anecdotal records, and interviews with staff IO Demonstrate knowledge of other health- care professionals expertise, background, knowledge, and values in all interactions. IO Explain the training and expected areas of expertise of the members of the health profession or discipline with which one works. IO For each of the professionals with whom one interacts, explain that other healthcare professions view of its role and responsibilities in collaborations on patient-centered care. IO Define a collaborative professional working relationship. IO Explain the structures and content of collaborative working relationships that are possible between the pharmacist and the physician and between the pharmacist and other healthcare professionals. IO Explain the limits that are imposed on possible collaborative relationships by the presence or absence of guidelines, legal and regulatory requirements, and organizational policies and procedures. IO Explain the limits that are imposed on possible collaborative relationships by distance and access to information. IO Exercise skill in the use of group techniques to include communication, negotiation, delegation, time management, assessment of group dynamics, and consensus building. IO Explain the principles and applications of negotiation as they apply to working with other healthcare professionals. IO Explain the principles and applications of delegation as they apply working with other healthcare professionals. IO Explain the principles and applications of time management as they apply to working with other healthcare professionals. IO Explain the principles of group dynamics and how they apply to working with other healthcare professionals. IO Explain the principles of conflict management and how they apply to working with other healthcare professionals. IO Explain a systematic approach to building consensus. IO Explain how healthcare professionals working collaboratively develop unique communication patterns (shared language). IO Explain the importance of adhering to use of a shared language among healthcare professionals. IO Exercise skill in the coordination and integration of pharmacists care with the contributions of other healthcare professionals. Goal R2.2: Establish collaborative pharmacist-patient relationships. OBJ R2.2.1: (Synthesis) Formulate a strategy that effectively establishes a patient-centered pharmacist-patient relationship. Pharmacist incorporates the patients role and responsibilities in the making of care decisions Pharmacist conveys his/her role in the making of care decisions to the patient Roles and responsibilities attributed to patient and pharmacist are appropriate for a patient-centered pharmacist-patient relationship Pharmacist displays appropriate behavior to gain the respect of the patient Pharmacist displays respect for the preferences and expressed needs of the patient Relationship reflects trust from both parties Relationship reflects appreciation of cultural factors and patients health literacy Suggested assessment activities: Examination of the relationship between the resident and a specific patient in his or her care through direct observation and interviews with staff IO Explain the meaning of the term patient-centered and the rationale for its use. IO Explain the appropriate sharing of power and responsibility between the pharmacist, patient and caregivers in a patient-centered, pharmacist-patient relationship. IO Explain why it is important that the pharmacist communicate with the patient in a shared and fully open manner in a patient-centered, pharmacist-patient relationship. IO Explain the role of demonstrating respect for the patients individuality, emotional needs, values, and life issues in a patient-centered, pharmacist-patient relationship. IO Explain the influence that the community pharmacys approach to continuity of care, focus on health promotion, and focus on health care maintenance can have on the establishment of the pharmacist-patient relationship. IO Explain the role of cultural competence and health literacy in achieving an effective pharmacist-patient relationship, both in gathering information and in achieving patient adherence to prescribed therapy and/or prevention and health promotion strategies. IO Explain how the strategy for establishing a patient-centered pharmacist- patient relationship must change as the age category of the patient (i.e., adolescent, adult, geriatric) changes. IO Explain the characteristics of the rapport that must be established between the pharmacist and patient in the community pharmacy environment. Goal R2.3: Collect and analyze patient information to identify medication or non-medication-related problems. OBJ R2.3.1: (Application) Effectively apply appropriate physical assessment skills employed by community pharmacists to secure needed patient-specific information. As appropriate, utilizes a core physical assessment reference library Chooses appropriate physical assessment parameters specific to individual patient needs. Identifies appropriate physical assessments to perform specific to individual patient needs Documents physical assessment parameters appropriately. Suggested assessment activity: Direct observation of resident applying appropriate physical assessment skills with a specific patient. IO Identify a core physical assessment reference library. IO List the pertinent physical assessments necessary to appropriately evaluate ones practices typical patient population. IO Explain the technique for executing each physical assessment required for ones own practice. OBJ R2.3.2: (Analysis) Collect and organize all patient-specific information (including information from the referring provider, if applicable) needed by the pharmacist to prevent, detect, and resolve medication-related problems and to make appropriate evidence-based, patient-centered, medication and/or non-medication, health improvement, wellness, and/or disease prevention recommendations in collaboration with other healthcare professionals. Information base is thorough and complete (demographic, medical, medication therapy, immunization history, behavioral/lifestyle, social/economic, and administrative [e.g., physician/prescriber, informed consent, pharmacy], and patients values, preferences, and goals for therapy) Information base does not contain extraneous information Sources of information are the most reliable available Utilizes a systematic process for recording information that is functional for subsequent problem solving and decision making Suggested assessment activity: Audit of residents information base for a specific patient or pharmacy departments patient information base IO Identify the types of patient-specific information the community pharmacist requires to prevent, detect, and resolve medication-related problems and to make appropriate evidence-based, patient-centered medication and/or non-medication, health improvement, wellness and/or disease prevention recommendations in collaboration with other healthcare professionals. IO Explain the increased importance in the community pharmacy environment of collecting information regarding the patients culture, literacy, emotional needs, preferences, values, and life issues in formulating evidence-based, patient-centered care decisions. IO Explain circumstances in which there is increased importance for the community pharmacist to collect pharmacogenomic and/or pharmacogenetic information. IO Explain unique community pharmacy environmental issues surrounding confidentiality of patient information and the impact of HIPPA regulations on the collection and safeguarding of patient-specific information. IO Explain prevention, signs and symptoms, epidemiology, risk factors, pathogenesis, natural history, pathophysiology, clinical course, etiology, biopsychosocial factors, socioeconomic factors, and treatment of diseases commonly encountered in the community pharmacy environment. IO Explain the mechanism of action, pharmacokinetics, pharmacodynamics, pharmacoeconomics, usual regimen (dose, schedule, form, route, and method of administration), indications, contraindications, interactions, adverse reactions, and therapeutics of medications used in the treatment of diseases commonly encountered in the community pharmacy environment. IO Where known, explain the mechanism of action, pharmacokinetics, pharmacodynamics, usual regimen, indications, contraindications, interactions, adverse reactions, and therapeutics of nontraditional medications used in the treatment of community pharmacy patients. . IO Integrate effective communication techniques in interviews with patients, caregivers, health care professionals, or others so that the patient-specific information needed by the pharmacist for evidence-based, patient-centered care is collected. IO When presented with a limited time frame visit use an interview strategy that elicits maximum pertinent information IO Explain effective phone techniques to be used to obtain information for the patient database. IO Explain the impact of having discontinuous or fragmented patient-care information when developing an interview strategy for patients (e.g., patient seeing multiple caregivers, last visit 6 months ago). IO Distinguish the meaning of non-verbal cues in patient encounters (e.g., broken sentences in an asthmatic patient, difficult ambulation in an arthritic patient). IO Determine the most reputable and credible source of required patient-specific information. IO Explain strategies for getting information from unwilling or inaccessible participants. IO Record required patient-specific information in a manner that facilitates detecting and resolving medication-related problems and making appropriate evidence-based, patient-centered medication therapy recommendations to prescribers. IO In a setting where none exists, create an effective organizational system for recording patient-specific data. OBJ R2.3.3: (Analysis) Determine the presence of any of the following medication or non-medication problems, including non-adherence, in a patient's current therapy: 1. Medication used with no medical indication 2. Patient has medical conditions for which there is no medication or non-medication therapy prescribed 3. Medication or non-medication therapy prescribed inappropriately for a particular medical condition 4. Immunization regimen is incomplete 5. Current medication therapy regimen contains something inappropriate (dose, dosage form, duration, schedule, route of administration, method of administration) 6. There is therapeutic duplication 7. Medication to which the patient is allergic has been prescribed 8. There are adverse drug or device-related events or potential for such events 9. There are clinically significant drug-drug, drug-disease, drug-nutrient, or drug-laboratory test interactions or potential for such interactions 10. Medication or non-medication therapy has been affected by social, recreational, or nontraditional drug use by the patient or others 11. Patient not receiving full benefit of prescribed medication or non-medication therapy 12. There are problems arising from the financial impact of medication or non-medication therapy on the patient 13. Patient lacks understanding of medication or non-medication therapy 14. Patient not adhering to medication or non-medication therapy regimen 15. Other problems not listed above All medications used with no medical indication are identified All medical conditions for which there is not a medication prescribed are identified All medications inappropriately prescribed for a particular medical condition are identified All missing immunizations are identified Everything inappropriate in the current medication therapy regimen (dose, dosage form, schedule, duration, route of administration, method of administration) is identified All therapeutic duplications are identified All medications in the regimen to which the patient is allergic are identified Any presence or potential for adverse drug events that may affect outcomes of the patient is identified Any presence or potential for clinically significant drug interactions is identified Any interference with medical therapy by social, recreational, nonprescription or nontraditional medication use is identified Any instance of the patient not receiving full benefit of prescribed medication therapy is identified (e.g., system failure, clinical failure) All problems arising from the financial impact of medication therapy on the patient are identified Any lack of patient (or caregiver) understanding of his/her medication therapy is identified Any lack of patient adherence to medication regimen is identified Nothing is identified as a problem that is not a problem If medication-use problems are found, documentation exhibits the following characteristics: o Recorded in time to be useful o Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base IO Explain the increased impact of psychological, cultural, and economic factors on patients adherence to prescribed medication and/or non-medication therapy. IO Explain how the patients failure to sense importance or urgency of complying with therapy may affect adherence. IO Explain factors to consider when comparing the benefits and risks of an alternative medication therapy. IO Explain factors to consider when trying determining the likelihood that a reaction is occurring because of a medication. IO Assess criteria for assessing the severity of an adverse drug reaction. IO Explain acceptable approaches to the therapeutic management of an adverse drug reaction. IO) Explain mechanisms of determining therapeutic consequence resulting from defective medications or drug products (e.g., exacerbation of asthma due to a defective inhaler). IO Use a functional format to list patients' pharmacotherapy problems. IO Prioritize patients' pharmacotherapy problems. IO Explain varying methods of payment for medication therapy for community pharmacy patients and their effect on adherence. IO Explain how the perspective of long-term management influences the prioritization of community pharmacy patients' medication and non-medication therapy problems. IO Explain how the community pharmacys priorities for patient care influence management of patients medical problems. OBJ R2.3.4: (Analysis) Based on an analysis of the comprehensive patient information, prioritize a patients healthcare needs. Identifies unmet healthcare needs of patient Needs are prioritized appropriately based on professional judgment as well as patients values, preferences, priorities and goals Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base and direct observation of interaction with patient. Goal R2.4: Design comprehensive evidence-based medication or non-medication, health improvement, wellness, and/or disease prevention regimens for patients. OBJ R2.4.1: (Synthesis) Specify therapeutic goals, compatible with long-term management of the patient, incorporating the principles of evidence-based medicine that integrate patient-specific data; disease, medication and non-medication-specific information; ethics; and quality-of-life considerations. Goals reflect consideration of all relevant patient-specific information including culture and preferences Goals reflect consideration of the goals of other interdisciplinary team members Goals reflect consideration of the patient's disease state(s) Goals reflect consideration of medication-specific information Goals reflect consideration of best evidence Goals reflect consideration of ethical issues involved in the patient's care Goals reflect consideration of quality-of-life issues specific to the patient Goals reflect integration of all the above factors influencing the setting of goals Goals are realistic Goals are measurable Documentation exhibits the following characteristics: 1. Recorded in time to be useful 2. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base IO Explain the use in the community pharmacy environment of evidence-based consensus statements and guidelines in the setting of patient-specific therapeutic goals. IO Explain how culture influences patients perceptions of desirable outcomes. IO Explain the impact of quality-of-life issues on making decisions about therapeutic goals. IO Explain ethical issues that may need consideration when setting therapeutic goals. IO Explain how goals of other healthcare professionals influence the specification and prioritization of therapeutic goals. IO Explain unique aspects of the patients role in the community pharmacy setting in determining his/her therapeutic goals. IO Explain the roles of disease prevention, health maintenance, and adherence to prescribed therapy in the specification of therapeutic goals. IO Explain the increased influence in the community pharmacy environment of culture on patients perceptions of desirable outcomes IO Explain the realistic limits of treatment outcomes in the community pharmacy setting. IO Explain how the community pharmacy environments emphasis on long-term planning and patient continuity affects the setting of therapeutic goals. IO Explain unique aspects of the patients role in the community pharmacy environment in determining his/her therapeutic goals. OBJ R2.4.2: (Synthesis) Design a patient-centered regimen, including any necessary referrals, compatible with long-term management of a patient, that meets the evidence-based therapeutic goals established for a patient; integrates patient-specific information, disease, medication and nonmedication-specific information, ethical issues and quality-of-life issues; and considers pharmacoeconomic principles. Regimen reflects the therapeutic goals established for the patient Regimen reflects the patient's and caregiver's specific needs Regimen reflects consideration of adherence to medication and non-medication regimens Regimen is appropriate to the disease states being treated and reflects consideration of best evidence Regimen reflects consideration of any pertinent pharmacogenomic or pharmacogenetics Regimen reflects consideration of pertinent ethical issues Regimen reflects consideration of pharmacoeconomic components (patient, medical, and systems resources) Regimen reflects consideration of culture and/or language differences Regimen adheres to the organizations medication-use policies Documentation exhibits the following characteristics: 1. Recorded in time to be useful 2. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise 3. Recommended plan is clearly presented Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base IO Explain the use in the community practice environment of evidence-based consensus statements and guidelines in the design of patient-specific therapeutic regimens. IO Accurately interpret best evidence for use in the design of a patient-centered regimen for a specific patient. IO Explain where and how to find the best possible sources of evidence for a specific patient case. IO Explain how to conduct a search for relevant answers to a specific clinical question, including searches of resources that evaluate or appraise the evidence for its validity and usefulness with respect to a particular patient or population. IO Explain how to integrate seemingly applicable findings of best evidence with clinical judgment to arrive at an optimal evidence-based regimen for a specific patient. IO Explain how culture influences community pharmacy patients perception of disease and how this affects responses to various symptoms, diseases, and treatments. IO Explain how patient-specific pharmacogenomics and pharmacogenetics may influence the design of community pharmacy patients medication regimens. IO Explain how the community pharmacy environments emphasis on long-term planning and patient continuity affects the design of therapeutic regimens. IO Explain procedures for acquiring medications for patients who lack adequate medical insurance coverage. IO Explain how to incorporate disease prevention and wellness promotion into community pharmacy patients therapeutic regimens. IO Explain additional concerns with compliance, cost, and route of administration when making decisions on medication regimens. Goal R.2.5: Design evidence-based monitoring plans for patients. OBJ R2.5.1: (Synthesis) Design a patient-centered, evidenced-based monitoring plan for a patients medication and/or non-medication, health improvement, wellness, and/or disease prevention regimen that effectively evaluates achievement of the patient-specific goals. Parameters are appropriate measures of therapeutic goal achievement Plan reflects consideration of best evidence and appropriate standards of care Selects the most reliable source for each parameter measurement Value ranges selected are appropriate for the patient Parameters measure efficacy Parameters measure potential adverse drug events Parameters are cost-effective Measurement of the parameters specified is obtainable Plan reflects consideration of adherence to medication or non-medication therapy Plan includes strategy for assuring patient returns for needed follow-up visit(s) When applicable, plan reflects preferences and needs of the patient Documentation exhibits the following characteristics: 1. Recorded in time to be useful 2. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise 3. Recommended plans are clearly presented Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base IO Explain the use in the community pharmacy environment of evidence-based consensus statements and guidelines in the design of patient-specific monitoring plans. IO Compare and contrast various methods for monitoring patient adherence (e.g., refill rates, questioning, return demonstration). IO Determine monitoring parameters that will measure achievement of goals for a therapeutic regimen. IO State customary drug-specific monitoring parameters for medical regimens commonly prescribed. IO Explain the relationship between what are normal value ranges for parameters and the influence on those ranges by a given disease state. IO Identify the most reliable sources of data for measuring the selected parameters. IO Define a desirable value range for each selected parameter, taking into account patient-specific information. IO Explain factors that should influence the frequency and timing of parameter measurements in monitoring plans. IO Explain cultural and social issues that should be considered when designing a monitoring plan for a community pharmacy patient. IO Explain the importance of considering what is feasible and useful when designing a monitoring plan for a community pharmacy patient. IO Explain effective approaches to assuring patient return for follow-up visits in the community pharmacy environment. IO Explain effective strategies for measuring adherence to prescribed medication and non-medication therapies for the community pharmacy patient. Goal R2.6: Design patient education for a patients regimen and monitoring plan. OBJ R2.6.1: (Analysis) For a specific patient accurately identify what pharmacist delivered education will be essential to the patient and/or the caregiver understanding of the patients therapeutic plan, how to adhere to it, and the importance of adherence. Identifies effective methods for addressing barriers to the patients adherence to medications Utilizes a systematic and educationally sound method to identify potential patient educational materials Selects appropriate educational materials based on patients needs Suggested assessment activity: Review of residents proposed pharmacist delivered education for a particular patient. IO Explain strategies for convincing patients of the importance of adhering to their therapeutic plans. IO Use a systematic and educationally sound method for determining when it is appropriate to use handouts or visual aids and for selecting the appropriate aid. OBJ R2.6.2: (Synthesis) Design an effective and efficient plan for meeting the educational needs of a specific patient including, but not limited to, providing a comprehensive list of the patients medications, information on medication and/or non-medication therapy, adverse effects, adherence, appropriate use, handling, and medication administration. Plan meets the educational needs of the patient and the interdisciplinary team. Plan takes into account the health literacy of the patient and/or caregiver(s) Plan includes adequate and appropriate information about the patients medication and/or non-medication therapy Plan includes adequate and appropriate information about adverse effects Plan includes adequate and appropriate information about adherence Plan includes adequate and appropriate information about appropriate use Plan includes adequate and appropriate information about handling Plan includes adequate and appropriate information about medication administration Suggested assessment activity: Review of residents written plan for meeting the educational needs of a specific patient Goal R2.7: Recommend or communicate regimens and monitoring plans for patients. OBJ R2.7.1: (Application) Recommend or communicate a patient-centered, evidence-based, medication and/or non-medication, health improvement, wellness, and/or disease prevention regimen and corresponding monitoring plan to patients and other healthcare professionals in a way that is systematic, logical, accurate, timely, and secures consensus from the patient and other healthcare professionals. Recommendation is persuasive Presentation of recommendation accords patients right to refuse treatment If patient refuses treatment, resident exhibits responsible professional behavior Creates an atmosphere of collaboration Skillfully defuses negative reactions Communication conveys expertise Communication is assertive, but not aggressive Where the patient has been directly involved in the design of the plans, communication appropriately reflects previous collaboration Medical record documentation exhibits the following characteristics: 1. Recorded in time to be useful 2. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise 3. Recommended plans are clearly presented Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base where recommendation to the caregiver is done in writing; direct observation of communication process to a specific patient IO Explain the right of patients to refuse a treatment. IO Explain the importance of explicitly citing the use of best evidence when recommending or communicating a patients regimen and monitoring plan. IO Explain what would be a pharmacists responsible professional behavior in the circumstance that a patient refuses a proposed treatment. IO Differentiate between circumstances where documenting in the patient chart is sufficient and when communication to other healthcare professionals requires immediacy. Goal R2.8: Implement regimens, monitoring plans, and provide patient education for patients. OBJ R2.8.1: (Application) When appropriate, order or conduct tests according to the organizations policies and procedures. Tests are appropriate No tests are omitted that should be included Excessive tests that are not clinically warranted are avoided. Testing procedure follows organizations policies and procedures Testing technique is appropriate Suggested assessment activity: Review of residents documentation of tests ordered and/or direct observation of resident conducting tests. OBJ R2.8.2: (Application) Use effective patient education techniques to provide and evaluate the effectiveness of the patient education designed to meet the patients needs and empower patients to become active participants in their care. Resident utilizes appropriate behavioral techniques (such as using open-ended questions, identifying non-verbal cues) Resident utilizes appropriate communication techniques to convey risk and benefit Resident ensures patient can demonstrate understanding Suggested assessment activity: Direct observation of resident providing patient education to a particular patient OBJ R2.8.3: (Complex Overt Response) When permissible, use skills to administer immunizations. Uses appropriate immunization technique Follows organizations policies and procedures for management and administration of immunizations Documents immunization appropriately Suggested assessment activity: Direct observation of resident administering an immunization. IO Explain the states regulations regarding scope of practice for immunization administration. IO Explain the clinical management and administration considerations for each type of permissible vaccine to be administered by pharmacists. OBJ R2.8.4: (Application) When permissible, prescribe, administer, and/or monitor medications under collaborative practice agreements. Appropriately prescribes medication as outlined in collaborative practice agreement Appropriately administers medication Appropriately monitors medication Follows organizations policies and procedures Effectively communicates actions to physician or other prescriber responsible for the collaborative agreement Suggested assessment activity: Direct observation of resident prescribing, administering, and/or monitoring medications under collaborative practice agreements; or review of a patient medical record for which resident prescribed, administered, and/or monitored medications. IO Explain the states regulations regarding scope of practice for collaborative practice agreements. OBJ R2.8.5: (Application) Use a working knowledge of the organizations referral process to make any necessary patient referrals. Referral is the correct option Referral is to the most appropriate category of health care professional to meet the patients health care need Referral contains all pertinent information required by the recipient to take appropriate action Patient is part of the decision to refer Referral is made according to the organizations policies and procedures Suggested assessment activities: A combination of direct observation of practice; audit of patients healthcare records, residents patient information base, or pharmacys patient information base; interview of patient who has been referred; and interview of health care professional to whom the resident has referred the patient IO Explain the organizations process for making a patient referral. IO Explain the information needed to make an appropriate referral. IO Explain a systematic process for assessing the acuity of a patients illness. IO Explain the importance of following up on patients who are referred to other health care providers. IO Explain the importance of integrating follow-up information into the long-term management plan. Goal R2.9: Evaluate patients progress and redesign regimens and monitoring plans. OBJ R2.9.1: (Evaluation) Accurately assess the patients progress toward the specified therapeutic goal(s) using all available information including information from referrals. Accounts for all patient data specified in the monitoring plan Interprets each monitoring parameter measurement accurately Accounts for the patient's current status Properly judges the reliability of data (e.g., timing or site of collection, differences in test sites) Where monitoring data are incomplete, makes sound judgments in determining if there are sufficient data upon which to base a conclusion Conclusions drawn reflect consideration of any significant trends in laboratory values or clinical endpoints Conclusions drawn reflect consideration of the safety and effectiveness of the current medication therapy Conclusions drawn reflect consideration of any ineffectiveness in patient counseling Conclusions drawn reflect consideration of patients adherence Overall conclusions about reasons for patients progress or lack of progress toward each stated goal is appropriate Medical record documentation exhibits the following characteristics: 1. Warrants documentation 2. Recorded in time to be useful 3. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base for residents interpretation of monitoring data for a specific patient IO Gather data as specified in a monitoring plan. IO Determine reasons for a patients progress or lack of progress toward the stated health care goal. IO Explain the potential for decreased reliability of self-reported monitoring data. IO Explain the importance of the analysis of trends over time in monitoring parameter measurements for community pharmacy patients. IO Accurately assess the effectiveness of a patient-specific education program. IO Explain methods for assessing the effects of patient-specific education. OBJ R2.9.2: (Synthesis) Redesign a patient-centered, evidence-based medication and/or non-medication, health improvement, wellness, and/or disease prevention regimen and/or corresponding monitoring plan, as necessary, based on evaluation of monitoring data and outcomes. Modifications to the regimen and/or monitoring plan are appropriate (See criteria above for building the information base, designing therapeutic regimens, and designing monitoring plans) Modifications to the plan are effectively communicated to the patient, caregivers, prescriber, and other relevant health care professionals in a timely manner Conditions of urgency for communicating results to the prescriber are honored Suggested assessment activity: Audit of patients healthcare records, residents patient information base, or pharmacys patient information base for modifications and communication of modifications to a specific patients plan Goal R2.10: Communicate ongoing patient information to other healthcare professionals. OBJ R2.10.1: (Application) Communicate accurate, timely, and pertinent medication and/or non-medication, health improvement, wellness, and/or disease prevention information to the receiving health care professional(s) when transferring a patient from one health care setting to another. Includes all necessary information Information is conveyed in a timely manner Transfers information to all concerned health professionals Is available to clarify any related issues Follows organizations policies and procedures for communication If a medical record entry is made, it exhibits the following characteristics: 1. Warrants documentation 2. Recorded in time to be useful 3. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise Suggested assessment activity: Direct observation of resident communication of continuity of care information of a specific patient and, if medical record entry is made, review of documentation of communication of information IO Explain the requirements of HIPAA privacy regulations pertaining to the communication of patient information. OBJ R2.10.2: (Application) Ensure that accurate and timely medication-specific information regarding a specific patient reaches those who need it at the appropriate time. Information conveyed at the time it is needed Information conveyed is accurate Information conveyed in a format that is usable by the receiver Information is transmitted by means that are accessible to the receiver Suggested assessment activity: Review of residents communication of patient-specific information at various stages of a patients care IO Explain the importance of effective communication of modifications of the therapeutic plan to the patient and other healthcare professionals. IO Determine instances in which there is urgency in communicating the results of monitoring to other healthcare professionals. Goal R2.11: Document patient care activities appropriately. OBJ R2.11.1: (Analysis) Appropriately select patient -care activities for documentation. Activity selected for documentation is appropriate and relevant to patient care goals Suggested assessment activity: Review of resident documentation of his or her direct patient care activities for a specific period of time OBJ R2.11.2: (Application) Use effective and efficient communication practices when documenting a patient -care activity. Appropriate documentation tool is utilized Medical record documentation exhibits the following characteristics: 1. Warrants documentation 2. Recorded in time to be useful 3. Follows the organizations policies and procedures, including that entries are signed, dated, timed, legible, and concise 4. Content includes pertinent subjective and objective data 5. Assessment reflects accurate interpretation of the objective and subjective data 6. Recommended plans are clearly presented and relate to the conclusion Reports of medication-related problems (e.g., ADRs, medication errors, drug interactions) adhere to the organizations policies and procedures Suggested assessment activity: Review of resident documentation of his or her direct patient care activities and of reports of medication-related problems for a specific period of time IO Explain the characteristics of exemplary documentation systems that may be used in the community pharmacy environment. OBJ R2.11.3: (Application) Record patient outcomes according to the organizations policies and procedures. Uses appropriate documentation tools and methods Follows organizations policies and procedures Records clinically appropriate data for measuring outcomes Records financially appropriate data for measuring outcomes Records patients preferences Collects and records data for humanistic outcomes Suggested Assessment Activity: Review of resident documentation of outcomes for a particular patient IO Explain the characteristics of patient outcomes that should be documented. Outcome R3: Exercise leadership and practice management skills. Goal R3.1: Exhibit essential personal skills of a practice leader. OBJ R.3.1.1: (Characterization) Practice self-managed continuing professional development with the goal of improving the quality of ones own performance through self-assessment and personal change. Makes accurate, criteria-based assessments of own ability to perform practice tasks Routinely seeks applicable new knowledge and skills when performance does not meet expectations Sets realistic expectations of performance Regularly integrates new knowledge and skills into subsequent performances of a task to meet expectations Documentation of the ability to perform a practice tasks is concise and readily interpretable by a peer Takes responsibility for work quality System for staying current with literature includes review of literature pertinent to the area of practice System for arranging and storing pertinent literature is efficient and effective Suggested assessment activity: Cumulative direct observation of practice IO Explain the systematic process by which professionals pursue expertise. IO Formulate and adhere to an integrated system for staying current with, arranging, and storing pertinent practice-related literature. IO State the literature pertinent to ones area of practice. IO State sources of information outside of pharmacy that contain ideas and/or information that may be effectively applied to ones practice. IO Explain the importance of storing practice-related information in an organized manner. IO Explain the components of an effective self-assessment system. OBJ R3.1.2: (Characterization) Act ethically in the conduct of all practice-related activities. When presented in practice with an ethical dilemma, chooses a course of action that reflects accepted ethical standards for pharmacists Can explain the course of ethical reasoning that led to the ethical decision made All work prepared for publication is properly attributed Suggested assessment activity: Direct observation of practice when an ethical decision is required or interview with other staff regarding choice of action when ethical decision required and preceptor not present IO Explain ethical/conflict of interest issues in business relationships. IO Explain the system of ethical reasoning (consequentialist or nonconsequentialist) employed in arriving at a particular ethical decision. IO Explain systems of ethical reasoning. IO Explain ethical principles embodied in the American Pharmacists Associations Code of Ethics for Pharmacists. IO Explain rules for attribution of sources of published work when preparing written documents or presentations. OBJ R3.1.3: (Application) Demonstrate commitment to the profession through active participation in the activities of local, state, and/or national professional associations. Is a member of and activity participates in local, state, national, or international pharmacy associations In discussion offers an accurate comparison of the benefits to own practice of active participation in the array of associations at each level In discussion accurately identifies the benefits to own practice of publishing in the professional literature Suggested assessment activity: Cumulative direct observation of practice IO Explain the local, state, and national organizations and the activities of each that are essential to the developing pharmacy professional. IO Explain why it is important to publish in the professional literature. IO Explain why it is important to become actively involved in the leadership of professional associations. OBJ R3.1.4: (Characterization) Serve as a role model for pharmacists, pharmacy students, pharmacy technicians, and other healthcare professionals. Exhibits professional behavior Understands the need to be a positive role model Understands the impact their decisions and behavior have on others Suggested Assessment Activity: Direct observation of residents behavior OBJ R3.1.5: (Organization) Choose and manage daily activities so that they fulfill practice responsibilities and place an appropriate priority on the delivery of patient-centered care When insufficient time is available to meet all practice responsibilities, gives preference to those of the highest priority Selects appropriate daily activities Meets work responsibilities within the confines of a reasonable workday Meets deadlines appropriately and in harmony with others Suggested assessment activity: Direct observation of job performance for a specific time period IO Explain an effective system for the management of one's time in professional practice. OBJ R3.1.6: (Comprehension) Explain the role and importance of pharmacist active engagement in the political and legislative process. Discussion includes roles for pharmacists in the political and legislative process Discussion includes the importance of active engagement in the political and legislative process Discussion includes national, regional, and local health care policy issues. Suggested Assessment Activity: Resident discussion of the role and importance of pharmacist active engagement in the political and legislative process IO Explain current national health care policy issues. IO Explain current regional health care policy issues. IO Explain current local health care policy issues. Goal R3.2: Exhibit practice leadership in organizational and management activities. OBJ R3.2.1: (Synthesis) Participate in the pharmacy's planning processes. Actively participates in the planning process Contributions reflect understanding of effective planning principles for the type of planning engaged in Suggested assessment activity: Direct observation of residents contributions during a pharmacy planning meeting; review of any written contributions prepared by the resident IO Explain the principles and application of various approaches to pharmacy planning, including the development of an organizational strategic plan. IO If in the corporate pharmacy or health-system environment, explain the organizations vision and mission statements. IO Explain the necessity for congruence between the corporate pharmacy or health-system and the pharmacys vision and mission statements. IO Explain the purpose of a pharmacys vision and mission statements. IO Explain the expected components of a pharmacy vision and a pharmacy mission statement. IO Explain who should be involved in the writing of a pharmacy vision and a mission statement. OBJ R3.2.2: (Synthesis) Use knowledge of an organization's political and decisionmaking structure to influence the accomplishment of a practice area goal. Resident obtains consensus to pursue the proposed course of action Suggested assessment activity: Direct observation of the residents strategy in achieving a practice area goal that requires management/leadership approval IO Explain the importance of networking in achieving practice area and other professional goals. OBJ R3.2.3: (Application) Use group participation skills when leading or working as a member of a committee or informal work group. When leading, keeps the group focused on meeting its purpose and responsibilities When leading, prepares an effective agenda for meeting When leading, meets the site needs for the meeting When leading, writes effective minutes or notes When leading, supplies information from the meeting to appropriate individuals When leading, uses consensus-building skills as follows: 1. Assesses the desirability of group input 2. Identifies the type of decision needed (debatable, exploratory, negotiated, routine, emergency decisions) 3. Selects appropriate tools for group action (i.e., brainstorming, procedure setting, individual polling, etc.) 4. Provides a clear definition of the problem (What is the problem? How did we get here? What are the effects of the problem?) 5. Communicates a clear understanding of who has the responsibility for the decision 6. Uses effective communication and open-ended questions for producing ideas (What results do we want? What solutions can we think of?) 7. Selects an appropriate size of group for decision making 8. Provides a means for effectively testing different alternatives relative to the problem (What decision is best for us?) 9. Elicits ideas from others on how to make change go smoothly 10. Facilitates commitment to the decision 11. Presents an honest commitment to the group decision-making process (Who will do what by when? Where? How?) 12. Obtains agreement on the procedures and methods for decision making prior to deliberation of the issue 13. Offers ideas 14. Asks key or clarifying questions 15. Keeps the group focused on the task 16. Summarizes the discussion and decisions When leading, manages group dynamics When a member, participates actively and positively in the meeting When a member, makes required decisions appropriately and without hesitation When a member, remains focused on the main issues When a member, does one's share of the work Suggested assessment activities: Direct observation of resident leading a committee and/or workgroup; direct observation of resident at work in a specific committee or informal work group; interview with other members of the committee or informal work group IO Explain effective strategies for leading a meeting. IO Explain the role of delegation for task accomplishment in effective leadership. OBJ R3.2.4: (Synthesis) Integrate compliance with community practice accreditation, legal, regulatory, and safety requirements into daily practice. Accurately assesses pharmacys compliance with regulatory and safety requirements Develops an appropriate course of action to resolve any discrepancies with regulatory and/or safety requirements. Implements the course of action into practice. Appropriately follows federal, state, and local safety/practice requirements (e.g. OSHA, CLIA) Suggested Assessment Activity: Direct observation of resident practice; review of written assessment and plan IO State current regulatory and safety requirements affecting community practice. IO Explain the importance of these regulations and safety requirements. IO Explain how the regulations and safety requirements affect community practice. IO State the process by which the regulations and safety requirements are implemented. IO State the agencies responsible for regulating community practice. OBJ R3.2.5: (Synthesis) Prioritize the work load, organize the work flow, and verify the accuracy of the work of pharmacy technical and clerical personnel involved in all community pharmacy services. Needed work is accomplished in the time allotted Properly delegate work to technical and clerical personnel Work load is properly prioritized After review by the resident, all work performed by support personnel is accurate Suggested assessment activity: Direct observation of the residents use of pharmacy technical and clerical personnel during a specified time period; review of accuracy of work performed by support personnel under the direct supervision of the resident IO Explain the principles of work delegation. IO Explain systematic approaches to organizing and keeping track of the work of multiple participants in a given work activity. IO Explain the importance of routine checks on accuracy of the work of pharmacy technical and clerical personnel or others under ones supervision. IO Explain a systematic process for scheduling staff, including back-up plans for when assigned staff are not available. OBJ R3.2.6: (Application) Observe organizational customer service policies and procedures in the conduct of daily practice activities. OBJ R3.2.7: (Application) Use knowledge of the principles of change management to achieve organizational, departmental, and/or team goals. Assures that the practice environment is conducive to the desired change Assures that staff have the opportunity to acquire any necessary new knowledge or skills in order to accommodate the change Assures that those involved in the change are motivated to exercise their roles Follows through by monitoring the progress of the planned change Keeps others informed of progress on the implemented change Suggested assessment activities: Direct observation of resident performance when tasked with a significant change to be planned and executed; review of outcome of the task/step ---success or failure of change effort IO Explain the principles of change management. Goal R3.3: Contribute to the development, implementation, and evaluation of a new pharmacy service or to the enhancement of an existing service. OBJ R3.3.1: (Synthesis) Generate an idea for a new service or evaluate a current pharmacy service or program to determine if it meets the stated goals. Accurately identifies unmet customer need Utilizes modeling to predict the financial outcome(s) of implementing a proposed new or enhanced product or service on meeting unmet customer needs Accurately identifies resources (i.e., system, facilities, and human resource) needed for developing and implementing a new or enhanced product or service. Accurately predicts the outcome(s) for patients of implementing a new or enhanced product or service. Accurately predicts financial benefit to the community pharmacy of implementing a new or enhanced product or service. Suggested assessment activity: Evaluation or review of a residents written plan for new service or appraisal of existing service IO Accurately identify unmet customer (i.e., patient or plan member; physicians and other health care providers; pharmacies; and, payers) needs. IO Use modeling to predict the financial outcome(s) of implementing a proposed new or enhanced product or service on meeting unmet customer needs. IO Accurately identify resources (i.e., system, facilities, and human resource) needed for developing and implementing a new or enhanced product or service. IO Accurately predict the outcome(s) for patients of implementing a new or enhanced product or service. IO Accurately predict financial benefit to the community pharmacy of implementing a new or enhanced product or service. IO Explain the role of other healthcare professionals in meeting the needs of patients involved in disease state management programs. IO Explain why and how potential shifts in market share should be factored into decisions on the marketability of a product or service. IO Explain the potential barriers to acceptance of community pharmacy patient care services (e.g., medical practitioner acceptance, community attitudes, staff motivation) OBJ R3.3.2: (Synthesis) Develop a business plan for a new service or an enhanced service, if applicable. Proposal identifies the components of a business plan that are essential to the new/enhanced service Proposal identifies necessary stake holders in the new/enhanced service Proposal identifies how to assess the effectiveness of and value of the new/enhanced service for the pharmacy, organization, and patients Proposal identifies potential revenue sources Suggested assessment activity: Review of a proposal for a new or enhanced pharmacy service to which the resident has contributed OBJ R3.3.3: (Application) Use presentation and persuasive skills to secure approval of a plan for a new or enhanced service. Presentation is appropriate for audience Resident uses appropriate presentation and persuasive skills Suggested assessment activity: Direct observation of resident presentation IO Explain how to identify the stakeholders for a specific proposal. OBJ R3.3.4: (Synthesis) Contribute to the development of a marketing strategy for a new or enhanced service that is integrated with the overall marketing plan. Strategy is integrated with the overall marketing plan Strategy is appropriate for target audience Strategy proposes appropriate method of delivery Suggested assessment activity: Review of written marketing strategy to which resident has contributed IO Explain the aspects of a marketing strategy including target audience, method of delivery, and evaluation. IO Explain the organizations existing marketing plan and/or business model. OBJ R3.3.5: (Comprehension) Explain the various mechanisms by which pharmacists can be paid for the patient care services they provide. IO State sources of information for public and private sector payment for pharmacist patient care services. OBJ R3.3.6: (Analysis) Employ an effective strategy for obtaining compensation for a new or enhanced service from appropriate potential sources of compensation. IO Explain the process for evaluating and/or negotiating contracts with third party payers. IO Explain the use of payment codes, including for MTM and CPT, for billing for pharmacist patient care services. OBJ R3.3.7: (Synthesis) Implement a new or enhanced service according to the business and marketing plans. Follows business and marketing plans Incorporates team members appropriately Assessment activity: Review of implementation process of a new or enhanced service; review of result of implementation OBJ R3.3.8: (Evaluation) Evaluate the new or enhanced service to determine if it meets the stated goals. Accurately identifies if stated goals are being met by a service or program Accurately identifies the effectiveness with which goals are being met Accurately judges the efficiency of delivery Suggested assessment activity: Review of residents written appraisal of the effectiveness of the new or enhanced pharmacy service or program Outcome R4: Demonstrate project management skills. Goal R4.1: Conduct a practice-related project using effective project management skills. OBJ R4.1.1: (Synthesis) Identify a topic for a practice-related project of significance for community pharmacy. Choice of project is practice-related Choice of project is in alignment with pharmacys patient care and/or operational goals Choice of project warrants investigation Project can be completed in reasonably expected timeframe Suggested assessment activity: Review of residents proposed project topic IO Explain the types of resident projects that will meet residency program project requirements and timeframe. IO Explain how one determines if a potential project topic is of significance in ones particular practice setting. IO Explain how to conduct an efficient and effective literature search for a project. OBJ R4.1.2: (Synthesis) Formulate a feasible design for a practice-related project. Project proposal contains all customary elements of a proposal Each proposal element contains all necessary information Project proposal includes identification of all key stakeholders who must approve Project timeline milestones, if adhered to, would result in project completion by agreed-upon date Suggested assessment activity: Review of residents project design IO Explain the elements of a project proposal. IO When given a particular approved residency project, explain how to identify those individuals who will be affected by the conduct of the project and strategies for gaining their cooperation. IO When given a particular approved residency project, explain how to determine a timeline with suitable milestones that will result in project completion by an agreed upon date. OBJ R4.1.3: (Synthesis) Secure any necessary approvals, including IRB and funding, for ones design of a practice-related project. Appropriate strategies designed and implemented for gaining cooperation of all stakeholders affected by conduct of the project If required, IRB approval secured If required, secures funding Suggested assessment activity: Review of residents project implementation strategy and documentation of approvals/agreements IO When given a particular proposed residency project, explain how to identify those key stakeholders who must approve that project. IO Explain the components that make up a budget for a practice-related project. IO Explain the role of the organizations IRB in the approval process of investigations involving human subjects. OBJ R4.1.4: (Synthesis) Implement a practice-related project as specified in its design. Project completed on time During conduct of project, project materials well-maintained for accessibility and efficient retrieval Project process appropriately documented Project materials well organized and maintained with documentation of the projects ongoing implementation Suggested assessment activity: Review of residents implementation strategy and project files IO Explain strategies for keeping ones work on a project at a pace that matches with the timeline plan. IO When given a particular approved residency project, explain methods for organizing and maintaining project materials and documentation of the projects ongoing implementation. OBJ R4.1.5: (Synthesis) Effectively present the results of a practice-related project. Secures audience attention at the beginning Style of the speech is appropriate to presentation of a practice-related project report Portrays credibility Does not distract with physical mannerisms Does not distract with verbal habits Presentation is well organized Uses appropriate transitions when proceeding from one topic to another Summarizes key points at the close Appears poised Uses body language to add interest Pauses appropriately to emphasize points Displays energy and enthusiasm Accurately reads the audiences body language and adjusts the presentation accordingly Answers questions with ease and confidence Suggested assessment activity: Direct observation of residents presentation of completed project OBJ R4.1.6: (Synthesis) Successfully employ accepted manuscript style to prepare a final report of a practice-related project. Project manuscript utilizes appropriate manuscript style and meets criteria for writing with use of that style Project manuscript completed by assigned deadline Suggested assessment activity: Review of residents completed project report IO When given a particular residency project ready for presentation, explain the type of manuscript style appropriate to the project and criteria to be met when using that style. OBJ R4.1.7: (Evaluation) Accurately assess the impact, including sustainability if applicable, of the residency project. Assessment accurately reflects impact on the organization Assessment accurately reflects consideration of all elements that would determine sustainability Suggested assessment activity: Review of residents assessment of the impact and sustainability of the residency project. Outcome R5: Provide medication and practice-related information, education, and/or training. Goal R5.1: Provide effective medication and practice-related education and/or training to groups of patients, groups of caregivers, healthcare professionals, student pharmacists, and the public. OBJ R5.1.1: (Application) Use effective educational techniques in the design of all educational activities. Choice of content for instruction is based on an accurate assessment of the learners needs Activities are based on behaviorally stated educational objectives Selection of teaching method is based on the type of learning required (cognitive, psychomotor, affective) Content selected for instruction is matched with the intent of the stated educational objectives Content of instructional materials is accurate Content selected for instruction is complete Instruction is properly organized and sequenced Written instructional materials are matched to the learners reading level Design of instruction includes use of visual aids when appropriate Suggested assessment activity: Review of resident written plan and written instructional materials for delivery of a specific education or training program or other learning activity IO Design instruction that meets the individual learners needs. IO When given a particular patient data base, therapeutic regimen, and monitoring plan, explain the educational needs of the patient for successful implementation of the therapeutic regimen and monitoring plan. IO Explain the concept of learning styles and its influence on the design of instruction. IO Explain the importance of considering the learners reading level when designing patient education. IO Write appropriately worded educational objectives. IO Design instruction to reflect the specified objectives for education or training. IO Explain the match between instructional delivery systems (e.g., demonstration, written materials, videotapes) and specific types of learning commonly required of patients. IO Design instruction that employs strategies, methods, and techniques congruent with the objectives for education or training. IO Explain effective teaching approaches for the various types of learning required of patients (e.g., imparting information, teaching psychomotor skills, inculcation of new attitudes). OBJ R5.1.2: (Synthesis) Design an assessment strategy that appropriately measures the specified objectives for education or training and fits the learning situation. Plan for assessment will accurately measure the participants attainment of the educational objectives Suggested assessment activities: Review of resident-designed assessment instrument(s) designed to accompany a specific education or training program to assess participants learning; review of data collected by the resident through use of the assessment instruments and the residents conclusions about the level of achievement of learners on the stated objectives IO Explain appropriate assessment techniques for assessing the learning outcomes of pharmacist-provided educational or training programs. OBJ R5.1.3 (Application) Use skill in the four preceptor roles employed in practice-based teaching (direct instruction, modeling, coaching, and facilitation). Provides effective, focused direct instruction when warranted Models problem solving by talking out loud about problem-solving process Coaches according to the learners current need for degree of intensity Selects appropriate problem-solving situations for independent work by the learner Moves with ease between the four preceptor roles as learner needs change Suggested assessment activity: Cumulative direct observations of resident when engaged in practice-based teaching IO Explain the stages of learning that are associated with each of the preceptor roles. OBJ R5.1.4 (Application) Use public speaking skills to speak effectively in large and small group situations. Secures audience attention at the beginning Style of the speech is matched to its intent (persuasion, information giving, entertainment) Relates remarks to those of previous speakers (if appropriate) Portrays credibility Does not distract with physical mannerisms Does not distract with verbal habits Speech is well organized Uses appropriate transitions when proceeding from one topic to another Summarizes key points at the close Uses phrases, facts, or stories to increase audience interest Paints mental images or pictures to increase audience understanding Uses humor appropriately Appears poised Uses body language to add interest Pauses appropriately to emphasize points Displays energy and enthusiasm Accurately reads the audiences body language and adjusts the speech accordingly Answers questions with ease and confidence Suggested assessment activity: Direct observation of a resident presentation to a large group; direct observation of a resident presentation to a small group IO Explain techniques that can be used to enhance audience interest. IO Explain techniques that can be used to enhance audience understanding of one's topic. IO Explain speaker habits that distract the audience. IO Use a systematic and educationally sound method for determining when it is appropriate to use handouts or visual aids and for selecting the appropriate aid. IO Explain accepted conventions for the design of visual aids and handouts. IO Exercise skill in the operation of audio-visual equipment. Goal R5.2: Provide concise, applicable, comprehensive, evidence-based, and timely responses to requests for drug information from health care providers and patients. OBJ R5.2.1: (Analysis) Discriminate between the requesters statement of need and the actual drug information need by asking for appropriate additional information. Determines if question is patient-specific Secures appropriate background information for question type Accurately identifies request urgency Suggested assessment activity: Direct observation of residents communication process for clarification of a specific drug information request IO Explain the characteristics of a clearly stated clinical question. OBJ R5.2.2: (Synthesis) For drug information requests that can be met by drawing upon ones memory, provide appropriate, evidence-based responses. Response is accurate and based on current evidence When appropriate, source is cited When correct response is unknown, indicates appropriately and provides timely follow-up Responds confidently Suggested assessment activity: Direct observation of communication of a response to a particular unanticipated impromptu drug information request that occurs during the fulfillment of regular practice responsibilities OBJ R5.2.3: (Synthesis) When the drug information request requires further evaluation of the literature, formulate a systematic, efficient, and thorough procedure for retrieving drug information. Searches the scope of resources that are appropriate to answer the question Search strategy matches with the response time required for the request Search moves appropriately from the general to the specific Suggested assessment activity: Resident discussion of his or her search strategy for a particular information request to occur at the time the strategy is formed but prior to the search itself IO Explain the strengths and weaknesses of manual and electronic methods of retrieving biomedical literature. IO State sources of evidence-based meta-analysis reviews. IO Compare the characteristics of each of the available resources for biomedical literature. OBJ R5.2.4: (Analysis) When the drug information request requires further evaluation of the literature, assess the usefulness of biomedical literature gathered. Selects studies that have the following characteristics: 1. Sound design 2. Utilize appropriate statistics and statistical inference 3. Conclusions are supported by results Selects only literature that has the following characteristics: 4. Currency 5. Lacks bias 6. Reputable source 7. Pertains to the question 8. Accuracy 9. Appropriate referencing Suggested assessment activity: Review of the residents literature review for studies selected for inclusion for a particular drug information request IO Assess the potential for bias of the author or preparer of all forms of drug information. IO Determine whether a studys methodology is adequate to support its conclusions. IO Determine whether the endpoint established for a study is appropriate. IO Explain methods used to test study end point (e.g., pulmonary function studies). IO Explain the effects on study outcomes of various methods of patient selection (e.g., volunteers, patients, or patients with different disease severity). IO Explain the effects of various methods of blinding (e.g., double-blind, single-blind, open-research designs) on study outcomes. IO Explain the effects on study outcomes of various methods of drug assay and quality assurance procedures (e.g., high performance liquid chromatography, assay coefficient of variations). IO Explain the types of pharmacotherapy studies (e.g., kinetic, economic, dynamic) and the kind(s) of data analysis appropriate for each. IO Explain how the choice of statistical methods used for data analysis (e.g., t test, analysis of variance) affects the interpretation of study results and conclusions. IO Determine if a studys findings are clinically significant. IO Explain the strengths and limitations of different study designs. IO Explain how data from a study can be applied to expanded patient populations. OBJ R5.2.5: (Synthesis) When a drug information request requires further evaluation of the literature, provide evidence-based responses to drug information requests based on that evaluation. Draws logical and accurate conclusions Draws conclusions that focus on answering the question Written and oral communication provides credible background to support or justify the primary theme Properly sequences ideas in written and oral communication Depth of communications is appropriate to the individual Choice of words and terms is appropriate to the individual Communication reflects the needs of the individual Length of communication is appropriate to the situation Communication conveys expertise Suggested assessment activity: Direct observation of communication of a response to a particular drug information request Outcome R6: Utilize medical informatics. Goal R6.1: Use information technology to make decisions and reduce error. OBJ R6.1.1: (Comprehension) Explain security and patient protections such as access control, data security, data encryption, HIPAA privacy regulations, as well as ethical and legal issues related to the use of information technology in pharmacy practice. Explanation includes reasons for security and patient protections of patient information Explanation includes how access control, data security, data encryption, and HIPAA privacy regulations work to ensure security of patient information Explanation includes description of ethical issues related to use of information technology in pharmacy practice Explanation includes description of legal issues related to use of information technology in pharmacy practice Suggested assessment activity: Resident discussion of security and patient protections OBJ R6.1.2: (Comprehension) Explain the principles and uses of databases and how one analyzes the data to produce useful information. Accurate conclusion drawn about the significance of information derived from statistical analysis Appropriate databases drawn upon to answer question posed Suggested assessment activity: Review of analytical work performed by resident plus resident discussion of resources used in performing analysis OBJ R6.1.3: (Evaluation) Use electronic data and information from internal information databases and external online databases and resources for the purposes of making patient care, operational, and financial decisions. Decision utilizes only valid and reliable electronic sources Only pertinent resources are utilized Decisions made are appropriate, based on data/information accessed, and integrated with other sources of information Suggested assessment activity: Review of multiple resident decisions involving individuals and populations in which the resident has used electronic data and information from internal information databases, external online databases, and/or the internet IO Explain the type of data collected, transmitted and stored by information systems. IO Explain the impact on the quality of decision-making facilitated by information systems by the validity, reliability, and consistency of data put into the system. IO Explain the use and risks of decision support tools. IO Explain the sources, the benefits and potential risks of patients drug and medical information on the Internet. Potential Elective Educational Outcomes for Postgraduate Year One (PGY1) Community Pharmacy Residencies Outcome E1: Provide public health programs for health improvement, wellness, and disease prevention to the community. Goal E1.1: Design and deliver education programs to the community that center on health improvement, wellness, and disease prevention. OBJ E1.1.1: (Comprehension) Explain the pharmacists role in public health, including specific contributions to public health efforts. Accurately describes the overall role of pharmacists in public health Accurately describes specific contributions that can be made to public health by pharmacists Suggested assessment activity: Discussion by resident of pharmacists role in public health OBJ E1.1.2: (Application) Use effective educational techniques in the design of health improvement, wellness, and disease prevention programs for the community. Topic is appropriate to the needs of the target audience Objectives are matched to the learning needs of the target audience Content development matches objectives Instruction is matched to the audiences level of health literacy Suggested assessment activity: Review of a resident-designed disease prevention and wellness promotion program IO Explain the prevalent health improvement educational needs of patients. IO Explain the prevalent wellness educational needs of patients. IO Explain the prevalent disease prevention educational needs of patients. OBJ E1.1.3: (Application) Use skill in the delivery of health improvement, wellness, and disease prevention programs for the community. Delivery reflects choice of appropriate educational methods Secures audience attention at the beginning Style of the speech is matched to its intent (persuasion, information giving, entertainment) Relates remarks to those of previous speakers (if appropriate) Portrays credibility Does not distract with physical mannerisms Does not distract with verbal habits Speech is well organized Uses appropriate transitions when proceeding from one topic to another Summarizes key points at the close Uses phrases, facts, or stories to increase audience interest Paints mental images or pictures to increase audience understanding Uses humor appropriately Appears poised Uses body language to add interest Pauses appropriately to emphasize points Displays energy and enthusiasm Accurately reads the audiences body language and adjusts the speech accordingly Answers questions with ease and confidence Suggested assessment activity: Review of a resident-delivered disease prevention and wellness promotion program Goal E1.2: Design and deliver intervention programs (e.g. immunizations, health screenings, etc.) to the community that center on health improvement, wellness, and disease prevention. OBJ E1.2.1: (Synthesis) Use effective educational techniques in the design of community intervention programs that center on health improvement, wellness, and disease prevention. Topic is appropriate to the needs of the target audience Objectives are matched to the learning needs of the target audience Content development matches objectives Instruction is matched to the audiences level of health literacy Appropriate educational materials are provided Collaborates with other healthcare providers as appropriate Appropriate venue is selected, if appropriate Suggested assessment activity: Review of a resident-designed intervention programs that center on health improvement, wellness, and disease prevention IO Explain the need for primary prevention programs (e.g., immunizations, weight loss, etc.). IO Explain the need for secondary prevention programs (e.g., screening for diabetes, dyslipidemia, osteoporosis, etc.). IO Explain the need for tertiary prevention programs (e.g., aspirin for post-MI patients, foot checks for diabetics, etc.). OBJ E1.2.2: (Synthesis) Exercise skill in the delivery of various health improvement, wellness, and disease prevention activities (e.g., immunizations, cholesterol or diabetes screening). Follows applicable legal and regulatory requirements Follows organizations policies and procedures Uses skill in necessary technique(s) Appropriately documents activities Suggested assessment activity: Direct observation of resident providing health improvement, wellness, and/or disease prevention activities IO Explain how to implement primary prevention programs (e.g., immunizations, weight loss, etc.). IO Explain how to implement secondary prevention programs (e.g., screening for diabetes, dyslipidemia, osteoporosis, etc.) IO Explain how to implement tertiary prevention programs (e.g., aspirin for post-MI patients, foot checks for diabetics, etc.). IO Explain the various federal, state, and local regulations regarding the safe and effective use of screening tests using blood or other bodily fluids (e.g., CLIA, OSHAs Bloodborne Pathogen Standard, etc.). Outcome E2: Participate in the planning for and/or management of medical and public health emergencies. Goal E2.1: Participate in the planning and implementation of plans for medical emergencies. OBJ E2.1.1: (Comprehension) Explain the pharmacists role in the development of plans for medical emergencies at the organizational, local, state, and national levels. OBJ E2.1.2: (Synthesis) Participate in the development or revision of organizational plans for emergency preparedness. Resident contributions reflect understanding of essential needs in emergency situations Resident contributions reflect efficient deployment of resources in emergency situations Resident contributions reflect understanding of internal and external resources that would be available in emergency situations Suggested assessment activity: Direct observation of resident participation in organizational planning for emergencies or review of residents written document concerning organizational planning for emergencies IO Explain the essential components of an organizations plan for emergency preparedness. IO Explain who should be involved in the development of an organizations plan for emergency preparedness. OBJ E2.1.3: (Synthesis) Exercise skill in the delivery of staff training as specified in the organizations emergency preparedness plans. Utilizes appropriate public speaking skills Provides appropriate training materials Content is appropriate Suggested assessment activity: Direct observation of resident delivery of staff training as specified in the organizations emergency preparedness plans OBJ E2.1.4: (Synthesis) If needed, provide services and programs as specified in the organizations emergency preparedness plan. Outcome E3: Conduct pharmacy practice research. Goal E3.1: Design, execute, and report results of investigations of pharmacy practice-related issues. OBJ E3.1.1: (Analysis) Identify potential practice-related issues that need to be studied. Topic is relevant to pharmacy practice Topic is sufficiently focused to be manageable for study Suggested assessment activity: Review of residents written topic statement OBJ E3.1.2: (Application) Use a systematic procedure for performing a comprehensive literature search. Literature search is comprehensive Methods used to conduct search are efficient Methods used to conduct search are effective Suggested assessment activity: Review of resident literature search and resident explanation of search strategy employed OBJ E3.1.3: (Analysis) Draw appropriate conclusions based on a summary of a comprehensive literature search. Interpretation of the literature is correct Conclusion is applicable to the requesters question Suggested assessment activity: Review of written conclusions drawn by the resident from literature search OBJ E3.1.4: (Synthesis) Generate a research question(s) to be answered by an investigation. Investigation question(s) is/are appropriate for the hypothesis Suggested assessment activity: Review of residents written investigation questions OBJ E3.1.5: (Synthesis) Develop specific aims and design study methods that will answer the question(s) identified. Study methodology is appropriate Design is adequate to answer the questions Complexity of design is equal to executors expertise Design specifies the type of data to be collected Obtains appropriate approvals Suggested assessment activity: Review of residents written description of investigation methodology OBJ E3.1.6: (Analysis) Develop a realistic timeline and budget for completing the study. Study schedule identifies each step and accurately estimates the amount of time, personnel, and resources needed Budget for conducting the project is clearly articulated Investigation can be completed in the time allotted Suggested assessment activity: Review of residents written timeline and budget for completing the study OBJ E3.1.7: (Application) For a research study involving human subjects, successfully apply the process for securing IRB approval. Appropriate strategies designed and implemented for gaining cooperation of all individuals affected by conduct of the project If required, IRB approval secured Suggested assessment activity: Review of residents project implementation strategy and documentation of approvals/agreements IO Explain the ethics of research on human subjects and the role of the IRB. IO Explain the steps in the IRB approval process. OBJ E3.1.8: (Application) Use a systematic procedure to collect and analyze data. Study designs specifies a systematic procedure for data collection Data collected reflects adherence to procedure specified Suggested assessment activities: Review of residents written procedure for data collection; inspection of data collected for evidence of adherence to specified procedure OBJ E3.1.9: (Evaluation) Draw valid conclusions through evaluation of the data. Data analysis is accurate Data analysis is efficient Conclusions are based on the results Results of statistical analysis are accurately interpreted Suggested assessment activities: Review of residents written results; review of residents written conclusions OBJ E3.1.10: (Synthesis) Use effective communication skills to report orally and in writing, using accepted manuscript style, the results and recommendations of an investigation into a pharmacy practice-related issue. Report is effectively written Report is effectively delivered orally Suggested assessment activities: Review of residents final written report of investigation; direct observation of residents oral delivery of investigation Goal E3.2: Participate in clinical, humanistic and economic outcomes analyses. OBJ E3.2.1: (Evaluation) Contribute to a prospective clinical, humanistic and/or economic outcomes analysis. Perspective of the study is appropriate for the studys intended use Study design is appropriate for answering the research questions Data collection adheres to the plan specified in the study design Presentation of data analysis is clear and understandable Conclusions drawn are appropriate for the data collected and the analysis performed Suggested assessment activity: Review of a prospective outcomes study to which the resident contributed IO Explain the principles and methodology of basic pharmacoeconomic analyses. IO Explain the purpose of a prospective clinical, humanistic or economic outcomes analysis. IO Explain study designs appropriate for a prospective clinical, humanistic and economic outcomes analysis. IO Explain the technique and application of modeling. IO Explain the types of data that must be collected in a prospective clinical, humanistic and economic outcomes analysis. IO Explain possible reliable sources of data for a clinical, humanistic and economic outcomes analysis. IO Explain methods for analyzing data in a prospective clinical, humanistic and economic outcomes analysis. IO Explain how results of a prospective clinical, humanistic and economic outcomes analysis can be applied to internal business decisions and modifications to a customer's formulary or benefit design. OBJ E3.2.2: (Evaluation) Contribute to a retrospective clinical, humanistic, and/or economic outcomes analysis. Perspective of the study is appropriate for the studys intended use Study design is appropriate for answering the research questions Data collection adheres to the plan specified in the study design Presentation of data analysis is clear and understandable Conclusions drawn are appropriate for the data collected and the analysis performed Suggested assessment activity: Review of a retrospective outcomes study to which the resident contributed IO Explain the purpose of a retrospective clinical, humanistic or economic outcomes analysis. IO Explain study designs appropriate for a retrospective clinical, humanistic and economic outcomes analysis. IO Explain the types of data that must be collected in a retrospective clinical, humanistic and economic outcomes analysis. IO Explain the content and utilization of reports and audits produced by the pharmacy department. IO Explain possible reliable sources of data for a retrospective clinical, humanistic and economic outcomes analysis. IO Explain methods for analyzing data in a retrospective clinical, humanistic and economic outcomes analysis. IO Explain the impact of limitations of retrospective data on the interpretation of results. IO Explain how results of a retrospective clinical, humanistic and economic outcomes analysis can be applied to internal business decisions and modifications to a customer's formulary or benefit design. Outcome E4: Exercise additional leadership and practice management skills. Goal E4.1: Understand the pharmacy procurement system. OBJ E4.1.1: (Comprehension) Explain the processes and contractual relationships that form the structure of the pharmacys medication procurement process. Explanation includes an accurate description of the role of wholesalers and GPOs in the supply of medications Explanation includes an accurate description of the role of competitive contracting Explanation includes an accurate description of inventory management Explanation includes an accurate description of special procedures for unique drug entities (e.g., controlled substances, refrigerated medications) Explanation includes accurate description of issues surrounding the return or disposal of medications Suggested assessment activity: Resident discussion of processes and contractural relationships for structure the medication procurement process IO Explain the role of wholesalers and GPOs in the supply of medications. IO Explain the role of competitive contracting. IO Explain principles of inventory management. IO Explain special procedure for unique drug entities (e.g., controlled substances, refrigerated medications.) IO Explain issues surrounding the return or disposal of medications. Goal E4.2: Understand the use and management of investigational drug products (medications, devices, and biologicals). OBJ E4.2.1: (Comprehension) Explain the purposes of involving the community pharmacy in patient use of investigational drug products. OBJ E4.2.2: (Comprehension) Explain the principles of managing investigational drug products in the community pharmacy, including the use of protocols, regulatory requirements, and the pharmacys policies and procedures. Identifies the appropriate protocol Determines if a patient meets study criteria Confirms that an informed consent has been signed before proceeding Documents all necessary patient data Accurately follows policies and procedures for storing and dispensing Monitors the patient's progress according to the protocol Takes appropriate action toward rectifying any problem Accurately completes all documentation Suggested assessment activity: Direct observation of the residents management of the use of a specific investigational drug product Goal E4.3: Understand the principles of a systematic approach to staff development in pharmacy practice. OBJ E4.3.1: (Comprehension) Explain the steps in a systematic approach to staff development. OBJ E4.3.2: (Comprehension) Explain the importance of approaching staff development systematically. Goal E4.4: Resolve conflicts through negotiation. OBJ E4.4.1: (Application) Use effective negotiation skills to resolve conflicts. Negotiation focuses on intended conflict Negotiation includes consideration of the other person's position Negotiator separates feelings about the people or the situation from the problem Position is based on objective criteria Opinions are expressed positively and without making accusations Negotiator suggests options that lead to mutual gain Settlement is acceptable to both sides Suggested assessment activity: Direct observation of resident negotiating process occurring during the fulfillment of a specific practice responsibility IO Explain the principles of negotiation. Goal E4.5: Participate in the management of the organization's human resources. OBJ E4.5.1: (Synthesis) Contribute to the formulation of recruitment strategies for a specific position. Describes how to determine the duties of a specific position Discusses how to advertise for a new position, whether it is to be filled by an internal or external candidate Discusses factors to consider when determining the individual's qualifications for a position Discusses factors to consider when deciding to hire internally versus externally Describes the information to be included in an advertisement for a position Discusses the organizations policy regarding EEO/Affirmative Action Describes how to decide where to advertise and for how long Discusses the impact of the Americans with Disabilities Act on interviews Suggested assessment activity: Resident discussion of recruitment strategies for a specific position IO Explain how to determine the duties of a specific position. IO Explain differences in the advertising approach for a position to be filled internally versus externally. IO Explain factors to consider when determining the individual's qualifications for a position. IO Explain factors to consider when deciding to hire internally versus externally. IO State the information to be included in an advertisement for a position. IO Explain the organization's policy regarding equal employment opportunity and affirmative action. IO Explain the impact of the American Disabilities Act on interviews. OBJ E4.5.2: (Evaluation) Participate in the interview of candidates and recommend personnel for employment. Implements the organizations policies and procedures for screening and interviewing applicants Appropriately determines how many times to interview an applicant Incorporates knowledge of what should be discussed and not discussed in an interview Appropriately determines with whom candidates should interview Appropriately determines how many candidates to interview Follows an appropriate course of action when none of the candidates interviewed is acceptable Determines an appropriate number of references to require and checks references appropriately Prepares an appropriate "offer to hire" letter Suggested assessment activity: Direct observation of resident participation in the organizations process to interview and recommend personnel for a specific job opening IO State the organization's policies and procedures for screening and interviewing applicants. IO Explain considerations in determining how many times to interview an applicant. IO State what should be discussed and not discussed in an interview. IO Explain considerations in determining with whom candidates should interview. IO Explain considerations in determining how many candidates to interview. IO State actions to pursue when none of the candidates interviewed is acceptable. IO Explain considerations of how many references to require and how to check references. IO State information to be included in an "offer to hire" letter. OBJ E4.5.3: (Synthesis) Contribute to the orientation and training of practice area personnel. Applies an understanding of the purposes of orientation and training, and the roles of the organization and of the department in orientation and training Appropriately determines the subjects that should be covered in training for a specific position Appropriately determines length of training for a specific position Appropriately determines when a new employee is sufficiently trained for his/her position Applies an understanding of the organizations probationary period Follows organizations orientation materials when providing orientation/training Suggested assessment activity: Direct observation of resident participation in orientation and training for practice area personnel organization IO State the purposes of orientation and training. IO State the roles of the organization and of the department in orientation and training. IO State the subjects that should be covered in the department's orientation. IO State the subjects that should be covered in training for a specific position. IO Explain how to determine the length of training for a specific position. IO Explain an effective measure for determining that a new employee is sufficiently trained for his or her position. IO Explain the impact of the Family Medical Leave Act and union contract on human resources policy. IO Describe the organization's probationary period. OBJ E4.5.4: (Comprehension) Explain the components of an employee performance evaluation system. Describes the performance standards for a specific position Discusses effective methods for communicating performance standards and evaluation of performance to employees Describes effective ways to measure work against performance standards Discusses the role of subjective criteria in evaluating performance Suggested assessment activity: Resident discussion of the components of an employee performance evaluation system IO State the performance standards for a specific position. IO State effective methods for communicating performance standards and evaluation of performance to employees. IO Explain effective ways to measure work against objective and subjective performance standards. OBJ E4.5.5: (Comprehension) Explain the principles and application of a progressive discipline process. Describes the components of the progressive discipline process Describes the benefits of the progressive discipline process to the employer and the employee Suggested assessment activity: Resident discussion of the principles and application of a progressive discipline process IO Explain the components of the progressive discipline process. IO State the benefits of the progressive discipline process to the employer and the employee. Goal E4.6: Contribute to the pharmacy's approach to customer service. OBJ E4.6.1: (Application) Formulate accurate responses to patient inquiries. Asks appropriate questions to clarify inquiry Response is accurate and delivered in an appropriate and professional manner Response is delivered in an appropriate and professional manner Response reflects health care literacy of patient and/or caregivers Suggested assessment activity: Direct observation of residents response to a specific patient inquiry. OBJ E4.6.2: (Application) Provide accurate descriptions of the community pharmacy's services. OBJ E4.6.3: (Application) Apply appropriate organizational policies and procedures when responding to patient grievances. Collects information required by policies and procedures Determines appropriate type of response (verbal, written, etc.) Responds in a timely manner Responds in a professional manner Response follows organizations policies and procedures Determines if escalation or referral is required Suggested assessment activity: Direct observation of residents response to a specific patient grievance. IO Explain the importance of maintaining a customer-friendly demeanor when responding to patient complaints. OBJ E4.6.4: (Comprehension) Explain the key components for assuring patient satisfaction. NO SNAPSHOT IO Explain the role of patient surveys in determining levels of patient satisfaction. OBJ E4.6.5: (Synthesis) Formulate an effective patient satisfaction survey that secures the information desired. Identifies appropriate issue to investigate Chooses appropriate method of delivery Chooses appropriate survey instrument Develops appropriate questions Selects appropriate patient population Suggested assessment activity: Review of survey created by resident IO Explain the principles of survey instrument construction. OBJ E4.6.6: (Evaluation) Implement a patient satisfaction survey including the evaluation of data collected according to survey design plan. Implements the survey based on its design Collects data appropriately Analyzes data appropriately Draws appropriate conclusions Suggested assessment activity: Review of residents written report for a patient satisfaction survey IO Explain methodology for analyzing survey data. Goal E4.7: Balance obligations to oneself, relationships, and work in a way that minimizes stress. OBJ E4.7.1: (Synthesis) Devise an effective plan for minimizing stress while attending to personal needs, maintaining relationships, and meeting professional obligations. Sets realistic expectations for self when confronted by unrealistic expectations from others Behavior demonstrates use of stress management techniques research has proven to be effective Seeks counsel of others (e.g., mentor, preceptor, employee assistance programs) if needed Behavior reflects understanding of expectations placed on self Practices time for self on a routine basis Suggested assessment activity: Direct observation of juggling of practice and residency obligations and of activities and relationships in personal life during a designated time period IO Explain various approaches advocated for achieving balance in ones life. Goal E4.8: Participate in the community residency accreditation process. OBJ E4.8.1: (Comprehension) Explain the steps involved in establishing a pharmacy residency program at a particular site. Accurately identifies the resources required to establish a pharmacy residency program Accurately describes each of the steps in establishing a pharmacy residency program Accurately describes the residency accreditation process Suggested assessment activity: Resident discussion of how to establish a pharmacy residency program IO Explain the sources of published information to be used when establishing a residency program (i.e., accreditation regulations, accreditation standards, ASHP website, APhA website). OBJ E4.8.2: (Synthesis) Contribute to the organizations preparation and participation in the residency accreditation process. Contribution reflects consideration of residency accreditation process Written contributions are comprehensive and concise, and prepared in a professional manner Resident interacts professionally with surveyors as applicable Assigned tasks are completed in a timely manner Suggested assessment activity: Direct observation of residents contribution, to the organizations preparation and participation in the residency accreditation process or review of written work assigned to resident to contribute to the residency accreditation process. Goal E4.9: Maintain the appearance of a professional. OBJ E4.9.1: (Application) Dress in attire that conveys a professional image. . Stays clean and well-groomed Dresses to meet the expectations of other professionals and patients Dress meets health and safety requirements Dress conforms to the organizations dress code Suggested assessment activity: Cumulative direct observation of practice IO Explain guidelines for professional dress and its importance. IO Explain strategies for maintaining personal self-control and professional decorum. Outcome E5: Demonstrate knowledge and skills for successful community practice interface with the managed care or self-insured employer environment. Goal E5.1: Maintain confidentiality of patient and proprietary business information. OBJ E5.1.1: (Application) Observe legal and ethical guidelines for safeguarding the confidentiality of patient information. Handling of patient information follows ethical guidelines Handling of patient information follows legal guidelines Suggested assessment activity: Cumulative direct observation of resident handling of patient information IO Explain patient confidentiality issues related to data collection, transmission, and storage by pharmacy information systems and by electronic medical records. IO Explain situations unique to managed care that may raise the issue of confidentiality of patient information. OBJ E5.1.2: (Application) Observe the organizations and the managed care or self-insured employers policy for the safeguarding of proprietary business information. Demonstrates understanding of differences among policies of various managed care organizations and self-insured employers Maintains confidentiality of proprietary business information Suggested assessment activity: Cumulative direct observation of resident handling of proprietary business information IO Explain the concept of "proprietary business information" and its importance in the conduct of business activities. IO Explain the role of written policy and tacit knowledge in the development of normative procedure for the disclosure of business information. Goal E5.2: Understand the interrelationship of the pharmacy benefit management company, the health plan, and the delivery system functions of managed care. OBJ E5.2.1: (Comprehension) Explain the health plan functions of managed care, including benefit design and management, co-pay, formulary coverage, prior authorization, access, and contract negotiations (medication acquisition and/or network pharmacy). Accurately explains benefit design and management Accurately explains co-pay Accurately explains formulary coverage Accurately explains prior authorization Accurately explains access Accurately explains contract negotiations Suggested assessment activity: Resident discussion of health plan functions of managed care IO Explain the difference between pharmacy risk and capitation. OBJ E5.2.2: (Comprehension) Explain the effect that the health plan has on the delivery functions of managed care. Accurately explains how the health care plan affects delivery functions of managed care Suggested assessment activity: Resident discussion of health care plans and delivery functions OBJ E5.2.3: (Comprehension) Explain the interrelationship of the health plan and the delivery system functions of managed care. Accurately explains the interrelationship of the health plan and the delivery system functions of managed care Suggested assessment activity: Resident discussion of the interrelationship of the health care plan and delivery system functions of managed care Goal E5.3: Understand marketing strategies for establishing the pharmacy as the provider of evidence-based medication therapy management for plan patients. OBJ E5.3.1: (Comprehension) Explain unique aspects of the managed care environment that would affect the creation of a successful proposal and marketing strategy for provision of evidence-based medication therapy management for plan participants. NO SNAPSHOT IO Explain the appropriate audience in a managed care organization to whom to market a proposal for a medication therapy program and usual strategies for contacting these individuals. IO Explain the components of a proposal for a medication therapy program that would be suitable for submission to a managed care organization. IO For a specific managed care organization, explain the organizations credentialing requirements. OBJ E5.3.2: (Comprehension) Explain unique aspects of the self-insured employer environment that would affect the creation of a successful proposal and marketing strategy for provision of evidence-based medication therapy management for plan participants. NO SNAPSHOT IO Explain the appropriate audience in a self-insured employer organization to whom to market a proposal for a medication therapy program and usual strategies for contacting these individuals. IO Explain the components of a proposal for a medication therapy program that would be suitable for submission to a self-insured employer. IO For a specific self-insured employer, explain the organizations credentialing requirements. OBJ E5.3.3: (Comprehension) Explain the role of the human resources director/department in the decision-making process for health benefit design. NO SNAPSHOT OBJ E5.3.4: (Application) Accurately calculate the return on investment (ROI) for a specific medication therapy management plan proposal for a specific managed care or self-insured employer proposal. Calculation includes appropriate factors Calculation uses accurate, timely, and appropriate data ROI is calculated correctly Suggested assessment activity: Review of residents written ROI report OBJ E5.3.5: (Comprehension) Explain the contents of a response to a request for proposal (RFP). NO SNAPSHOT Outcome E6: Demonstrate skills required to function in an academic setting. Goal E6.1: Understand faculty roles and responsibilities. OBJ E6.1.1: (Comprehension) Explain variations in the expectations of different colleges of pharmacy for maintaining a balance between teaching, practice, research, and service. OBJ E6.1.2: (Comprehension) Explain faculty governance structures and how they influence decision making in the academic environment. OBJ E6.1.3: (Comprehension) Explain the roles and influence of various academic administrative positions. OBJ E6.1.4: (Comprehension) Explain steps in the promotion and tenure process. Goal E6.2: Exercise teaching skills essential to pharmacy school faculty. OBJ E6.2.1: (Synthesis) Participate in the creation of a course design that is in harmony with the college curriculum. OBJ E6.2.2: (Synthesis) Create an evaluation mechanism to measure learner achievement for one element of a course that reflects testing possibilities in the academic environment. OBJ E6.2.3: (Evaluation) Initiate the construction of a teaching/research portfolio suitable for use in applying for a faculty position. OBJ E6.2.4: (Application) Use skill in case-based teaching. Outcome E7: Create a community pharmacy drug information library. Goal E7.1: Identify a core library for use by community pharmacy patients that includes electronic media. OBJ E7.1.1: (Analysis) Use knowledge of standard resources to select a core library of medication-related information for use by the pharmacys patients. Identifies appropriate information for patient population based on common conditions Selects information based on the health literacy of the patient population Selects information based on the various ways patients learn Chooses appropriate variety/quantity of information Accurately reviews information for potential bias Suggested Assessment Activity: Review of residents selection of information Goal E7.2: Identify a core library for use by the pharmacys health professionals. OBJ E7.2.1: (Analysis) Use knowledge of standard resources to select a core library of primary, secondary, and tertiary references appropriate for use by the healthcare professionals in the community pharmacy. Selection covers the practice area drug information needs Selection is appropriately distributed among tertiary, secondary, and primary sources List reflects what can be reasonably acquired Suggested assessment activity: Review of the list of suggested core medical and drug information resources prepared by the resident for a specific practice setting Outcome E8: Participate in the organizations formulary management processes. Goal E8.1: Participate in the implementation and maintenance of formularies. OBJ E8.1.1: (Comprehension) Explain the process for developing, implementing, and maintaining a formulary system. Accurately identifies the components of a formulary system Accurately describes the approval process for establishing a formulary Accurately describes the role of committees in addressing formulary issues Accurately describes how formularies are revised and maintained Accurately describes the organizations procedures regarding exceptions to the formulary Accurately describes the organizations process for making additions and deletions to the formulary Accurately describes how pharmacoeconomic principles are used in the formulary decision process Accurately describes how the organization communicates formulary decisions to prescribers Suggested assessment activity: Resident discussion of the process for developing, implementing, and maintaining a formulary system in his or her organization IO Identify the components of a formulary system. IO Explain the approval process for establishing a formulary. IO Explain the role of committees in addressing formulary issues. IO Explain how formularies are revised and maintained. IO Explain procedures regarding exceptions to the formulary. IO Explain the process of making additions and deletions to the formulary including those resulting from drug shortages. IO Explain effective methods of communicating changes to the formulary including those resulting from drug shortages. OBJ E8.1.2: (Evaluation) Develop formulary recommendations based on analysis of the biomedical literature and practice standards. Recommendation is based on a thorough review of pertinent literature Recommendation reflects an appropriate analysis of the literature Recommendation is written in the appropriate format Recommendation is objective Suggested assessment activity: Review of residents written formulary recommendations for a specific formulary recommendation. OBJ E8.1.3: (Evaluation) Make recommendations for drug class decisions based on comparative reviews. Recommendation is based on a thorough review of pertinent literature Recommendation is presented in the appropriate format Recommendation is objective Suggested assessment activity: Direct observation of resident presenting a medication-use policy recommendation based on a comparative review IO State the elements of a comparative review. IO State sources to consult in the preparation of a comparative review. IO Explain the importance of including consideration of medication-use safety in the preparation of a comparative review. OBJ E6.1.4: (Synthesis) Participate in the implementation of the organization's formulary. OBJ E6.1.5: (Analysis) Contribute to the customization of a formulary so that it meets the needs of a particular organization. Contribution reflects needs of different patient populations Contribution reflects needs of different practice settings Recommendation(s) is/are appropriate Suggested Assessment activity: Review of residents contributions to the customization of a formulary Outcome E9: Demonstrate knowledge and skills particular to generalist practice in the home care practice environment. Goal E9.1: Understand the scope of services that might be provided in a typical home care practice. OBJ E9.1.1: (Comprehension) Compare and contrast the scope of services that might be provided by a typical home care practice for a variety of health systems or stand-alone organizations. Explanation of scope of services is comprehensive Explanation of nature of services is accurate Suggested assessment activity: Discussion by resident of scope of home care services OBJ E9.1.2: (Comprehension) Explain the relationship between the scope of services offered by a home care practice and the applicable legal, regulatory, and accreditation issues. Explanation accurately identifies the scope of regulatory, legal, and accreditation issues affecting home care services Accurately identifies how each of these issues affects the availability and delivery of home care services Suggested assessment activity: Discussion by resident of legal, regulatory, and accreditation issues applicable to home care services Goal E9.2: Determine the suitability of individual patients for home care. OBJ E9.2.1: (Analysis) Collect and organize all patient-specific information needed by the home care pharmacist to determine the suitability of individual patients for home care. Accurately identifies the patient information needed Collects needed information Organizes information appropriately Suggested assessment activity: Audit of residents information base for a specific patient or organizationspatient information base IO Identify the types of information the home care pharmacist requires to determine the suitability of individual patients for home care. OBJ E9.2.2: (Evaluation) Assess patients suitability for home care. All patients who are suitable for home care are selected All patients who are not suitable for home care are not selected Suggested assessment activity: Audit of residents selection of patients as suitable for home care and of those not designated as suitable IO Explain criteria for acceptance into home care. IO Explain factors to consider when determining the ability and willingness of a patient or caregiver to fulfill the tasks of home care. IO Explain factors to consider when evaluating a potential home care patients psychosocial and family support. Goal E9.3: Understand unique aspects of providing evidence-based, patient-centered medication therapy management with interdisciplinary teams in the home care environment. OBJ E9.3.1 (Comprehension) Explain aspects of providing medication therapy management that are unique in the home care environment. Explanation accurately describes the rights and responsibilities of a home care patient. Explains effective strategies for getting information from unwilling or inaccessible participants. Explains concerns with compliance, cost, route of administration, and vascular access and medication devices when making decisions on medication regimens for home care patients. Explains how to determine whether the first dose of medication should be administered at home or in a controlled-care setting. States customary monitoring parameters for the effects of the use of access and administration devices. Explains strategies for communicating with other members on the interdisciplinary team about the home care patient. Suggested assessment activity: Discussion by resident of unique aspects of providing medication therapy management to home care patients IO Explain the rights and responsibilities of a home care patient. IO Explain strategies for getting information from unwilling or inaccessible participants. IO Explain additional concerns with compliance, cost, route of administration, and vascular access and medication devices when making decisions on medication regimens for home care patients. IO Explain how to determine whether the first dose of medication should be administered at home or in a controlled-care setting. IO State customary monitoring parameters for the effects of the use of access and administration devices. Goal E9.4: Understand unique aspects of preparing and dispensing medications for home care patients. OBJ E9.4.1 (Comprehension) Explain aspects of preparing and dispensing medication that are unique in the home care environment. Explains an effective method for selecting appropriate supplies for the patients method of administration, access device and medication. Explains appropriate technique for care of a catheter and a catheter site. Explains procedures for administering medications used in the home care environment. Explains procedures for managing complications resulting from the administration of medications. Explains various alternative delivery methods for getting supplies and medications to the home of a home care patient. Suggested assessment activity: Discussion by resident of unique aspects of preparing and dispensing medication in the home care environment IO Select appropriate supplies for the patients method of administration, access device and medication. IO Explain appropriate technique for care of a catheter and a catheter site. IO Explain procedures for administering medications used in the home care environment. IO Explain procedures for managing complications resulting from the administration of medications. IO Use knowledge of alternative delivery methods to determine the best way to get supplies and medications to the patients home. Goal E9.5: Understand unique aspects of participating in the management of medical emergencies occurring in the home care environment. OBJ E5.5.1 (Comprehension) Explain aspects of the management of medical emergencies that are unique in the home care environment. Explains what constitutes a medical emergency in the home care setting. Explains differences in strategy that must be used in the management of a medical emergency that occurs in the home. Suggested assessment activity: Discussion by resident of unique aspects of the management of a medical emergency occurring in the home care environment IO Explain what constitutes a medical emergency in the home care setting. Goal E9.6: Manage the use, maintenance, and troubleshooting of medication administration equipment and medicationrelated equipment used in the management of home care patients. OBJ E9.6.1: (Synthesis) Solve operational problems related to the use and maintenance of medication administration equipment and medicationrelated equipment used in the management of home care patients. Resident appropriately identifies the problem if necessary Resident resolves problems efficiently and effectively Resident successfully performs maintenance functions Suggested assessment activity: Direct observation of resident solving operational difficulties and performing maintenance of medication administration equipment and medication-related equipment; repeated for different types of equipment IO Explain proper maintenance procedures for medication administration equipment and medicationrelated equipment used in the management of home care patients. IO Devise effective troubleshooting strategies for medication administration equipment and medicationrelated equipment that is not working properly. IO Skillfully operate medication administration equipment and medicationrelated equipment used in the home. OBJ E9.6.2: (Analysis) Participate in the development of criteria for selection of medication administration and medicationrelated equipment. Resident contributions reflect an understanding of the equipments capabilities and the specific needs of home care patients Suggested assessment activity: Direct observation of resident participation in working sessions in which the purpose is to develop criteria for selection of medication administration and medication-related equipment Goal E9.7: Understand the appropriate relationship between the home care pharmacist and home care suppliers. OBJ E9.7.1: (Comprehension) Explain the role of the home care pharmacist in establishing policies for working with the pharmaceutical industry. Evidences understanding of the organization's policies for working with the pharmaceutical industry Articulates the importance of establishing policies and procedures for working with the pharmaceutical industry Accurately describes the principles put forth in the ASHP Guideline on Pharmacists Relationships with Industry Describes an appropriate working relationship with the pharmaceutical industry, including ethical considerations Suggested assessment activity: Resident discussion of the role of the home care pharmacist in establishing policies for working with the pharmaceutical industry IO State the home care practice's policies for working with the pharmaceutical industry. IO Explain the importance of establishing policies and procedures for working with the pharmaceutical industry. IO Explain an appropriate working relationship with the pharmaceutical industry including ethical considerations. OBJ E9.7.2: (Comprehension) Explain the role of the home care pharmacist in establishing policies for working with the manufacturers of medication-use related equipment and supplies used in home care. Evidences understanding of the organizations policies for working with manufacturers of medication-use related equipment and supplies used in home care Articulates the importance of establishing policies and procedures for working with the pharmaceutical-related equipment and supplies manufacturers Accurately describes the principles put forth in the ASHP Guideline on Pharmacists Relationships with Industry Describes an appropriate working relationship with the suppliers of medication-use-related equipment and supplies used in home care including ethical considerations Suggested assessment activity: Resident discussion of the role of the home care pharmacist in establishing policies for working with the manufacturers of medication-use-related equipment and supplies used in home care IO State the home care practice's policies for working with manufacturers of medication-use related equipment and supplies used in home care. IO Explain the importance of establishing policies and procedures for working with manufacturers of medication-use related equipment and supplies used in home care. IO Explain an appropriate working relationship with manufacturers of medication-use related equipment and supplies used in home care, including ethical considerations. Goal E5.9: Appreciate the complexity of the financial environment of home care practice. OBJ E9.8.1: (Comprehension) Explain various factors that affect the financial environment of home care practice. Accurately describes how various factors affect financing home care services Suggested assessment activity: Resident discussion of factors affecting the home care financial environment OBJ E9.8.2: (Comprehension)Explain the different types of payers in home care and the effect of that mix on the finances of the home care practice. Accurately identifies payers for home care services Accurately describes how having a mix of payers affects the finances of home care Suggested assessment activity: Resident discussion of home care payers and their effect on home care service financing OBJ E9.8.3: (Comprehension) Explain the ethical and pharmaceutical issues involved in providing home care to patients with little or no insurance coverage. Explain potential ethical dilemmas that may arise when a home care patient has little or no insurance Accurately identify pharmaceutical issues for patients with little or no insurance Suggested assessment activity: Resident discussion of ethical and pharmaceutical issues arising when patients have little or no insurance OBJ E9.8.4: (Comprehension) Explain the effect of patient mix (therapy type) on profitability. Accurately explains how the mix of home care patients receiving different types of therapy affects profitability Suggested assessment activity: Resident discussion of home care patient mix and profitability OBJ E9.8.5: (Knowledge) Identify resources for financial and reimbursement advice when working in the home care environment. List of resources is complete List of resources is accurate Suggested assessment activity: Resident statement of resources for financial and reimbursement advice for home care pharmacy Goal E9.9: Conduct ethical informational and marketing visits to payers, potential referral sources, and patients of the home care organization. OBJ E9.9.1: (Synthesis) Formulate effective strategies for conducting ethical informational and marketing visits to payers, potential referral sources, and patients of the home care organization. Strategy developed observes applicable home care business ethics Implementation of strategy is effective in achieving desired ends Suggested assessment activity: Review of residents strategy for a specific informational and marketing visit to a payer, potential referral sources, or patient of the home care organization IO Explain ethical issues involved in providing information about and marketing of home care services. OBJ E9.9.2: (Application) Use effective presentation techniques to conduct ethical informational or marketing visits to payers, potential referral sources, and patients of the home care organization. Presentation is well-organized Presentation style is suited to the audience Presentation manner is professional Suggested assessment activity: Direct observation of resident conducting and informational and marketing visit to a payer, potential referral source, or patient of the home care organization Endorsed by the ASHP Board of Directors September 22, 2006 and supported by the APhA Board of Trustees September 15, 2006. Developed by the ASHP Commission on Credentialing and an APhA advisory panel comprised of the following community pharmacy practitioners, residency program directors, and APhA and ASHP staff: Marialice S. Bennett, R.Ph., Professor of Clinical Pharmacy, The Ohio State University; Jeffery A. Goad, Pharm.D., MPH, Associate Professor of Clinical Pharmacy, University of Southern California; Pamala S.Marquess, Pharm.D., Owner East Marietta Drugs; Matthew C. Osterhaus, R.Ph., FASCP, Owner Osterhaus Pharmacy; James A. Owen, R.Ph., Director, Clinical Services and Professional Development, Happy Harrys Inc.; Sarah C. Ray, Pharm.D., BCPS, Ambulatory Clinical Coordinator, Aurora Health Care; Kushal B. Shah, Pharm.D., Community Pharmacy Practice Resident, Virginia Commonwealth University and Buford Road Pharmacy; APhA Group Director, Practice Development and Research, Anne L. Burns, R.Ph.; ASHP Accreditation Services Division Operations Director, Bruce A. Nelson, R.Ph., M.S., and ASHP Accreditation Services Division Standards Development and Training Manager, Christine M. Nimmo, Ph.D. This document replaces the goals and objectives associated with the previous Accreditation Standard for Pharmacy Practice (with emphasis in Community Care) approved by the ASHP Board of Directors April 21, 1999 and approved by the APhA Board of Trustees May 20, 1999. The contribution of reviewers is gratefully acknowledged. Copyright 2006, American Society of Health-System Pharmacists, Inc. All rights reserved. The effective date for implementation of these educational outcomes, goals and objectives is commencing with the entering resident class of July 2007. Glossary Adverse drug event (ADE) -- an injury from a medicine (or lack of an intended medicine). (ASHP. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. AJHP, 1998; 55:165-6.) Collaborative practice agreements In collaborative drug therapy management, pharmacists enter agreements with physicians and other prescribers that may authorize pharmacists, for patients who have a confirmed diagnosis, to select appropriate medication therapies and regimens and adjust them on the basis of patients responses. (American Society of Health-System Pharmacists. ASHP statement on the pharmacists role in primary care. Am J Health-Syst Pharm. 1999; 56:1665-7.) Culture -- an integrated system of learned behavior patterns that are characteristic of the members of any particular group. It is more than race or ethnicity. Culture includes race or customs, rituals, food, religion, and music; and, in addition, it includes health beliefs and practices, death and birth rituals, structure, and dynamics, social practices and beliefs that define personal space, eye contact, time orientation, and nonverbal communication behaviors. (Randall-David E. Culturally competent HIV counseling and education. Material & Child Health Clearinghouse: McLean, VA: 1994) Cultural competency -- is more than cultural awareness or cultural sensitivity, competency implies skills and expertise to work with and within diverse cultural groups with sensitivity and effectiveness. In its most developed meaning cultural competence includes advocacy. (Randall-David E. Culturally competent HIV counseling and education. Material & Child Health Clearinghouse: McLean, VA: 1994) Disease state management Disease management is a system of coordinated health care interventions and communications for populations with conditions in which patient self-care efforts are significant. Disease management: Supports the physician or practitioner/patient relationship and plan of care; Emphasizes prevention of exacerbations and complications utilizing evidence-based practice guidelines and patient empowerment strategies; and Evaluates clinical, humanistic, and economic outcomes on an on-going basis with the goal of improving overall health. Disease management components include: * Population identification processes; Evidence-based practice guidelines; Collaborative practice models to include physician and support-service providers; Patient self-management education (may include primary prevention, behavior modification programs, and compliance/surveillance); Process and outcomes measurement, evaluation, and management; Routine reporting/feedback loop (may include communication with patient, physician, health plan and ancillary providers, and practice profiling). *Note: Full-service disease management programs must include all six components. Programs consisting of fewer components are disease management support services. (Disease Management Association of America. DMAA definition of disease management Accessed at  HYPERLINK "http://www.dmaa.org/definition.html" http://www.dmaa.org/definition.html 2006 August 14. Evidence-based medicine -- the integration of best research evidence, clinical expertise, and patient values in making decisions about the care of individual patients (Institute of medicine, 2001; Straus and Sackett, 1998). Best research evidence includes evidence that can be quantified, such as that from randomized controlled trials, laboratory experiments, clinical trials, epidemiological research, and outcomes research and evidence derived from the practice knowledge of experts, including inductive reasoning (Guyatt et al., Higgs et al., 2001). Clinical expertise is derived from the knowledge and experience developed over time from practice, including inductive reasoning. Patient values and circumstances are the unique preferences, concerns, expectations, financial resources, and social supports that are brought by each patient to a clinical encounter. (Institute of Medicine. Health professions education: a bridge to quality. Washington, DC: The National Academies Press; 2001.) Home care -- Home care is the provision of specialized, complex pharmaceutical products and clinical assessment and monitoring to patients in their homes. This generally includes home infusion therapy and other injectable drug therapy and parenteral and enteral nutrition therapy. Specific pharmacist education and training, drug product admixtures and administration techniques, equipment operation and maintenance, and patient monitoring are required to ensure successful outcomes. (American Society of Health-System Pharmacists. ASHP guidelines on the pharmacists role in home care. Am J Health-Syst Pharm. 2000; 57:1252-7. Interdisciplinary team -- a team composed of members from different professions and occupations with varied and specialized knowledge, skills, and methods. The team members integrate their observations, bodies of expertise, and spheres of decision making to coordinate, collaborate, and communicate with one another in order to optimize care for a patient or group of patients. (Institute of Medicine. Health professions education: a bridge to quality. Washington, DC: The National Academies Press; 2001.) Leadership -- leadership practices include scanning, focusing, aligning/mobilizing, and inspiring. Scanning: Identify client and stakeholder needs and priorities. Recognize trends, opportunities, and risks. Look for best practices. Identify staff capacities and constraints. Know yourself, your staff, and your organization values, strengths, and weaknesses. Focusing: Articulate the organizations mission and strategy. Identify critical challenges. Link goals with the overall organizational strategy. Determine key priorities for action. Create a common picture of desired results. Aligning/Mobilizing: Ensure congruence of values, mission, strategy, structure, systems and daily actions. Facilitate teamwork. Unite key stakeholders around an inspiring vision. Link goals with rewards and recognition. Enlist stakeholders to commit resources. Inspiring: Match deeds to words. Demonstrate honest in interactions. Show trust and confidence in staff, acknowledge the contributions of others. Provide staff with challenges, feedback and support. Be a model of creativity, innovation, and learning. (Management and Leadership Program. Leading and managing framework. Management Sciences for Health, Ballston, VA. 2004.) Management -- management practices include planning, organizing, implementing, and monitoring and evaluating. Planning: Set short-term organizational goals and performance objectives. Develop multi-year and annual plans. Allocate adequate resources (money, people, and materials). Anticipate and reduce risks. Organizing: Ensure a structure that provides accountability and delineates authority. Ensure that systems for human resource management, finance, logistics, quality assurance, operations, information, and marketing effectively support the plan. Strengthen work processes to implement the plan. Align staff capacities with planned activities. Implementing: Integrate systems and coordinate work flow. Balance competing demands. Routinely use data for decision making. Coordinate activities with programs and sectors. Adjust plans and resources as circumstances change. Monitoring and Evaluating: Monitor and reflect on progress against plans. Provide feedback. Identify needed changes. Improve work processes, procedures, and tools. (Management and Leadership Program. Leading and managing framework. Management Sciences for Health, Ballston, VA. 2004.) Medical informatics -- the development and application of information technology systems to problems in health care, research, and education. (Institute of Medicine. Health professions education: a bridge to quality. Washington, DC: The National Academies Press; 2001.) Medication: For the purposes of this document this term may refer to prescription medications, non-prescription (over-the-counter) medications, and herbal and/or other dietary supplements. Medication-use system - medication use is a complex process that comprises the sub-processes of medication prescribing, order processing, dispensing, administration, and effects monitoring. The key elements that most often affect the medication use processare., patient information; drug information, communication of drug information; drug labeling, packaging and nomenclature; drug storage, stock and standardization; drug device acquisition, use and monitoring; environmental factors; competency and staff education; patient education; and quality processes and risk management. (Institute of Safe Medication Practices web site accessed May 31, 2005 http://www.ismp.org/Pages/ismp_faq.html#Question%207.) Patient-centered care -- identify, respect, and care about patients differences, values, preferences, and expressed needs; relieve pain and suffering; coordinate continuous care; listen to, clearly inform, communicate with, and educate patients; share decision making and management; and continuously advocate disease prevention, wellness, and promotion of healthy lifestyles, including a focus on population health. (Institute of Medicine. Health professions education: a bridge to quality. Washington, DC: The National Academies Press; 2001.) Pharmacy practice research includes all forms of scholarly scientific inquiry that may be performed by pharmacy residents. Broad in scope, it may include prospective or retrospective clinical studies, pharmacokinetic or pharmacodynamic studies, outcome studies, or evaluation of some aspect of pharmacy practice (e.g., impact of a new program or service). Typically, research projects should be applied in nature, using human data, but exceptions may occur. Professional -- the active demonstration of the 10 traits of a professional. Knowledge and skills of a profession. Commitment to self-improvement of skills and knowledge. Service orientation. Pride in the profession. Covenantal relationship with the client. Creativity and innovation. Conscience and trustworthiness. Accountability for his/her work. Ethically sound decision making. Leadership. (Ten marks of a professional working smart. New York, NY: National Institute of Business Management, March 11, 1991;17[5].). Quality -- the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge. (Institute of Medicine. Health professions education: a bridge to quality. Washington, DC: The National Academies Press; 2001.) Quality improvement -- identify errors and hazards in care; understand and implement basic safety design principles, such as standardization and simplification; continually understand and measure quality of care in terms of structure, process, and outcomes in relation to patient and community needs; and design and test interventions to change processes and systems of care, with the objective of improving quality. (Institute of Medicine. Health professions education: a bridge to quality. Washington, DC: The National Academies Press; 2001.)  Nimmo, CM. Developing training materials and programs: creating educational objectives and assessing their attainment. In: Nimmo CM, Guerrero R, Greene SA, Taylor JT, eds. Staff development for pharmacy practice. Bethesda, MD: ASHP; 2000.     PAGE  PAGE 72 012356git h <  | xqdq]V hq;hA hq;hxCjhq;hl!b0JU hq;hl!bhq;hfQ6 hq;h]ohq;h]o5hq;h+5 hq;hdh}3hf65h}3h]o5h}3hm5h}3hd5hq;hH5jmhq;h#Uj HH hq;h#UVjF hq;h#UV hq;h#jhq;h#U!56 < =  ytjjaaaa gd]o @&gdgddhkd*$$Ifl,"" t0644 layt}3$ $Ifa$gd}3 gddgd#   #$%&fgb 8^8`gd+ 0@&^`0gd+ `^``gd+0@&^`0gd+ gdd gd]o #$:BC&Cfb {m{f hq;h$hq;h$B*\]phhq;h+B*\]phhq;h+6B*\]phhq;h+6B*phhq;h+B*phhq;h+6 hq;h+ hq;hdhq;hd56>*hq;hd5>*hq;hd>* hq;h37 hq;h]o hq;hA hq;hxC$b eX 0^`0gdpnhkd+$$Ifl,"" t0644 layt}3 $$@&Ifa$gd}3@&gd+ 7$8$@&H$gd+87$8$@&H$^8`gd+ 5>fgijk~wx>z%&k|}ͿͿ͸ͬ~~wwpipipiw hq;hA hq;h> hq;hl7hq;hpn6hqhL56CJ]aJ hL6 hSh8rhL hIhLhL56CJ]aJ hq;h hq;hm hq;hi hq;hpnhq;hl756hq;h+w56 hq;h$h}3h&v5h}3h$5)_DrBxz= G08p0^p`0gdq 0^`0gdi^gdL & F gd8r & F gdL G08^gdq 0^`0gdpn `^``gdpn0@&^`0gd=nNO\/b & F `gdL & F 8gdL^gd_s 0^`0gdl7 `^``gdl7 p0^p`0gdA G0pp0^p`0gdpn G08p0^p`0gdpnNO!!!!!!!"$7%n%v%w%x%y%z%%%%%%(&F&T&U&m&o&''(((e)))Ϩxphq;hQ6hq;hl76B*ph hq;h\> hq;h hq;h)O hq;h1 hq;hihq;hl76hq;h6hq;hA6h_shL56CJ]aJ hL6hLhL56CJ]aJ hq;hx hq;h> hq;hm hq;hl7*b2 !!!!":"b"tgg 8h^8`hgdl7 $ |^$ `|gdA ^`gd_s^gd_s `@^gdL & F `gdLM & F `EƀvRFgdL b"@##7$$7%o%m&n&o&&M'''''<((=) @ 0^@ `0gdl7 `@^gdL & FgdL p0^p`0gd_s 0^`0gdl7^gd1 p0^p`0gdA p0^p`0gdl7=))u***H+++c,,----'.. `@^gdL & FgdL^gd_s 0^`0gdl7 `8p0^p`0gd1 `8\ ^\ `gdl7 `8^gdl7 p0^p`0gd1 @ 0^@ `0gdl7)s*t*u****b,c,,,,,,,,,%-3-4---'....a/b//1122222޹޲rjbj޲Z޲hq;hQr6hq;h+6hq;h m6h_shL56CJ]aJ hL6hLhL56CJ]aJ hq;hQ hq;hm hq;h1 hq;hi hq;hl7hq;hQ6hq;hl76B*phhq;hx6hq;h@~6hq;hl76hq;h16B*phhq;hl76B*ph#...%/Z//Y00{1123t 0^`0gdl7Np0Eƀ&^p`0gd p0^p`0gdl7 p0^p`0gd m p0^p`0gd_s^gd_s 22222333\44U6(7*7+7-7.77788888-8C8D8X8Y8l8m8{8|899b9c999a;i;j;k;l;m;;y hq;h$ hq;hihq;h7P6hq;h{c6hq;h$6hq;hl76hyhy6CJ]aJhy6CJ]aJhyhL56CJ]aJ hL6hLhL56CJ]aJ hq;hq( hq;hm hq;h+ hq;hl7,33345P5x555U6(7)7*7+7\7789c9 `8p0^p`0gdl7 `8gdy `@^gdL & F `d1$gdL & F `gdL & FgdL `8^gdyc99z::b;3<4<5<<<9===>>>>>e? p0^p`0gdy `@^gdL & F `gdL & FgdL^gdy 0^`0gd p0^p`0gdl7 `8p0^p`0gdl7;;;3<5<X<<<=>>>d?m?n????????o@p@q@r@BBBBBBBBBBBCگ돋|un hq;h hq;h4? hq;hPh?KhPh4?hq;hJ :hJ : hq;hm hq;hihq;hl76&hyhL56B*CJ]aJph hL6hL hyh8r hyhL hL56B*CJ]aJph hq;hl7 hq;h hq;h@~%e??q@r@s@@A4AqAAABBBCKC 7$8$H$^gdy 0^`0gd?K & F gd?K 0^`0gdl7N`Eƀ&^``gd CCCCCCDLDMDNDDDYE+F,FPF[FgFFFFFF G6Gпxg_WO_H_@_O_hq;hKW6 hq;hl7hq;h_6hq;h@~6hq;hl76 hy56B*CJ]aJph&hyhy56B*CJ]aJphh45B*CJaJph&h4hKihKi5B*CJaJph h4h45B*CJaJph h4hKi5B*CJaJph h4hy5B*CJaJphhO l5B*CJaJph hyhy5B*CJaJphKCCNDDD&EYE,FFGGG$HHI|I J_J p0^p`0gd7P p0^p`0gd)O p0^p`0gdl7 G088^8gdl7 G08p0^p`0gdl7^gdy 7$8$H$^gdy6GBG{GG$H>HAHBHIHJHUHzHHHHHHHHHHHIIIIII J J]J_JJJJJJJKK K9K:KUKظ袛蔍u hyhy5B*CJaJph hq;h_ hq;h hq;h@~ hq;hm hq;h4? hq;hihq;h7P6hq;hKW6hq;h)O6hq;h?6hq;hx6hq;h$6hq;h@~6 hq;hl7hq;hl76hq;h_6+_JJ:K{KKKL)LLM~MNzm` p0^p`0gd_ p0^p`0gdy^gdy & F-7$8$H$gdKi 7$8$H$^gdyN0Eƀ&^`0gd  G08p0^p`0gd_ UKaKL)LGLXLLMMNaNgOhOoOpOqOrOsOOO0P2PiPkPPPXQ{Q|Q~QἴxgxgVgxgHgxhR5B*CJaJph hyh;5B*CJaJph hqhq5B*CJaJph h_sh;5B*CJaJph hq;hm hq;hKW hq;hi hq;hl7 hq;hJ :hq;hR6hq;h_6&hyhy56B*CJ]aJph h4hKi5B*CJaJph hyhy5B*CJaJphhO l5B*CJaJphNOhOO0PiPP|QQRSSS TTT UEU & FgdIX 0^`0gdq^gdq & F.7$8$H$gdKi 7$8$H$^gdq 0^`0gdl7 p0^p`0gdJ : G08p0^p`0gd_~QQQQRRRRRSS TTTTTTTU±~mYRKRD=6= h4hKi h4hV h4hIX h4hIT h4hq&h4hq56B*CJ]aJph h4hKi5B*CJaJph h4hD.5B*CJaJph h4hq5B*CJaJph h4h;5B*CJaJph hqhO l5B*CJaJphhO l5B*CJaJph h_shO l5B*CJaJphhq5B*CJaJph hqhq5B*CJaJphEUUUWVXVVV\W6X7XXXXX#Yzzzz `8`$If^``gd}3 `8d$If^d`gd}3$ `8`$If^``a$gd}3^gdX |^`|gdXgdl7^gdIX gdD. & FgdD. & FgdIXUWVXVVVVW W W.W2W:WYWZW[W\WWWWWXX*X+X2X3X5X7X>XvXXXXXX¸¸®~~wpipbX jh}3hr%4 hq;hk5 hq;h hq;h hq;h"60 hq;h? hq;hX hq;h$ hq;hKW hq;hmhq;hm5B*phhq;h]o56hq;h56hq;hk556hq;hII56hq;hV56hq;hl756 hq;hVhVhD. h4hD."XXXXXXXXX Y"Y#Y&Y'Y(Y)Y/Y6YFY]YaYbYcYiYYYYYYYYYYYYYYYZ+Z3ZEZHZIZJZKZRZZZZZZZZZZZZZZZZ [ [[[[[ hq;hVhq;hm5B*ph hq;h7L hq;hr%4 hq;hX jh}3hmh}3hm6B*ph hq;h]o hq;hm hq;hC#Y)Y]YcYYYYYYYEZKZZZZZ[[ $Ifgd/W `8$If^`gd}3 G0`8$Ifgd}3 `8$Ifgd}3 `8`$If^``gd}3[[[[\\\\n]]Z^[^xxpppppx & Fgd[5O 0^`0gdII `^``gdVgdmhkd+$$Iflh ! t0644 layt}3 [`[e[[[[[\\\]]Z^^^b_n_i`k````aaa2aSaaaaaaaZbmbubbb cccccû仳䞓zsszzzz h#I|h*u h#I|h h#I|hD.hV[56B*phhII56B*phhq;hII56B*ph hq;hmhq;h7L6hq;hII6 hq;h[5Oh1 h[5Oh[5Oh[5OhII hq;hm hq;hII hq;h hq;hk5 hq;hV+[^^^N__`k``aaa bZbb cccc!d"dd 0^`0gd"9^gdV[ & Fgd & Fgd*u & FgdV[ 0^`0gdII p0^p`0gdII^gd[5Occdd!d"d+d,d-ddddddddLeNeeegfif'gggg]h^hȺ}lX}G hO;56B*CJ]aJph&hO;h]56B*CJ]aJph h]56B*CJ]aJph&hO;hO;56B*CJ]aJph hO;hO;5B*CJaJph hyhO;5B*CJaJph hq;h"9 hq;hU w hq;hdU hq;h7L hq;hm hq;hII hq;h ShV[ h#I|hKi h#I|h1h#I|h156dLeegf'g^hhfij[j"kk`l mmmznn_oop 8p0^p`0gd"9 ^`gd"9 @ 0^@ `0gdH @ 0^@ `0gd"9 8^gdO; 7$8$H$^gdO;^hhhhhhh-iMieifiiiiiiiiijjkkk_l`lVmpmtmmmmmmJncngnunnnnn/oIoMo\oooooApDpQp^pbppppppppqqq?q@qغ hq;h hq;hsb hq;hU w hq;hHhq;hH6hq;hL]6 hq;h"9hq;hdU6hq;hK6hq;h7L6hq;h"96Apupp@qq#rtrrMsss+tt6uuv5w p0^p`0gd"9 `8p0^p`0gd"9 8^gdO; 7$8$H$^gdO; 0^`0gd"9 `^``gdU w @ 0^@ `0gdsb @ 0^@ `0gd"9@qGqHqqqqqqqrr#r%rErersrtrvrrsEsMsOssssss*t±ӠsbThI;5B*CJaJph hyhI;5B*CJaJphhO;5B*CJaJphh]5B*CJaJph hyhO;5B*CJaJph hO;hO;5B*CJaJph h#I|h*u5B*CJaJph h#I|h]5B*CJaJph h#I|hO;5B*CJaJph hq;h"9 hq;h hq;hsb hq;h S*t+ttt4w5w=xQxRxxxxxfznzozzzzzzzzzzz{ {4{>{w{y{z{»xqqjcqq[Shq;h~5hq;h S5 hq;h/ hq;h hq;h S hq;hL] hq;h+ hq;hm hq;h)g hq;hU whq;hL]6hq;hm6hq;hdU6hq;h~6 hq;h~hq;h"96 hO;56B*CJ]aJph&hO;hO;56B*CJ]aJph hO;hI;5B*CJaJph 5wxyyfzz{{|{{|w|||7}8}r}}O~ p0^p`0gdm^gd{83 & Fgd(@ & F gdKi & Fgd{83 p`^p``gdm `^``gdU w p0^p`0gd~z{|{{{{{{|||&|F|v|w||||||}}6}7}8}N~O~̾̾~wpwi hq;h hq;h>Wb hq;hk5 hq;hh hq;hL] hq;h+ hq;hw$hq;hw$56B*phhq;hm6 hq;h{83 h{83hm h{83hH> h{83h~ h{83h] h{83h(@h(@ h#I|h*u h#I|hKi h#I|h] h#I|h{83 h]5%O~.j%#(Ņ+# @ 0^@ `0gd"9 `8p0^p`0gd"9 `8p0^p`0gd p0^p`0gd @ 0^@ `0gd^gdO; 7$8$H$^gdO; 0^`0gdw$%=>Ti+.0jl%﹫xxxjVE hO;56B*CJ]aJph&hO;hO;56B*CJ]aJphh*u5B*CJaJph hyhO;5B*CJaJph hH>hH>5B*CJaJph hO;hH>5B*CJaJphhH>5B*CJaJph hO;hO;5B*CJaJph&h#I|hD.hD.5B*CJaJph h#I|hD.5B*CJaJph h#I|hO;5B*CJaJphƃ %̍΍(ُ܏ߏ {tmt{mft hq;hh hq;hL] hq;h+ hq;hU' hq;h)g hq;h S hq;hhq;hHhH6hq;hH6hq;ht6 hq;hthq;h"96hq;h56B*phhq;h>Wb6hq;hAt6hq;hL]6hq;h+6hq;hh6hq;h6(ʌo΍).\Đ*PY `8p^p`gd S `8^gd S 0^`0gd S `8p0^p`0gdt `8p0^p`0gd"9 0^`0gd"9 `80^`0gd"9ҐՐِؐORS]oz ilmwÔĔΔ%'1KLNFHrt!#PR֗ ȰhD.5B*CJaJph hO;hO;5B*CJaJph hyhO;5B*CJaJph hq;h}a hq;hh hq;hOu hq;hSD} hq;hH hq;hU' hq;h S hq;h+ hq;hL]9=œה'LFr!P exޙ> 7$8$H$^gdO; h^`hgdOu `8p^p`gd Segxzޙ>@ ()>?AM[24Nǹ|s|dXdLdh6[56CJ]aJh{8356CJ]aJhO;hO;56CJ]aJhE[5CJaJhO;hO;5CJaJ#hO;hO;5CJOJQJ^JaJh5B*CJaJph hO;hE[5B*CJaJphhE[5B*CJaJph,hO;hO;5B*CJOJQJ^JaJph hyhO;5B*CJaJph hO;hO;5B*CJaJph?OdϝK=56 0^`0gdU w `8p0^p`0gdOu `8^gd"9 `8p0^p`0gd"9 p0^p`0gd"9 `8^gdO; p7$8$H$^pgdNOϜԜלڜܜb̡  456+yü뮧sgs` hq;h6[h:h{83CJ]aJh:hyiCJ]aJ h:hyi h:h6[hyih6[hU w hq;hU' hq;hs8 hq;h)g hq;h S hq;hOu hq;h"9hq;h"96hq;hL]6hq;h+6hq;h>Wb6hq;hU'6hq;hOu6hO;56CJ]aJ#6cJ|>AQ 7$8$H$^gdO; 0^`0gdOu `^``gdU w 0^`0gdU w `8^gdyi 0^`0gdyi & F^gd]Σݣ JQR$),-78LMTUyz{|~>@亳֥亝}l}l}l hO;hO;5B*CJaJph hyhO;5B*CJaJphhq;hOu6 hq;hOuhq;h S6 hq;hW hq;h>Wb hq;h+ hq;h S hq;hh hq;h#l hq;hL] hq;h+ hq;hL hq;h}a hq;hm hq;h)g hq;hU w*æACT\]#5gi(Kd(dпޫxph`h`hphq;h)6hq;h"96hq;hOu6 h&56B*CJ]aJph hE[56B*CJ]aJph h{8356B*CJ]aJph&hO;hO;56B*CJ]aJph hO;hE[5B*CJaJphhE[5B*CJaJph hO;hO;5B*CJaJph hyhO;5B*CJaJph$Qs*zת.);)AȰ! 7$8$H$^gd& 0^`0gdOu `8p0^p`0gdOu p0^p`0gdOu p0^p`0gd"9^gdO; 7$8$H$^gdO;defgqrܯ>@ACȰʰ !^Ľ凜udS hwFhD.5B*CJaJph hwFh&5B*CJaJph h&hE[5B*CJaJphhE[5B*CJaJph h&h&5B*CJaJph hyh&5B*CJaJph hq;hOu hq;h+ hq;h}a hq;hU w hq;hm hq;h)g hq;h Shq;h6hq;hOu6hq;hm6!ӲMoSŵ)Ʒi p0^p`0gdOu p0^p`0gd"9^gd& 7$8$H$^gd&!ӲղPXY~IST[ппппбпУУЃwhw\Pwh&56CJ]aJhE[56CJ]aJh&h)#56CJ]aJh)#56CJ]aJh&h&56CJ]aJ h&hE[5B*CJaJphhE[5B*CJaJphhN|5B*CJaJph hyh&5B*CJaJph h&h&5B*CJaJph hwFh&5B*CJaJphhkS5B*CJaJphQSƷ~ @HIƻȻMOQż)+-dfžӰөveWvhwF5B*CJaJph hwFhD.5B*CJaJph hwFhK5B*CJaJph hKhK5B*CJaJph hyhK5B*CJaJph hq;hOu hq;hh hq;hL] hq;h+ hq;h) hq;h/ hq;h S hq;h)g hq;hU whq;h"96 hq;h"9hq;hOu6"AO+dؽe:\ڿ=^gdK7$8$H$^`gdD. 7$8$H$^gdwF 7$8$H$^gdK 0^`0gdOu `^``gdU wؽڽ2cdegh=EFky8J|~;Hпޱ~m~m~\TLhq;hS6hq;hOu6 hK56B*CJ]aJph h)#56B*CJ]aJph&hKhK56B*CJ]aJph hKh]5B*CJaJphh]5B*CJaJphhD.5B*CJaJph hKh)#5B*CJaJphh)#5B*CJaJph hyhK5B*CJaJph hKhK5B*CJaJph=$gIT]^_ `^``gd p0^p`0gdOu @ 0^@ `0gdS p0^p`0gdSH #$.\]^_ghi 7>BLZj|789|»ɴ´ЉЅЅЗ~vhq;hW6 hq;h]h>WC h+`h+` hwFhdh)#h S hq;hW hq;h hq;h2W hq;h S hq;h # hq;h/ hq;hh+` hq;h+` h6hq;h>Uu6hq;h+6 hq;hOuhq;hOu6+}cccM & FEƀCF^gd]N0EƀCF^`0gdW89~PT Puuuu & F^gd{y & F^gd] 0^`0gd>Uu `8p0^p`0gd'u^gd'uJEƀCF^gd] |PVWX$=EHIST FO-.MѼѮѼʜxtxtxtxtxtxtph[ah{y hq;h{y hq;hd hwFhd hwFh{yh+`h>WCh hq;h>Uu hq;h+ hq;h}a hq;hS hq;h hq;h/ hq;h hq;h Shq;h'u6 hq;h'uhq;hS6hq;hW6hq;h>Wb6*./Mw} 7$8$H$^gd 7$8$H$^gd 7$8$H$^gd8 0^`0gdS `^``gdgd]^gd] 0^`0gd>Uu & F^gd{yQRShisu]iMOwy}Ϻ򳢑h[a5B*CJaJph h8h85B*CJaJph hyh85B*CJaJph hq;hS hq;hk5 hq;hh hq;h>Uu hq;hgG hq;h  hq;h # hq;h S hq;h/ hq;h hq;h>WC- mn:Cq}ĻĦėskdk\k\T\kMFM hq;h/ hq;hhq;hgG6hq;h+6 hq;hShq;hS6h856CJ]aJh[a56CJ]aJh{8356CJ]aJh8h856CJ]aJh[a5CJaJh8h]5CJaJh]5CJaJh8h85CJaJh5B*CJaJph h8h85B*CJaJph h8h[a5B*CJaJphen~Cde^gd^\I & F^gdD. & F^gd^\I 0^`0gd S `^``gd p0^p`0gdS^gd8 7$8$H$^gd 3>Uc}~UV]^b(ʼ뵮ʦʼ럮Φ hq;h hq;h # hq;h shq;h^\I6 hq;h+h"hJ$ hq;hJ$ hq;h hq;h^\I hwFhD.h[ah^\Ih S hq;h5 hq;hL hq;h/ hq;h S hq;h hq;hgG1XcccM & FEƀMf^gd^\IN0EƀMf^`0gdUV@ef%<=} p0^p`0gd j p0^p`0gdJ$ ^gd^\I & Fgd^\I 0^`0gdJEƀMf^gd^\I;<=vw*8rsuwÿ㷻}l h_sh;5B*CJaJph hq;hS hq;hF>= hq;h5j hq;h/ hq;h #hq;h6hq;hgG6 hq;h}n,hcdhShFm hwFhFm hwFhS hwFhcd hwFh}n,h(@h}n,hgG hq;h hq;h hq;h[v(=vwu n1x p0^p`0gd)D^gd)D 7$8$H$^gd)D 0^`0gdS p0^p`0gdtM^gd}n,^gdFm & FgdFm & Fgd}n, & Fgd(@w npK]1 )*12K}v}vovvgV hyh^5B*CJaJphhq;hGi6 hq;hSD} hq;h S hq;h/ hq;hF>= hq;hShq;hS6 h56B*CJ]aJph h{8356B*CJ]aJph&h)Dh)D56B*CJ]aJphh5B*CJaJph h_sh;5B*CJaJph h)Dh)D5B*CJaJph!x t*^^nq 7$8$H$^gd^ 0^`0gdS `^``gdF>= `8p0^p`0gdS^gdS!^`^`np~qпޱm\m h{8356B*CJ]aJph&h^h^56B*CJ]aJph h^h]5B*CJaJphh]5B*CJaJph h^h5B*CJaJphh5B*CJaJph hyh5B*CJaJphh^5B*CJaJph hyh^5B*CJaJph h^h^5B*CJaJph!JK+67Z^ab $%23ghikº«zzzveWh5B*CJaJph hyh^5B*CJaJphh S hq;h j hq;htM hq;hh hq;h>Uu hq;h+ hq;h/ hq;hF>= hq;h Shq;h j6hq;hGi6hq;hS6 h^56B*CJ]aJph&h^h^56B*CJ]aJph h56B*CJ]aJphqK}9Zi'(Vv 0^`0gd S `^``gd j 7$8$H$^gd^ 0^`0gdS @ 0^@ `0gdS 8p0^p`0gdGi 8p0^p`0gdS^gd^&'(*M_ 2U^_qп﫚xqjcj\jcjUNUNU hq;h=^> hq;hF>= hq;h j hq;h/ hq;h S hq;h^ hb56B*CJ]aJph h56B*CJ]aJph h{8356B*CJ]aJph&h^h^56B*CJ]aJph hyh^5B*CJaJph h^h5B*CJaJphh^5B*CJaJph h^h^5B*CJaJph-./uvx 567xy{̭̭̾}̭o^ h^h]5B*CJaJphh]5B*CJaJphh^5B*CJaJph h^hb5B*CJaJph hyhb5B*CJaJph h^h^5B*CJaJphhb5B*CJaJph hyh^5B*CJaJph hq;hF>= hq;hh hq;h S hq;h>Uu hq;h+$6yhiD 0^`0gd Sgd S 8p0^p`0gdGi 0^`0gdS 8^gd^ 7$8$H$^gd^$ ghicͼ͗yrkd͗\TLkDhq;h S6hq;hGi6hq;h 6hq;hS6 hq;hS hq;hGi hq;hF>= hq;h/ hq;h Shq;h j6hq;hMK$6 h^56B*CJ]aJph&h^hb56B*CJ]aJph hb56B*CJ]aJph&h^h^56B*CJ]aJph h^h^5B*CJaJphhb5B*CJaJphMNyz')78̾tcUh]5B*CJaJph h^hb5B*CJaJphhb5B*CJaJphh^h^5CJaJh;5CJaJhq;h S6 hq;h h^&h^h^56B*CJ]aJphh^5B*CJaJphhR5B*CJaJph h^h^5B*CJaJph hq;h`+ hq;h/ hq;h S'o*gQ9:k/ & F7$8$H$gdKi & F7$8$H$gd}n, 8^gd^ 7$8$H$^gd^ 0^`0gd S^gd^fgo}PQS89:]¶zslslse^esZVKhwFh#0CJaJh}n,h S hq;h5 hq;hSD} hq;h/ hq;h Shq;hO6hq;h S6hq;h/6h^56CJ]aJh^h^56CJ]aJhb5CJaJh^h^5CJaJh^5B*CJaJphhb5B*CJaJph h^h^5B*CJaJph h^h]5B*CJaJph]^j/abcY[\hrkZLh`5B*CJaJph h^h^5B*CJaJph hq;h #hq;hm6B*phhq;hm56 hq;hmhq;h>Uu6 h}n,h}n,h;B*CJaJphh}n,h;B*CJaJph h}n,h;hFmhFmCJaJhwFhKiCJaJhwFhFmCJaJhwFh;CJaJhwFhD.CJaJhkSCJaJ/abc\h"Pttt 7$8$H$^gd^ 0^`0gdm 0^`0gdm 0@&^`0gd `^``gdm 8p0^p`0gd>Uu^gd}n, 0^`0gd S 7$8$H$^gdFm & F7$8$H$gdFm k*/[\]XY   9 :  [ ^  ޼|hWOOH hq;hnhq;hl6 hc56B*CJ]aJph&hchc56B*CJ]aJph hchc5B*CJaJph hq;h hq;hlhq;h 6hq;hm6 h^56B*CJ]aJph&h^h^56B*CJ]aJphh`5B*CJaJph h^h^5B*CJaJph h^h`5B*CJaJphP(Q\0rZ    ^gdc 7$8$H$^gdc 0^`0gdl p0^p`0gdm G08gdm G08@ 0^@ `0gdm^gd^ 7$8$H$^gd^ :   b     AB 0^`0gdm p0^p`0gd? 7$8$H$^gdc 0^`0gdl `8@ 0^@ `0gdl `8^gdl p0^p`0gdl^gdc       @AB8˺|u|u|ng`nYnRnNJh#0hm hq;h& hq;h=^> hq;h # hq;h? hq;hm hq;hlhq;hl6 hwF56B*CJ]aJph hc56B*CJ]aJph&hchc56B*CJ]aJph hchwF5B*CJaJphhc5B*CJaJphh(@5B*CJaJph hchc5B*CJaJphhhl9j6]C$% p`^p``gd p0^p`0gd)D^gd)D & F/7$8$H$gdKi 7$8$H$^gd)D 0^`0gd5v^gd#0 & Fgd#0 0^`0gdm89Brsu568\]CDνn]IAhq;h?6&h)Dh)D56B*CJ]aJph h)DhKi5B*CJaJph h_'hKi5B*CJaJph h)Dh5B*CJaJphh5B*CJaJph h)Dh#05B*CJaJphh)D5B*CJaJph h)Dh)D5B*CJaJph hq;h5v hq;hU hq;hDu* hq;h? hq;h]o hq;h#0hh`D#$%9wx&E^aüᮧӠp\&hchc56B*CJ]aJph hch}5B*CJaJphh}5B*CJaJph hchc5B*CJaJph hq;ha` hq;h # hq;hm hq;h hq;h}h}hh#0h hq;h? hq;hhq;h6 hq;h]o hq;h5vhq;h5v6%x&'-a4P] G08p0^p`0gdm G08^gdc 7$8$H$^gdc 0^`0gdm gd? `8p0^p`0gd^gd#0 p`^p``gd & Fgd#0OP\]`v;PitVZdkǶxxxqjcq\q\q hq;hd hq;h # hq;hxC hq;hmhq;hU6hq;ha`6 hq;ha` hq;hqhq;hDu*6hq;hX6hq;hq6hq;hm6 hc56B*CJ]aJph&hchc56B*CJ]aJph&hch}56B*CJ]aJph h}56B*CJ]aJph$]-fLDm  _!! 7$8$H$^gd)D^gdc 7$8$H$^gdc 0^`0gdfi `8p0^p`0gda` p0^p`0gda`F[efKLNS[\ν߽xqjxYMD8h)Dh}5CJaJh}5CJaJh)Dh;5CJaJ h_sh;5B*CJaJph hq;h # hq;hxC hq;hmhq;hfi6 hc56B*CJ]aJph h}56B*CJ]aJph&hchc56B*CJ]aJph hchc5B*CJaJph hch}5B*CJaJphh}5B*CJaJphhchc5CJaJ hq;hfi\ DFKS$$$$$$%%;%=%J%K%%%%%%%%%%&&)'*'|'}'ȺȺȺȺȺȺȺٮٮٮ hq;hfihq;hfi6 h)D6h)Dh)D56CJ]aJh}5CJaJh)Dh)D5CJaJh}5B*CJaJph h)Dh)D5B*CJaJph h_sh;5B*CJaJphh;5CJaJh)Dh;5CJaJ0!>"{""7#c##?$Q$w$$$$;%%%%&*'~'(( 0^`0gdQ p0^p`0gdfi G088^8gd)D G08^gd)D 7$8$H$^gd)D}'''''''((((f((()f))) *'***J+^+_+`+e+j++&,),S,[,\,ƾughc5B*CJaJph h_'hD.5B*CJaJph h_'hc5B*CJaJph hq;h. hq;h& hq;hKW hwr6 hm6hq;hQ6hq;hfi6 hq;hC41h#0hwrhC41hQ hq;h hq;hQ hq;h # hq;hxC hq;hm!(f(()f)g))))*q**+_+`+),\,,,- 7$8$H$^gdc 0^`0gdKW `8p0^p`0gdfi G08p0^p`0gdc^gd#0 0^`0gdQ & F gd#0\,^,,,-..R//Q0R0S0T000*1+1-11111A2C22м~maXmGmGmGmG h)Dh)D5B*CJaJphh;5CJaJh)Dh;5CJaJ h_sh;5B*CJaJph hq;h3 hq;hhh& hq;h3:hq;h&6hq;hKW6 hc56B*CJ]aJph&hchc56B*CJ]aJph hchc5B*CJaJphh]5B*CJaJph hch]5B*CJaJph-.>..R//R0S0T00+111A22Y334 `^``gdm^gd)D 7$8$H$^gd)D 0^`0gd3: G08p0^p`0gdKW G08^gdc2+303Y3344'4(444544444444x5z566~666677;7<7z7{78̶̽̽~yrkd]yUhq;hfi6 h#0hKi h%hKi h%h h%h#0 h6h#0hB*CJaJph h#0h#05B*CJaJph h#0h h#0h5B*CJaJph hq;hfi hq;h #hq;hm6 hq;hmhq;h36 h56B*CJ]aJph&h)Dh)D56B*CJ]aJph 444x56~666z7{7 88@99#:: G08p0^p`0gdfi G08p0^p`0gd)D G08p0^p`0gd G08^gd#0 7$8$H$^gd)D$ ,p@ P !$p`^p``gdfi8888P:Z:;;;;<$<'<*<:<I<J<K<M<o<<<<<<<<<<=K=T=e=m=o={==ν|k|k||| h_sh;5B*CJaJphh`5B*CJaJph hLhL5B*CJaJph h%hLo5B*CJaJph h%hL5B*CJaJph h%h;5B*CJaJphhm hq;h3: hq;h # hq;hmhq;hm6hq;hfi6hq;h3:6$:4;;K<<<==<>>>>!?"?o?p?? ^`gdfi^gd#0 & Fgd#0 0^`0gdfi^gdL 7$8$H$^gdL 0^`0gdm G08p0^p`0gdfi=====;><>F>G>>>>>>>> ?!?"?o?p????V@W@X@e@@@@@TAUAYA®~~wok~~~~d\hq;h6 hq;h3[hmhq;hfi6 hq;h`h3[hlh7h`hfi hq;hfi hq;h # hq;hm hq;hL&hLhL56B*CJ]aJph hLh3[5B*CJaJphh3[5B*CJaJph h_sh3[5B*CJaJphhL5B*CJaJph"?W@X@@@@@gggI & F!Eƀ:JfgdlN0Eƀ:Jf^`0gdm@TAUAABBgS?2 0^`0gdm G08p0^p`0gd  G08p0^p`0gdITN0Eƀ:Jf^`0gdmJEƀ:Jf^gdlYAZAABB-B.B:BBBBBCCCCCCCCCCDzDDDDDDDDDDEEEEEEEEEEF٪Ҫ~Ҫwwp hq;hj8W hq;h5j hq;h39h39hm hq;hQhq;h446hhq;hIThIT hq;h # hq;hmhq;h|%{6h3[h|%{hq;h|%{h|%{ hq;h|%{ hq;hIT hq;h hq;h 6hq;h6hq;hIT6+BBCCCCDzDDD E3E4EEEEFgFFF 7$8$H$^gdL^gdl & F"gdl G08p0^p`0gd44 G08p0^p`0gd|%{ 0^`0gdmFFgFiFFFF?GRGnGpGGGGGGHHH(HJ?JGJJJJJJJJKK&K.K2K4KtKvKKKLLkLLLL͹}llll͹[ h~56B*CJ]aJph hch~5B*CJaJph hq;hM4 hq;h # hq;h hq;h!Xhq;h1k6hq;hIT6hq;hM46hq;h!X6&h~h~56B*CJ]aJph h~h~5B*CJaJph h%hLo5B*CJaJph h%h~5B*CJaJph!tKKLkLLLMTNN[OOOPPPfQQQGRsRR@SS p0^p`0gd 0^`0gd!X p0^p`0gd!X^gd~ 7$8$H$^gd~LLMMSN]N^N_NsNwNNNNNNNNN*O6O[O]OOOOOOOO责vhW h~hU5B*CJaJphhLo5B*CJaJph hchU5B*CJaJphh~5B*CJaJphhU5B*CJaJph h~h~5B*CJaJph hch~5B*CJaJph hq;h hq;h, hq;hM4 hq;h # hq;h hq;h!Xhq;h!X6hq;h6OPPPPPPeQfQoQpQqQQQQQQQQQQQQQQGRIRsRuRR?S@SSS[TgThTTTTTûvhvvvvӭӦhU5B*CJaJph h~h~5B*CJaJph hch~5B*CJaJph hq;hM4 hq;h # hq;h hq;h!X hq;hhq;h6hq;h6hq;h|%{6hq;h!X6 h~56B*CJ]aJph&h~h~56B*CJ]aJph(S]TTT@UXUUUUV@VRVxVVV WNWW1XXX$Y 0^`0gd~^gd~ 7$8$H$^gd~ 0^`0gd p0^p`0gdTTTT@UBUXUZUUUUUUUVV@VBVRVTVxVzVVVVV W"WNWWWW'X.X0X1X3X;XEXFXXXXüõîޠށp h0mh]5B*CJaJphh~5B*CJaJph h~h]5B*CJaJphh]5B*CJaJph hq;h!X hq;hM4 hq;h # hq;h&h~h~56B*CJ]aJph h~h~5B*CJaJph hch~5B*CJaJph*XXX$Y%YYQZSZZZZ8[C[k[l[m[[[[\\\\P]Q]X]ʸvoh^hWhWhKBKha5CJaJh~h~5CJaJ hq;h #hq;hZ56 hq;hZ hq;h!X h l56B*CJ]aJph h~h~5B*CJaJph hch~5B*CJaJph hq;h1khq;h!X6#h~h~6B*CJ]aJph&h~h~56B*CJ]aJph h~h]5B*CJaJph h0mhLo5B*CJaJph$YYQZZZl[m[[\\Y]] ^q^^^_T__ 0^`0gdZ 0^`0gdZ 8^8`gdZgdZ^gd~ 7$8$H$^gd~ 0^`0gd1k p0^p`0gd~X]Y][]]] ^^q^s^^^^^__C_D_T_V__R`S`dddGeIeeeeEfffggJhLhhhhh"i$ixizii7jjԲԲԲwhq;h&6 hq;h& h56B*CJ]aJph hq;h # hq;hZhq;hZ6 h~6&h~h~56B*CJ]aJphhn55B*CJaJph h~h~5B*CJaJph hch~5B*CJaJphh~5CJaJ._R``gaa+bbbbfccdGeegw^gd~ 7$8$H$^gd~ 0^`0gdZ G08p0^p`0gdZ G088^8gdZ @ 0^@ `0gdZ G08@ 0^@ `0gdZ G088^8gd~ G08^gd~ ggJhhh"ixii7jjj-kkkkl=lYlll mQm `8p0^p`0gd~ `8^gd~ 7$8$H$^gd~ 0^`0gd& p0^p`0gd~jjjjk,k-k/kkkkkkkll=l?lYl[lllll m mQmSmmmommmmmmmmmmGnInunoooopửᡒ~vhq;h'u6hq;h&6h7k56CJ]aJh~h~56CJ]aJh~h~5CJaJh7k5B*CJaJph h~h~5B*CJaJphh7k5CJaJh~h7k5CJaJ hch7k5B*CJaJph hq;h'u hq;h&.QmmmmmmmGnunoYoooppqq 0^`0gd`. 8h^8`hgd'u `8p0^p`0gd'u^gd'u p0^p`0gd& `8^gd~ 7$8$H$^gd7k 7$8$H$^gd~ppqqqqqqqqqq^r`rrrrrrssss^t_tatmtttսΌ{jYKhb5B*CJaJph h0mhFm5B*CJaJph h0mhL5B*CJaJph h0mh;5B*CJaJphh7Xhq;h7X6&hLhL56B*CJ]aJph hLhL5B*CJaJph h_sh;5B*CJaJph hq;hy hq;h7X hq;h # hq;h`. hq;hZhq;h'u6 hq;h'uq^rrrrss_tttu+uvvwdwwexx G0p0^p`0gdL G0^gdL 0^`0gdy^gdL 7$8$H$^gdL 0^`0gd7Xtttttuuu+uvvvvvvlvovvvwwdwfwwexxxxпбzsпп_WKWhq;h7X6OJQJhq;h7X6&hLhL56B*CJ]aJph hq;h, hq;h # hq;hy hq;h7X hq;hLhLhL56CJ]aJhLhL5CJaJhL5B*CJaJph h_sh;5B*CJaJph hLhL5B*CJaJphhb5B*CJaJph h_shb5B*CJaJphxxjytyuyvyyyyy zzzzy{|BLMN[`,.fh͂ς  GI軪ﻪ hq;ht hq;h+&hLhL56B*CJ]aJph hLhL5B*CJaJph h_sh;5B*CJaJph hq;hkm hq;h, hq;h # hq;hy hq;h7Xhq;h7X6hq;h|%{63xyky zHzYzzz{{{3{P{]{y{|n|| G0p0^p`0gdL G0^gdL 7$8$H$^gd" 7$8$H$^gdL 0^`0gd7X G0p0^p`0gd7X| }_}}~~:nC,f͂ G 7$8$H$^gdL 0^`0gdp G0@ 0^@ `0gd, @ 0^@ `0gd, G00^`0gd7X G0@ 0^@ `0gd7Xcp:&bc 7$8$H$^gdSU 07$8$H$^`0gd7k 7$8$H$^gd7k07$8$H$^`0gd@ 7$8$H$gd@87$8$@&H$^8`gdgdL M^gdL 7$8$H$^gdL$ cepr:DEGTVۼwlaVIhq;h@6B*phhq;hB*phhq;h<`B*phhh<`B*phhhB*ph hh hh # hh@&h7kh7k56B*CJ]aJph h7kh7k5B*CJaJph hch7k5B*CJaJph hq;h # hq;h@hq;h@B*ph!hq;h@56B*\]phhq;hL M6cUYxЊъҊԊ;=[\ǹn]n]n]O]O]hH05B*CJaJph h7kh7k5B*CJaJph hch7k5B*CJaJphhq;h@B*phhq;hhB*phhq;hB*phhq;hqbB*phhq;htB*ph hq;ht hq;h # hq;h@hq;hSU 6B*phhSU hSU 56CJ]aJhSU h5CJaJh@6B*phcҊ;]_ǎ$$7$8$H$Ifa$gd}3p07$8$H$^p`0gd@p07$8$H$^p`0gd7k 7$8$H$^gd7k07$8$H$^`0gd@ 7$8$H$^gdSU 7$8$H$^gdSU -.\^_ǎȎмvi[M[@h}3h&vB*]phh}3hq(5B*]phh}3h&v5B*]phhq;h&vB*]phhq;h&v6B*]phhq;h<`6B*]phhq;h@B*phhq;h@6B*]ph h56B*CJ]aJph&h7kh7k56B*CJ]aJph h7kh7k5B*CJaJphhH05B*CJaJph h7khH05B*CJaJphǎȎɎʎˎAɏQul[NA 0^`0gdkm `^``gdkm87$8$H$^8`gdd 7$8$H$gdd07$8$H$^`0gd:o5p07$8$H$^p`0gd@hkd,$$Ifl,"" t0644 layt}3ȎɎˎAHJK_rǏOPQSW`acqȻȮrr^QJ hq;h9hq;h #B*]ph&h&h&56B*CJ]aJph h&h&5B*CJaJph h_sh;5B*CJaJphhq;hkmB*]phhq;h2WB*]phhq;h0IxB*]phhq;h+wB*]phhq;hdB*]phhq;hd56B*]phhq;hd6B*]phhq;h@B*]phQW7~]4 7$8$H$^gdH0 0^`0gd& 8p0^p`0gd9 p0^p`0gd9^gd\G 7$8$H$^gd\G p`^p``gd&^gd& 7$8$H$^gd&79~]ߓ*234=>@NǿǿǸǿǰudXOhH05CJaJh&hH05CJaJ h_shH05B*CJaJphhH0B*]phh+wB*]phhq;h #B*]phhq;hkmB*]phhq;h+wB*]phhq;h+w6 hq;h9hq;hW 6hq;h96h&h\G56CJ]aJ h&h\G5B*CJaJph h_sh\G5B*CJaJph*+-͕ϕ;=WYǖɖ OQkm}ϗїEGstɻ㯠}hq;hH0B*]phhH0B*]phhH056CJ]aJh&hH056CJ]aJh&hH05CJaJhL5B*CJaJph h~hL5B*CJaJphhL5CJaJh~hL5CJaJ hchL5B*CJaJph,+͕;WǖOk}ϗEst 0^`0gd&^gdH0 7$8$H$^gdH0 7$8$H$^gdL'(IQRSEGvx"{|}RT󿵫rerXJ<hq;h6B*]phhq;hkm6B*]phhq;hLB*]phh!hLB*]phh!hL6CJ]aJh!hcB*]phh!hcB*CJaJphh!hLB*CJaJphhLB*]phhkmB*]phhq;hkmB*]phhq;hB*]phhq;hTWB*]phhq;h|buB*]phhq;h+wB*]phRS֚Ev|}ۜTН 0^`0gd+wp07$8$H$^p`0gdp07$8$H$^p`0gdkm^gdL^gdc 7$8$H$^gdL 0^`0gdkm `^``gdkmTkϝНڝ۝ žÞ 9:;ZpşƟȻȻȱ{pbTh[@_h[@_6B*]phh[@_h[@_6CJ]aJh[@_6CJ]aJh!hic 6CJ]aJhic B*]phh[@_B*]phh@B*]phhvB*]phhdB*]phhq;hkmB*]phhq;h+wB*]phhq;hkm6B*]phhq;h6B*]phhq;hw6B*]phÞ:;Ɵǟ)$_cdۣ `^``gd+w 7$8$H$gd+wp07$8$H$^p`0gd+w^gdic T^Tgdic  & F$TL^T`Lgdic 0^`0gd+wƟǟџ)3$)?Q^bcdۣݣ׹|reXKX: h_sh\G5B*CJaJphhq;hB*]phhq;h|B*]phhq;h{B*]phh+wB*]phhq;h+wB*]phhq;h.56B*]phhq;h56B*]phhq;hN56B*]phhq;h+w56B*]phhq;hw6B*]phhq;h+w6B*]phhq;hkm6B*]phhq;hLB*]phۣ6B78d=>gd| 0^`0gd+w^gd[@_ & F%TL^T`Lgd[@_ 0^`0gd&p07$8$H$^p`0gd9^gd\G 7$8$H$^gd\Gݣ68w678cdʹʗvlbXbNbN:&h&hB56B*CJ]aJphhBB*]phhGB*]phh{B*]phh[@_B*]phhB*]phhq;hB*]phhq;h96]hq;h96B*]ph&h&h{56B*CJ]aJph h{56B*CJ]aJph&h&h\G56B*CJ]aJph h_sh\G5B*CJaJph h&h\G5B*CJaJph<=>GHabܩީeop̪Ϊ"$Rʫ˫ի֫7˾wwcRwRwRwcNh7k h_sh;5B*CJaJph&h7kh7k56B*CJ]aJph h7kh7k5B*CJaJph hch7k5B*CJaJph hq;h{ hq;h|hq;h|56hq;hB*]phhq;h|B*]phhq;hGB*]phhBB*]phhq;hBB*]ph hB56B*CJ]aJphWܩe̪"R˫8g er 0^`0gd7k^gd7k 7$8$H$^gd7k 0^`0gd| 0^`0gd| 8|^`|gd|78:gi egqrtĮƮ24SڱڱӦra hdjh"5B*CJaJphhB5B*CJaJph h7khB5B*CJaJph h_shB5B*CJaJphhK6{ hq;hK6{h7k&h7kh7k56B*CJ]aJph hq;h{ hq;h| hq;h7k h7kh7k5B*CJaJph h_sh;5B*CJaJphh|#Į2Sae  8^`gd& 7$8$H$^gd&^gdB7$8$H$^`gddj 7$8$H$^gdB 0^`0gd|^gd7k 7$8$H$^gd7k°4`ajkeg VͿͫtctcNF>7 hq;h|hq;h6hq;h|6)h&h&56B*CJ]aJhph h&h&5B*CJaJph h_sh;5B*CJaJph hq;hK6{ hq;h hq;hB hB56B*CJ]aJph&h7khB56B*CJ]aJphhB5B*CJaJph h7khB5B*CJaJph h_shB5B*CJaJph h7kh"5B*CJaJph Vڳ \WthBc*z/s 0^`0gd|^gd7k 7$8$H$^gd7k 0^`0gd| 80`0gd| 80`0gd&ٳڳܳ "\VWYtvghqsöĶŶABDce)*34/1suL#$̸̸̸̸hq;h|6hq;h7k56 hq;h&v hq;hK6{ hq;h7k&h7kh7k56B*CJ]aJph h7kh7k5B*CJaJph h_sh;5B*CJaJphh| hq;h| hq;h{9sL_˻|PѾZ 0^`0gd| `88^8gd| `8p0^p`0gd| `8p0^p`0gd7k `8^gd7k 7$8$H$^gd7k$ѾӾZ\WXZ-/=?=xy.1./0 ӿӿ|xq| hq;hBh{ hq;hhq;h{6B*ph hq;h hq;h{hq;h{56hq;h{6hq;h|6 hq;h7k&h7kh7k56B*CJ]aJph h7kh7k5B*CJaJph h_sh;5B*CJaJphh| hq;h|*X$xC[-= 7$8$H$^gd7k 0^`0gd{ 0^`0gd{ `8gd{ `8@ 0^@ `0gd| `8p0^p`0gd|^gd7k=Jy2/0 4d 7$8$H$^gd^ 0^`0gd{ `^``gd{ p0^p`0gd{ 8h^8`hgd{ `88^8gd{ `8p0^p`0gd7k `8^gd7k 7$8$H$^gd7k  346dfY[ABlm Ŵ봠~ui`h;5CJaJh/bhM8 5CJaJhM8 5CJaJh/bh;5CJaJ hq;h8N hq;hh^h&5&h^h&56B*CJ]aJph h&h&5B*CJaJph h_shS5B*CJaJphhS5CJaJh^hS5CJaJ h_sh;5B*CJaJphhYB mc&^ 7$8$H$^gd/b h^hgd 0^`0gd 0^`0gd/b 0^`0gd `^``gd"^gd^ 7$8$H$^gd^ ce&(^`"LEFHmoCEL»ޡ{vnhq;h6 h/b6h/bh/b56CJ]aJhwx?5B*CJaJphh;5CJaJh/bh;5CJaJ hq;hW hq;h8N hq;hhq;h&6&h/bh/b56B*CJ]aJph h_sh;5B*CJaJph h/bh/b5B*CJaJph+"LFmC6V `8p0^p`0gd 7$8$H$^gd/b 0^`0gd 0^`0gd `88^8gd/b `8^gd/bMa8+7 k `8p0^p`0gd `8p0^p`0gd/b `8^gd/b 7$8$H$^gd/b 0^`0gd `88^8gdLWXZdf6ac|}8:a+Jaiy~±ӱᣱ±ᣱᣱᣱᣱᣱ~~ hn56B*CJ]aJph&h/bh/b56B*CJ]aJphhn5B*CJaJph h/bh/b5B*CJaJph h/bhwx?5B*CJaJphhwx?5B*CJaJph h_sh;5B*CJaJph hq;h\ hq;h,~Xadfoqʶ{{{{j\PGh> 5CJaJh/bh;5CJaJh> 5B*CJaJph h_sh;5B*CJaJph hq;h\ hq;hhq;h6&h/bhwx?56B*CJ]aJph h/b56B*CJ]aJph&h/bhn56B*CJ]aJph hn56B*CJ]aJph&h/bh/b56B*CJ]aJph hwx?56B*CJ]aJphYU]g `88^8gd/b `8=^gd>  `8^gd/b 7$8$H$^gd/b 7$8$H$^gd> 0^`0gd `88^8gd `8p0^p`0gd!UWop]_~,4Ez±m\m\mKm hwx?56B*CJ]aJph h> 56B*CJ]aJph&h/bh/b56B*CJ]aJph h/bhwx?5B*CJaJph h_shwx?5B*CJaJphh/b5B*CJaJph h/bh> 5B*CJaJphh> 5B*CJaJph h_sh;5B*CJaJphhwx?5B*CJaJph h/bh/b5B*CJaJphtv%'oq)*6ABB͹xg[[Lggh/bh/b56CJ]aJh/bh/b5CJaJ h/bh/b5B*CJaJphhrj5CJaJh/bh;5CJaJ h_shrj5B*CJaJph hq;h\ hq;hhq;h6 h/b6&h/bhwx?56B*CJ]aJph hwx?56B*CJ]aJph h> 56B*CJ]aJph h/b56B*CJ]aJphzt%o)f7B `88^8gd/b `8^gd/b 7$8$H$^gd/b 0^`0gd `88^8gd `8p0^p`0gdB[\23jYZ34lm UV 0ûóëϝ˕y˫rjbhq;h<6hq;h\6 hq;hhq;h6hq;hK6{6hQsh7\h> 5h7\hQs5 hq;h< hq;hxhxhRh7\h"5h7\h5h7\hx5h\ hq;h\ hxh\ hq;hhq;h6&h/bh/b56B*CJ]aJph&\kYZp$ ,p@ P !$p`^p``gd\^gd>  & F#TL^T`Lgd" & F#TL^T`Lgd> 0^`0gd\ 0^`0gd\ `8p0^p`0gd `8p0^p`0gd/b 4m$UV0 `8p0^p`0gdK6{^gd> ,p@ P !$^gd>  & F# TL^T`Lgd> $ ,p@ P !$p`^p``gd\]bc./$ ,p@ P !$p0^p`0gd> # & F& ,Tp@ P !$`gd> $ ,p@ P !$p`^p``gd `8p0^p`0gd< \]abcd-./8=NR`aft|}JY[žŲytlhq;h<6 h^6h^h^56CJ]aJh^hZ5CJaJhZ5CJOJQJaJ h^h^5B*CJaJphh^h^5CJaJ hq;h # hq;h< hq;h> h> hq;hK6{6 hq;hK6{ hq;hQshhQsh hq;h)/YuJYzmm 7$8$H$^gd^ 0^`0gd< 0^`0gd< ) @ P !$^gd> $ ,p@ P !$p`^p``gd# & F' ,Tp@ P !$`gd> v7 b;< 0^`0gd< `8p0^p`0gd_ `8^gd_ 7$8$H$^gd_ 0^`0gd 0^`0gd p0^p`0gd<^gd^ 7$8$H$^gd^567>?AB  bd:;<,0\]^ȴ򨤠yqhq;h5v6 hq;hu} hq;h5v hq;hE<hzI h7\hLo h7\h"h"hE<h<hq;hq6&h_h_56B*CJ]aJph h_h_5B*CJaJph h_shrj5B*CJaJphhq;h6 hq;h< hq;h+<MN]^Lz7 p0^p`0gd p0^p`0gd0l^gd0l 7$8$H$^gd0l 0^`0gd5vgd5v^gdQ]= 0^`0gd< & F(TL^T`LgdQ]=%,-57qü{{tccO&h0lh0l56B*CJ]aJph h_shrj5B*CJaJph hq;h_4 hq;he%%hq;h_456hq;hIb=56hq;h56hq;he%%56hq;h<56hq;h<6 hq;h< hq;h5vhq;h5v6h0lh0l56CJ]aJh"5B*CJaJph h0lh0l5B*CJaJph&{5q~MN `8p0^p`0gd< `8p0^p`0gd0l `8^gd0l 7$8$H$^gd0l `80^`0gd< `gd< 8^8`gd< `8^gd<gd< IRSMNghmnrsfhƵznezhrj5CJaJh0lhrj5CJaJ h_shrj5B*CJaJphhq;h<CJhq;h6 h0l6&h0lh0l56B*CJ]aJph h0lh"5B*CJaJphh"5B*CJaJph hq;hA hq;h hq;h_4 hq;he%% hq;h<hq;h<6 N;hf,Y G08gd< G08^gd0l 7$8$H$^gd0l G080d1$^`0gd< `0^`0gd< `8p0^p`0gd< `8^gd0l  ,.Yijl#$)*./ĵ{tp{haa hq;hhq;h0l6h hq;h0l&h0lh0l56B*CJ]aJphh< hq;h_4 hq;he%% hq;h<hq;h<6 h0l6h0lh0l56CJ]aJh0lh0l5CJaJh0l5B*CJaJph h_shrj5B*CJaJph h0lh0l5B*CJaJph$j$D < = I J K L     G08p0^p`0gd `gd~ `0^`0gd G080^`0gdt G08^gd0l 7$8$H$^gd0l G080^`0gd<% 0 C D I J K L  # ; < = H I K L p           1 F         BCNOPUVXκݣ݊ݜ hq;ht hq;h~h hq;h hq;hvhq;h6hq;ht6 hq;h0hq;h~5 h~5h0ht hq;h]o hq;h hq;he%% hq;h hq;h Yn hq;h6     QCOPBz G08^gdzI & F) G08TL^T`LgdzI G080^`0gdt G08p0^p`0gd `gd~ G080^`0gd&BR~BMOXY;>? wx}~˦x hM,h]W hM,h4" hq;hLh4" hq;h~4 hq;hO|2 hq;h]W hq;h4"hq;hO56hq;h]W56hq;h4"56hq;hv5 h~5 hq;h1 hq;he%% hq;h hq;h~hM,h~h-BNOx= G08gd4" G080^`0gd4" 0^`0gdv `gdv G080^`0gdt+?CJBCV FLMJKbn P[\o{ַ֩h zs hq;hhhM, hq;hiHBhLh1hq;h]W56hq;h156 hq;h1k hq;hiP hq;h|bu hq;h1 hq;hq( hq;h]W hq;h4" hM,h4" hM,hq(5=FK}iRR & F* G08TL^T`LgdM, G080^`0gd1 `^``gd1 G08gd1 G080^`0gd1kU G080EƀR^`0gd]W (\2Aop G08^gd0l 7$8$H$^gd0l G080^`0gd{e G08gd1 G08^gdM, G080^`0gd1 & F* G08TL^T`Lgd & F* G08TL^T`LgdM, 78ACnp VX\^®ӑzzz®h35B*CJaJphhrj5CJaJh0lhrj5CJaJhq;h]W56 hq;he%%&h0lh0l56B*CJ]aJph h0lh0l5B*CJaJph h_shrj5B*CJaJph hq;h{e hq;h]W hq;h1 hq;hL*op V\/ s  G0gd]W G08gd0l G08^gd0l 7$8$H$^gd0l 80^`0gdH `0^`0gd]W 0^`0gd]W G08gde%%!["\"]"_""""""""# #"#>#?#@######Ľpppp\H\H\&hAh 56B*CJ]aJph&hAh356B*CJ]aJph h0lh35B*CJaJphh35B*CJaJphh35CJaJh0lh35CJaJ h_sh35B*CJaJphhj=h]W hq;h]Whq;h]W6h0l6B*CJ]aJph&h0lh0l56B*CJ]aJph h356B*CJ]aJphs   d!!\"]""" #?#@###'$o$$$ 7$8$H$^gd0l `^``gd]W ^gd3 7$8$H$^gd3 `0^`0gd]W G0p0^p`0gd]W G0gd]W###'$)$n$o$q$$$$V%W%%%%%%%G&H&&"'#'='>'z'{')(*(3(ͧͧ||||upkfkfk^Thq;he%%56hq;h35 h+5 h35 h&v5 hAh]Whq;h]W6h0l6B*CJ]aJph&h0lh0l56B*CJ]aJph h0lh0l5B*CJaJphhrj5CJaJh0lhrj5CJaJ h_shrj5B*CJaJph hq;h]W hq;h3&h0lh356B*CJ]aJph$V%%%H&&"'#'`''''(()(*(( 8^8`gde%% `^gdp & F+ `TL^T`Lgdp `0^`0gd]W G0p0^p`0gd]W ^gd0l ^gd0l3(4(((( ) )))))(*~***0+1+3+++++,,,,,,,,---ͼͼͼ͊{{tfXhGo5B*CJaJphh%#5B*CJaJph hq;h_h_h_56CJ]aJh_h_5CJaJh_5B*CJaJphhe%%&h_h_56B*CJ]aJph h_h_5B*CJaJph h_shrj5B*CJaJph hq;h]W hq;he%%hq;he%%56hq;h]W56 ()))(*~*1++,,,----.. & F,7$8$H$^`gd+ G080^`0gd_ G08^gd_ 7$8$H$^gd_ G080^`0gde%% 0^`0gde%%-..s....#/)/*/i/k/////s0u0111^2_2228393ͼͷ{jͷYMDhrj5CJaJh_hrj5CJaJ h_shrj5B*CJaJph h_h_5B*CJaJphh&5CJaJh_h&5CJaJ h_sh&5B*CJaJph hq;h]W hq;he%%hq;he%%6 h_6 hGo56B*CJ]aJph&h_h_56B*CJ]aJph h_h+5B*CJaJphh+5B*CJaJph.$/i///t00111M22933T44A555 7$8$H$^gd" 0^`0gde%% `88^8gde%% `8^gd_ 7$8$H$^gd_ `8hd1$`hgde%% G08p0^p`0gde%%93;333T4V444@5A555B6D6666677!8"888888q9s99:L:N:::; ;;<<w<x<<пޚm#h_h_6B*CJ]aJph hq;h]W hq;he%%hq;he%%6 h_6&h_h_56B*CJ]aJph h_h"5B*CJaJph h^ h"5B*CJaJphh_5B*CJaJph h_h_5B*CJaJph h_shrj5B*CJaJph*5B6667"888q99L::;;<x< G08p0^p`0gd_ G08^gd_ 7$8$H$^gd_^gd 0^`0gde%% G08p0^p`0gde%% `8`gd_ `8^gd_x<<==>> ?U??f@@cA/BlBBB G080^`0gde%% p0^p`0gd_^gd_ 7$8$H$^gd_^gde%% 0^`0gde%% G08p0^p`0gde%% `8@ 0^@ `0gde%%<<<<==~==>>> ? ?U?W??f@@@@hAiA/B1BlBnBBBBCCmEsEtEEEE}FTGUG[G\GGGRHTHsHȴ٦ȴ}v hq;h_h_h_56CJ]aJhe%% h_6 h_shGo5B*CJaJphhGo5B*CJaJph&h_h_56B*CJ]aJph h_h_5B*CJaJph h_shrj5B*CJaJph hq;h]Whq;he%%6 hq;he%%.BCkDEnEE}FUGGRHH+IIJJ K}KK G08p0^p`0gd_ 0^`0gde%% 7$8$H$^gd_ G080^`0gde%% G08p0^p`0gde%% G08^gd_sHHHH+I-IIIJJKKKLLLLTMVMMM^N`NOOPPQQQ RRRRRRDSISJSSSSTTdTἴἴቭtt hqhq5B*CJaJphhe%%h_h_56CJ]aJ h^ h]W h^ he%% hq;h]W hq;he%%hq;he%%6&h_h_56B*CJ]aJph h_shrj5B*CJaJph h_h_5B*CJaJphhfk5B*CJaJph,KLTMM^NOOoPQQRRRDSS{ G080^`0gd_ G08^gd_ G08gde%% `8p0^p`0gde%% `8p0^p`0gd_ `8^gd_ 7$8$H$^gd_ G080^`0gde%%STdTTwUU6VVWWWnXXX-YYZZ [ 0^`0gde%% G080^`0gde%% G08^gdq 7$8$H$^gdqdTTTTTTTTvUwUyUUU6VVVVVWW!WWWWWWmXnXpXXXX,Y-Y3Y4Y7Y8YYYZZZZZvhq5B*CJaJphhq;he%%5 hqhq5B*CJaJph h_shrj5B*CJaJphhe%% hq;h]W hq;he%% hq;hq&hqh)56B*CJ]aJph h)56B*CJ]aJph&hqhq56B*CJ]aJph,Z [[[0\1\7\\\]]K]M]r]0^O^q^{^6_7_S_l_o_y_|________2`7`=`O`j`и~wwnene\enenenenehq;hv^Jhq;hva^Jhq;h^J hq;h hq;h hq;h~z hq;hu5&hqhq56B*CJ]aJph hqhq5B*CJaJph h_shrj5B*CJaJph hq;h]W hq;he%%hq;he%%6 hq6hqhq56CJ]aJhqhq5CJaJ$ [[1\\]K]r]1^2^9d:ddd~rrmmgd d7$8$H$gdu5 G08gdu5 G08^gdq 7$8$H$^gdq G080^`0gde%%$ ,08p@ !$p0^p`0gde%% ,08p@ !$^gdq j`l`t`w````````` aaaa!a"a#a*a_aaahakavawaxayaaaabbcc8d9d/e0e2e4e5e6e>e,f0fgh$hüõhq;h )6hq;h )5 hq;h ) hq;he%%hq;hu56hq;h^J hq;h hq;hu5 hq;h~z hq;h3vhq;h3v^Jhq;h^Jhq;h5h^Jhq;hva^Jhq;hu5^Jhq;h^J0d.e/e0e2e3e4e5e?e@eCfDf$h%hvjwjlll d7$8$H$gd&vgd ) $@&a$gd G08gde%% G080^`0gde%% G08gdu5 d7$8$H$gdu5gd$h%hl"l#lVpWppp%q*q+q8q9q@qAqKqWqXqqqqqqqqqrǷ|oZ|O|ohq;hn30J^J(j,hq;hn3B*U^Jphhq;hn3B*^Jph"jhq;hn3B*U^Jphhq;h&vB* \^Jphahq;hn3B* \^Jphahq;h&vB*phhq;h&v6B*]^Jphhq;hn36B*]^Jphhq;h&vB*^Jph hq;hn3 hq;h m hq;h ) hq;hHl5mm;ndnnnoooVppqquu x!xzzzzgd )@&gd&v d7$8$H$gdn3 & F d7$8$H$gdn3 d7$8$H$gd&v & F d7$8$H$gdn3rrssmttuuuuw xzzlm(?\%&HI[]apqsthijlmoprsuv𵱬jhS0JUjh.+Uh.+hSjhS0JU h1h ) h8w\6h8w\h )hq;h )\ hq;h hq;he%%hq;hn36^Jhq;hn3^J hq;hx hq;h hq;h )hq;h )61zzz{0{{{{{|<|h|}|||}D}m}x}}}}4~h~~gd ) & Fgd ) & Fgd ) & Fgd )^gd ) & Fgd )~~Q\&p@p~ŁRmǂ & F gd ) & F 8L^`Lgd ) & Fgd )^gd ) & Fgd )gd )ǂpq?'(BhΌ2St9:\ & Fgd ) d[$gd )gd ) & F gd )\]^_`abcdefghijklmnopqrsh G08gd ) G080^`0gd )gd )hiklnoqrtu~ G08gd ) &`#$gdov|}~ h1h )h.+h#.0JmHnHuhSjhS0JU hS0J ,1h/ =!"#$% mDd $j0  # AbGHU \-DnGHU \-PNG  IHDRsRGB pHYsodIDATx^y;;}orA{IzUfr8q4ىؖ-[ݒ(UHJHBD/~w;3[yo (mJ].{Smn4=/vՌzf-deF v4hHTG װm|b@9< šL@3nDLΰObY 0f}C0"47SNggf [(U ь9LN:l%g5rs2ߛufKaO2T"#&w: L8_AXݺϽª^nZ="e\oxX3BLwژ͜vkqW7C{w<;,LՆcUl%t>5ml6|?1M#)J #сo~M&qݴq,zhj85P>˘^-ƘUMEBtthխ.H_7Z# pòfR: "tS(@@0Y@G~-Rrn?vQx]DZp;fRs k1MlJ8 6Q} qlwO"I7h2s/԰WoV*xaz&77W(KUt$S Q ˇ-ƌB'L pE>Nv'$!qǘBHwX,$D+0ʆ4csק`%7-%Rv+^֛aX!REXvԪnn}&vwZHGBPkM+" 1 l-\½1rP޷Çv5;aP4knHp ջ?;|e,v:vq]6GS 4LeyqQ$D`Z:˯7fg+ӕc/Te ߋaD'3]p`D->@ݦ!?'2 ZbI,/HS5\1skMv1-@-1d yBAݑA!V+,/x_l K)E#Pb:ꊷ53QPqmJee94J Z |t ~{:Y5 )= $?z[W'Zʰꈓ(8m|c@Ѕ8IxЌO9Qty `1;S99665\FF(tQ3O |xa}䁁ۍGR@@ ań)W7&v 8u{:'ytDԂ00*y?Rq߲z\vu&+ c9D##k !3*NMP3N~;~'5ۊv öf/}F77_/ֆt E=#*5um0f^11/q[+5L͔\?7UQvW $63JOqP ' Pl, 2"E,evFX1tdJÍhn "(횰b&1Dj2D..$C(/Gm@P.+չ{5xo|lRID :ABkЭ0c0x^O""](GOOzŊ=/& r RC4k7r ,:(19G{##` O a u0g @pNN{vNm{dǓO91[EN7˜X4H$bDɟ|+Tӎuu &],Gm>jF+Cg̗ _0=LMUvٻۈ jMOLK`[SPQfH\C 0,c䙞{V($| f9ofmA« G8#dtaN8:H$Verxx.,GsV*j5VIyC!4)XLկDzFޮwZs2@P|~N48 ¾~.hd)C(K֫ŨM8vD6tvtFmc&̴Hq[;]/?km8xU3p>_5rD00P tCׯJOd"@+~sn5+x]gx+ XЂ@p`M@z9a,#\`B^~H^ٮ;=w[ U@jJD`E^[y5B3Ƭi y-XބD_6P*nLgF½aVk95GN8o` ^#`*9:]ٹ{vUN:jl lfƊGtiْxԝUn8dT  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./1234567>AHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F0 _?@@Data 0-WordDocument.^ObjectPool_?0 _?_1189407226 @96>@)_?_?Ole CompObjuObjInfo  @96>@)#Microsoft Photo Editor 3.0 PictureMSPhotoEditor MSPhotoEd.39q @96>@)#Microsoft Photo Editor 3.0 PictureMSPhotoEditor MSPhotoEd.39qCONTENTS Gg-CONTENTSV30_1223444492 @96>@)_?_?Ole       !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~ HW,/㥰ٖӭvuq}myjwiuhugueteterdrbqbpaoao^m^l[lZjZjYjXiWhPdNdMcLbHaFaFaD_>^=]9]8\6[5Z2Y2Y*V*V(U&T#S!S QRSpSpToWoYoZlYlZlYlYkUkRjNiLhGhEfQnIgHfMiNj^unwyȁ˂ǂ¿㳾߬ޣܦି椷娽䧻诽⫶఼ܳ୼⨻㥺㥹⨺᪺᪺᣹䜬ܭ̝|zwtr~sr~o|lyiwivgvgvdtdtdscrbrap`p_o\l\lZkZkYjXiVhVhLdLdKcJcGaEaD`D`>^=]9]8\6[5Z2Y0Y*V*V(U&T#S!S QQPPPPONMMJJIH G FFFBG JCAHN!NDv#KxJZw}bg;Rv(Hs Fx"G~G}H|FwGxK#J~#I}+K#I{J{I~HHHHHK1Q㣣țŔ~ywus~r~q}q}p~o}n|m{jyixiwfvfvdtcsas`q_q^p^o^n[n[mZlYlXjWiSiShKdKdJcHcDbBaA`A`=];]8\6[5Z3Z0Y0Y*V(U&T%S!S QQQNNMMMLKK H H G FF E DD JFDEIID|Bq5Ox}bg1Jr?kE}EFD?A F D E EFEEE ED@~Ev᪭ҚŐć}|{yxzwvs~p~n|l{kzk{jziziyhwgwfwevbsbs`s_r^q^q]o]oZmZlWkVkTiSiOhOhHdGcEbDbAa@`>`>`;];]8\6[5Z3Z0Y0Y(U(U&T%S!S QQQPPONMMLKLKJIIHG FEBBDF?x&LbjFWG}CI JADGCEEEEEEFFL"G걲Ц˘Œ„À}{{}~|yvttsqpo~n~jyjyjxiwiwiwfveubsbr`q_q^o^n]n]nZlZlYlXjWiVhQgOgJcJcHcGbBaA`@`>^9\9\6[5Z3Z3Z/X/X&T&T%S$S QQPPLKK J HHGFFFFEDCBB@GJGD|0RcmI>{FHFGDDDDDDDDCB ;u尮˜ċŇŃ|wzwwwwwsp~srrq~o}n}m|m{iwjwjwjwiwivfuetcrcrbrap`o_o^n^mZkZkYkXjWhVhSgSgJcJcHaGaDaB_A_>^9\9\6[5Z3Z3Z/X-W&T&T%S$S QQPPQQPNM L L LHGGFFEDCDGBG~Xho|G}C IEDFEEEEEEEDJDܨ˜È}}||{~|{{{{xur~r~r~r~r~r~r~r}lwmxkwkwjviueserdrdqcpbp`n_n^l^l\k\k[jZjXiWhTgTgMbMbKbIaE`D_B_A_;\8[5Z3Z3Z2X-W-W&T%S$S#RQPPPPPNL KJJIGGGFEDDCI@F|bn|2UDBBEEEEFFEEEIC{棤ÏÌČljƈņƄDŽ}zwvvyzxwts~s~p}p}o|o|o|lwmxmxmwivhterdpdqdqcpbpboam^l^l]k[j[jZjZiWhVgSfMcLbKbIaG`F`B_A^9[8[5Z3Z3Z2X-W-W%S%S$S#RQPPPNMKJIIHHIIHGFEDEG!I|nwfqDvDFCDDEFEEDDCAw旙ŒĊćÄÁ€~~||{{yxwwyxuts~p}n{myo|o{mykwjwivhugu`n_n_n^l]k]k[j[j\l[lYiVgReNdMbKbNdJbB_@]A^A^=\8Z;\8\5Z6[8\6[-V&T%S%S$S#RQPPONMLKK JKJFIFCFEBAy2Ox\i Ay@DBCDDDDDCEF|٣ÐĎɌȌNjƊĉňŅ…ÃÁ~||{{{zwws~r~p}o|o|o|n{n{fufugugugufudsdrcrcraq`p_p^n^n]nViWiWiWiWiShOgNeB_@^=^?^@_?^<\8[=]8[0X+U*T(T%S#R%S%S$S#RQPPNMMKKKJ JJNDHI? C1VQa0QFABBDDDDDDEE}찰ΚǍʋʌȉLjƈLJDŽăÁ~~{{{{xwvvvtsqn~m|kzkzixixixhwdubs_p^n]n\mZmYlYkYjUiUiGbHcJcJcFbDbB`?^?^B`BaBa@`=^8]8\8[6Z5Z3Y2X2X1X2Y%S$S#R!QPPNNLMLKKJ J IHEBI%LH|ju{I DCCDDDDDDE E~棤ƎnjȌNjNJƈLJƆƃÁ~~{{{{xwttp~o}mzizgwevduduhxhxfweuct`q_o^o^p^p]o\n[mZmYlYlSiRiPgNgIdFbCaB_@`Aa>`;_6[2X-X2X+T0W2Y5Y2X.V(T&S$S$S#R!QPPNNLLKJJI H HCDIB}0N@YHDBDDDDDDE Eݡ“̐ˍƍƌŌƋƉƈņу‚~~{{yxwvsso|n|n|n|kzkzkzkzgvgueueseseteufv`p`p_o^n\m[lZkZk[lZlTiQgNeNeLeLeHbGaB^?]9[9[;\;\;];]8\3Z/W+U#R!Q#R#R!Q QPNNNMMKKJI H G DJBxJZFzDCBCDDDDE D➝ǒˌʊɌȏƍƌŋƉňňŅƒƒ~}{{{xwwuttsrp~n}n|kzkzlxlxjuhsereqeocoam`m`m_m^k\k\k[iYiYhWfTfTeTeUeRdJ`E^A[A[F^I`G_A]=^4Z)T&R(T-V+V+V#R#R!Q QPNNMLLJ J H H GIGAsnv'LyDCBBCCCCED׬řƖ͌ʅȉɌǏƍƌƋŊÉÈÆ}}{{{yxwwwqzqzo|p}p}p}p}s~nvpxrxrzpxnujrfpfpeoendmclalakak]j]i^j]iZfVcP^H\RaK^F\K^RaOaE[2S>^2X)U+U2X3Z)UP#R!Q QPNNMMLL JIHH HI'P^kFCCCCCBCEE~󛘰ˑ͎͈˄ƌnjƌƋƋƊÉÉ~~}}}|{{x}{ɛϡЫٴۺ㱹ݦנӡӝЙϜОҙό}tn{lxmzmzeqRa8T:U8T5T3R0R-Q*P*P&N#MMLKK!K*LwF}CDDDCCCEE|ꟚŐȏˎ̎̌ˊʇņŇąÄƈĉʼnȵޤȕG~BGEDD@IEE~֝˕̐ˌ̊ȋnjǎȍˌˌȉňˆ͸qys}*MCGEDE@HEE~ޞɒƒ˔͐̌ˉÊÍƐȍŠcl,O>qDz EwKa?WEFEDFB FEE~̖̒ːʌȏɓ˒Ɋï^gCzABHB?tnyR` GEDDGB EEE~➡ǗǓʖΕ̑ȍVarFICFGCDCC#L~z_jDBGBECCEE~頡Ɲ̙ʐ3Q6qGEAGG?DI?yGv%GvDCCDDCCEE~؜™t{1Q?zAJEBED J@BE_!GyDCCDDCCEE~磣庽ݱٓ{yw~w}rzrzqzpypyoxoxowmumumulsksksjqjpcicibhbhagagag^gVcSdSdQbQbObN`N`J^J^H]H\G\G\E[E[BY[>xD JLDAFGCBGzECBDDDCCEE~࡟붼ޣʕ}yvwzz{vvusr~r|o{o{kwjwivgufuetdscs_r^q]q[oZmXlVkUjThThSgRgNfMeKdJcDbBa@a?_<^;^9]9]2X2X1W/W-U+T*T%S USQQQONLR%TG.N'LzGGDCGFGG>{>y2SZdDCCDDDCCEE~﨤◘~}{{zvtqo~p~o~p~n}mzjwiwlykykxjwhvgudsct]qZqXoWnTkQjPiOhPiPiLgKfHdGcFcEbDcBb>a>`9_9]6]8]2Y3Y/X/V*U*U&S!STSQQON M KGGO!K8R]a |Iz6O}D~DBDDDDCBEE~ޥ¢욗‹ċĉ€~~~{{zzxxxuo|n|mzlzkyjxjwiwhvhvgufteterdrcr_o^n]n\lZlZkYjYjRfRfPdNdKcJcHaHaE_F_E^E]B]@\>\;[3X2X1W/V/U/U0T-UQPPOONMM JKKGD HPEZ>sDDBG_k=tGCBDCCCCCEE~㧦śԖŌŋŊĉĉĈÃ~~|zzxwvvutn|n|mzlzkyjxiwiwhvhvgufteserdrbp_o_o^n^m[lZkZjYjSfSePdNdMcLbHaFaF_G^F_E]B]@\;[8[2X/X/V-V/U/U/U+T!QPPOOMLLKLK IFF I#O}bs@yILAyajsIIECCCCCCCCEE~ܮƝޥƐƋNJƉʼnʼnĉɃ~}|{xxvusss~rn|n|m{lzkyjxiwiwhvgufueserdrdqdq`o_n^m^l\l[kZjZjUfSePdNdMbLbJbIaF_F_B^?^;]8\5[3[/X-W+V*V(T(T&T&TQPOOMMLLKKK JHGE FDvB^ DB C(L񁉹#K}@{ HDCCDCCCCCEE~¿߭ʥ鹼ԡÏˈȈLJƇƈʼnĉ‰~}|{xvussrool|m{jzkzixiwgwiweuguetesdrdrbqbq_n^n^m]lZkZjYjYjReReNdMcLcKbGaGaD_B^?]9]3\2[-Z-Z*W*W(U&U(U&T%S#SPPOOMMLLL J I IIGDA C+NDuF?"LEv!JwF~ HACDDDCDDDCEE~寯ҡƜ馦˜ƍɌʇLJLJLJƈĉ‰~}{{xwussrqokzkzizizhxhwfvfvdtetdsdrbrbpapap[mZlZlYkVjTiQhQhKcKcGcEbBaAa@`@`@^@^;]5\0[*Z)Y'Y$V&W&U(U$T#S!S ROOONMLKKK HFFGGDB H CBZ&KH?A}G\uJ{ D| HEDDDDDDDDDDEE~祩ʝȠ͝ǢݤɓɒˌɉȇLJdžƆŇÈ}}{{wvtssqpp~jzjziyiwhwgwfvfuetetdsdrcqbpbp`oZlYmXlWjTiSiNgLgHcHcEbDbAb@`>`>`?]?]9\3Z/Z)Y'Y'Y$V&W*V(U$T#S RROOOMMLKKK HEEEGFDD HAtamgnD>DC}_jit!NA|FDDDEDDDDDDDDEE~鴹֣ɛǜʠϢϸږŖ˒ʏȍɏʉʼnňĈĈ‡ˆ}|{{zwvtssr~q~q~lylykwjwiwivhuhufteserdrdqcpbpao[nZlYlXjTiSiOhOhKeJdEbDbAa@`>`B`D^E]?\9[5Z2Y+Y+Y(W*V(U(T%S$S Q QOOMMLLKKJ IGFFFEDDEJDvw|Dzzlv@tIJABEBFDDDDDDDCEE~գŞƞ͢њȓ⒏̔͘ˑʐɐɏɌȊʼnĉĈŇĆąÃ~~}{{zzwvvutsr~r}oypyoxoynxnwlvmviujththsfrgqepepbmam`l_l^k]j[i[iXeXeSdRdNcMbLbMbN_N^M^G]B\>[8Z3Y/W/V*U(T%S!SRRONMMLKKK J J IHGDDB HEGFG{I{@}L HBrXf8mHFIDCDBCDDDCDCDCEE~ⶵͦâȢΝΚ̡ѓ敔ŔʑːʐɎnjNJʼnƈňƉƇƆƅŅŃ{{{|{{{{yxt~q|q{r|uxuzvzuztxqwqvoupusyx~~|swfl]d\b]c_dX]\bX_KXXcVd'ND]5W+T*T%T RPQONMMLKKKHHGGGFFECCEEB6R-Py]i|F|A KFL[an@q EM?CCCCDDCCCCCCCBCBEE~潿׮ǥȥʣͤѥӤҝΛɜȝȲ짭Ջϔ˒̑̏ˍɊȉDžńňƇƅĄ۽jqCX5U6XNOS KOMMLKJ J JHGGGFEEEBDBEJA DZgkv>uEF>{cl-SD}@BDACCCCCCBCCCCCCBCBEE~ݶү̫˪̩ͨϪԨԦҢҡўΝ̝ˠʢͿ䴻ݖ“ĕ͒ˑɌȌȌǍȍʏˈÆī̹ck3PE^$RKRMMMMLKJ J JGGGFEEEDCGDBFEBD}Oe=vA EF~hqeo(OAEECDBBCCCCCCCCCCCCBCCEE~սպֶձҭѪЫլթէԦԥԡҡПϠΡϥПȴܺ᚟Ɠ͎̌ŏǑȑȏNJYb3O(P OONMMLLJJ I IGFFEEDDDGEHHDD H"M?k4UII C#J}dn @t F JEBEGACCCCCCCCCCCCCCCCEE~ڼոг̯ˮέϯӭխ֭׭׫רդӝҞҞџѠП͞Ǟȧ覫ԐǓƔʒʒȑŎ4N}-N4WNPMMLLJJ I HFFFEDDDCBBIIECB>z*HtIA@}>xG~@Z-Q3lKA@GGDBFCDDDDCCCDCDCCCDCEE~¿־ԼҺҼ۹ڸڷص׳ֱذ׭֩֨էէԦԢҞС՟ԝѝПΡ̞Ɯ♠ǓǐØ͑ǕɓÐ~DV1Q(POMLLKJ I H HFEEEDDDCC GFFEBC'NiwMAFB?AOBEFEDEEFCDDDDDDDDDDDDDDCEE~޿ݾ޷ڶ۵ܶܵܳگ׮ׯ۬ب֧֦զԤҟФ֟ԙΚͥ͠ΩΪϙȗˏ͔Ɣü]d Fz7UMMLLKJ IHHFEEDDDDDFFBF J?wF_XjAyGDDFBDGEABFEADDDDDDDDDDDDDDDDEE~߽޼ߺ޹ݸݸݶ۷ڵڴٲٱخ׮خ٫֩קרئ֣ӠѝΟҞѤӣϛݫјɓɕ͖͖ÙYc ?t8W FLIMJEKCEEDCDEFEGDFFFzfr`lB}ECEDDDDDDDDCDDDDDDDDDDDDDDDCEE~߽ߺ฾޷޶ݶ޶۷ڵڳڲٰخ׬שժت٩ئբѠңѡУѦӟȜҤȗǕ˓ȘŴN]GMOEFKHFGGEDEHGDBIGD Ou@Z?|HAEDDCCDDDCCDDDDDDDDDDDDDDDEE~޽߽߻ߺ޸޷ݷݶڶٴٲذخ׬׬اԩباإԢӢѤЮآ̤Ŧ휟əǖ¡ž㹿౷ܫ٥ՠӞԢգԞΓ}z*M}KM JBI JCIDHFCCEHIC>u>ZI{AEDDDCCCBCDCDDDDDDDDDDDDDDDEE~޽ݼ޺ݹݸݶܸܵٵڳٱٯ٭ث׫ة٦֦զէզԤңЫӢ͖ğǮ峸ףơę{{wy{v}syquorprprqrlnlolplqhpemaj]iXfYj^l_m]h\d]a^`t}HENGE JDEDHFCCGI EAten}DvIDDDCCCCCDDDDDDDDDDDDDDDDDEE~ݽݼ޻ݺݹܸܷ۴ٴٲذخ٫ةبةڦפԣϣϤТΥʤ려Ɣ籸ܠώ}|{yx~x}v{u{szqxqwowjuhvhthsgqepeoeodmclal`l^k]k\kZlMhHfOhUhH\JZnsXhBFLEHGDHCB HIEC~IxoyD|@DDCCCCBCDDDDDDDDDDDDDDDDEE~Ἷݼ޻ݺݹݸ۷ܷܴٴٲٰٮ٫ةةئק֧ӤΣȦɫϳ֕麼ܨʛ~wt~s}vvq|pytr}q{oymvkuhtesbsasbsdtdrdqboamftdr^p\lXjUhQhPiAcEfLfIaVbsz>[@|JHGGEFBBG??vSdWd?yCCCCCCCCDDDDDDDDDDDDDDDDEE~⼿߼ߺ޹޸ݸܷܷܴٲذخجثשש֨ѩѪϭе㞟鼿ޙ~~|zwvurr~o{n{n{n{lzkykxjwiwgwdvdwdvdududscrbrZkZkVjThLgLfIfIeJdYj[jeo>WE HEFEDD EE-MfoSbDCBCDDDDDDDDDDDDDDDDDDDDEE~Ἷ޻޺޹ݸݸܷܶڲززدخ֭֭ӭҬ̫ʮɻ㤦Õ~}{xusrq~o~p~q~rkzjzizhxgwfveududubt`q^p]n^n^n^n[lZlZmYlVkSiNgPgZjSa^hsyEvFEDBF HC}.N~GzDCDDDDDDDDDDDDDDDDDDDDDEE~⻾ߺ޹ݸܶ۴ٴٴٴٳصٳֳӯϮʮǶѕਰז‹~}{zywutssrq~q~p~lzkziyhwgwfveveudtdtdscrbpao`o`n^nYiYjYjUiLdRg^mN\qwaiC{HBH FBzQaF|A KGFADDDDDDDDDDDDDDDDDEE~ཿ߼޻޻ݻݺܹܹܺ۹۹۷ԳѰʰȵ䣢ܣĖǎƉƋdžł~|{{zwwvvussr~q~p~lzkzjyixiwfveveveuesercrbpao^n^m^m^m\l[j[k[jSdM^O_EKBEn{nwBFGIDDDDDDDDDEE~״̩ŢéԣўѡОΚ˙ƛ췻ݟɕđȏȐˏˌˉʈȆƆŅĆĄÅÅąÄÃ~{ƟʨҴhwAu>{LG9o_l󀉾5U8pCNEA HDDDDDCCB FJ @pmuq#VBCCDGBDDDDDDDDEE~ܿ׵Ю˫άҪөԦգӘ͛ͣѝ͝ɰ욞ƌ̓ȍđ̋njɋɊɈƇĆƃ€~}¡ƮѾB^BxAJCA G B|epbmG| GEDCCEGDDDCCCCCHBB;l&RBCICC I IDDDDDDDDEE~¿ջ͸ͬĪɬЭӮԪԤҞϛРҘ͖˝ϝ˥о⨰ٕȐÓɑǒːˉĐˎɌljĈ§Ѽ{.QAzCFHADQAGt~[f ByAEECCGGBDDCCCCCDDDBFApy.QDAE IDBDADDDDDDDDEE~޻չԴѱͯͯϱұմۮתԥҤѠѝЙΚОҝЙ̙ǡέٶߑÖϔ̏Ēʔ̏ƌÐǍŋepE{B GEECGEABJG|1Q>wIDADJHBA JDDCCCCDDEDIEG@XeoBy>|GBBDDGHDDDDDDDDDEE~ܾԽ׻ָոնյմմٴڳڲڮٮثת֥ФҥӥԦ֥֡Ԟҝљ͠ӝ͘ë׽᭴ڐÐˏɑɖ̒ƍȶG\?uAIF?BFEDFEBF.OqxCvB HBEDFHGDBBCCCBCCDDFFAD FDzP`S_?w?IDDEEBABDDDDDDDDDEE~ݼܸݸݷݶݵܴݳݯگڮ٭٪ةةשרեԢԢգ֣נ֝ӢטȤј½㺽ޝǚѐʏƓ˖ɑýnv0P@~EEBDCHD E HFDDGCzEX]fAtHCEEDDEEDDBCBBCCCCCDDDEEBD*OVa-Ly}>EFDFFA?@EFEEGA!Ken]a(KH?DDEDDDDDDCCCBCCCCDDFFGFCAF.Py+LD~KHFFDDDDDDDDDDDDDDDDEE~ỽ޻޺ݹܸܷܵ۵۲ٰخخ׫תש֦֩բԞОϞҟҟџѤРƙ蛝Ǐ̔’AFDBDDFDCDEDEGEICx}1Lu>rODEDCCCCCCCCCCBCCDCCDEEFFDAA D=U^g#J9w?FFFGDDDDDDDDDDDDDDDDEE~༽ݻݺܹܸ۷ڶڶڲزدخ׭׬֤֫֩ӢӢѢӢӢҡѢϙʷٗÒ¿IzEAFEGEBBDDFEDDEEEECCD*KH| DLBEBCCCCBCCCCCCCCCCCBBDEEDBB*fal;P:u DGB?CEEDDDDDDDDDDDDDDDDEE~὿໻ݼܹܸܺ۸ڶڵٱױذ֭֯ԬիӪԦӤӤԢӡѠΡȣà럡›ɕശ٪Ϣ͛̋xCz FFDFHEBCFFFBBDDEEEEEBI;uJ\nx @tBBEBCCDDCCCCCCBBBBCCCCDCDFEE N8s]l}-LA}BEFDDDCADDDDDDDDDDDDDDDDEE~ົݺܸܸܷ۶ڵڵگׯخ֮׬֫ժԨԦӦԣӢҠ΢ʨɫΖǗ崻ݦЗ~x|}|{x}v{rwouktjtnxltnq]iAv DFJDDEBAFFCBHI GCA EFD?~BD I AyZd^k?wFBBDDDDDDDDDCCCCCCDFFECBFFCEAH1T*MD}DAEDDDEDDBDDDDDDDDDDDDDDDDEE~ཿ฻ݸݶݶܵܵ۳ڳڮ٬ثتשרէէ֦ҦӡѢҪԴ㟠ͳ櫴ٛŋ}zx~v}u}oxnxmvmuktiserdr`n_leokp7V>uHEDEDDEBBFB@E?|E|I}HzH{I}Ez@tJGA LB:sOeJBEDDDDDDDDDCBCCCCDEGFCBD DBDGKE?}@ H JBEECADEFDDDDDDDDDDDDDDDDEE~߽߸ܶܶݵݵܴ۱۱ګثتةרקէӧҦ˦˦̫͸ě嵵ҍ}{xu~u}t{r{r{ozozozozr{qzpyoxlvfudtgx_nkusxDx E E HFBDFDFCCGDGBWt}ȝج⪰ؙ{WgMC~L?wFtH{DHEEEEDDEEDCCCCCDDAEFCBD ECEEDDEFDDEDCFFCDFDDDDDDDDDDDDDDDDEE~ཿ߽޼߹ܷݵܵܳ۰گٮح٬تרӦЦϦ̧ʭū▙鳴؛ŏ{xxz{{{{{t}u~zskxjxq~t}uyw|fmercu`reubk~ N DCCGHGFEFB@{FzP\{Q]+Kx%DiF|CDGEDHFEGDCCCCCDDDDDDCCCCDDDDDDDDDDDCDDDDDDDDDDDDDDDDDDDDEE~᾿྿ཾ෻ڶܵ۴ڲٱٱٱٮ׮׮ԮҬϭͰγ랢ꥥyxwyyzzzs{zxnxnysmzal{y]jaq_qapclr}ExA}CBBDCBDG>xI[hcholrC|DFFDBFGBDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~྿྿ཾຼݸ۷۵ڳٳٶڷگѮͰɴʾÔ뼻ۤœ€{{zyxwvwvu~s}r|pyoxwpxhtcrbnhq0O~>yID H JDC GF @x8T[j D}BFEBEH@DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ཿ߼ݹ۶ڳֱӳҴҶѸѝ⫪ɛ~}~{|{{wussvs}t}t}qwygqeqbnqxEtLEG@@EH CF9RG[ A{? GBDHBDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߿ݼۼعԸӸӹչ׸ԹԾןݫ֙ČďƆ„}}}€}}{zwsrrmyu~t}qv荓fnckqvDuICE>AL C>pcn@U3qBFDEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ٙ鯱ϕÑőǐȍljąȉȆƃ~À}}{zusrrr~oysxkqfl3O|BEDD C|@X&H~>}E|~0RF HEDHDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~׿ؽؼػڹ۸۵ٲذٱ۱۲ܮ֮ԭԫӪԨӧӧӥѦӣӟћΙΛΞОɠɿ䰷ܕɕΎɘяʍƿ\fFz@zDIHGGD!Ft1O B9v&NalJ9rA IDBGDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ݽݽݼܼݺܹݸܶ۵ܳڱ۰ٱڱܲܭ֮׬֪֫ըէӧӦԥҢҠўϞϞСК렦ӐƜҔ̎É5RDy EGGFDEED#Ds-OH F?yCZ8S>sCEDBCCBCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ế฽޷ݶܶܶ޶ݵݴܳ۲ڱ۲ڬ֬֩֩ըէզӦԥԣӡѠϞΟϠ΢ʹ㓘ʕ̔ɑĿђq}I}DEFGECDD ED~$DnG~DK??|e1OzivVdDxB{BFHEDDBBBByM[JCBEII B{XhWhKEHCBADGGEEFEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~޾ݼݻݻܻݶصضٶڴٴزױجիթէզդբգԥԣҢʦǴ୯ҞŽjs)K{F{Fz.OYd}駱م\hJyF{DEGFABHFDB BG~L[BzCBEEAB@>}A E?@JDEDBDFDBDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ܿھڼڽܼ޼޸۸۶ڴڳٱ׭֭֮ثתקץ֤ԣӥҡ̛ޠΕ麹ۥȖ}}|~\j Au DB~KH{Ct&NGyG|F|F|F|F|F EECDDCEEECEKA:lfo]f @z FBEAEEEDDCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ܾۼ׺ָնֶֶڶ۵۵۳گٮج֥ЦѧҨҧҦЦͦɱҿÖݳѣ“|zywuz}AYFEBEE>}ICCDCCCDDCEFDBDGFG:v)LK] B} GCFAEEEDDBCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ݽݼݻ۸ڷٵֱ׶޵ݴ޳ݱۯڪة׮٫֩ϦɩȯͷӼԕ墦ɍ~}{zxvtsruz~JQj2QA~FBEDBDDDCCCDDDEDBCDF F9pJZ.O C HBEBEDEDCBBCDDDCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~Ἷ߼߼߼߻߹ݷ޶ܱױٯدٯ۰۰۱ۨΩ˭Ͷ㧣ަƔ}zxvtssposx}0Hj7Q|H}HBCN?DEDDCCDDDDDFEBBCYcbmE E GAEEEDDDBBBCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~Ỿ߻ߺ޹޸ݷ۶۶ع޶۳֮ѫΫάϮι竨Üʦօ{xvwwyvutssror~u}5P~ At=ZryEwDCDBDDDCCCDDDEHIA?y%O]j(N@EFBDEDDCCBBCCDDDDDDDEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߿߻޸ݷ۴״մӴҶӵѶѷѺ먥֦ǕËLJƄ~~~|ywutsssrp~su}G{HD}M_`j @tC@FDDDCCDDDEFE@~>r1Sdo B~ADDBCFECCCCCCDCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~Ἷ߻ݸܸڹټ޷˽笨ę驪ВˆĉɇɇǃĀ~{zyzz{{vvvutssuu} ByBJ?sswQ_GDDDDDDDDDEEDAI\fGtCCCBBDFEDDDDDDCCBBCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~޿۾뫧ÛؚɎȉɉʈȃĀ~}}|}}}|zyxwvvvutst~w}K>FG)Jx+MDEDDDDDDDDCAH`lQ^ AtFGCBDDFEDDDDDDDCBBCCDDCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~㙜죨ȑÊƋȇƆƅńŃłĂĂÅÄ}|||yyxvvt}r~u~w}IBDB EFwH|DAHCCGEBA?|%J~v~^iDz FCCCDDCDDDDDDDDDCCCDDDDCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ܙś̜ŠݟюÎɏɌNjȇƇƆŅńăĂÂ}|zxvvwvvs~r~r}p{r|G|BDBFFI`w~ArHBEHGILH2QdoG@FCCCCCCCDCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~୭̟ȓҝdzܛÏČȒɐljňĉÈDŽă‚|{{{zyxwssr~p~o}n|l{q{z~ExBDCGFv#Mo|?R>qFJFCDCCCCCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~콼֪ƠàɢΝ͟ΕݚʓʐȌŋčȒ˕͈ÈÇÆÅÀyxwwvwuwq}q}p|o|p|ozozszxxEyECBCCH GEs/R?q"GyAXhn.K8rDJBBJDDCCCBCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~۰ʤäɤϣСϜ̗à긽ޏƙȎÏʐʋƈĉnjȌȈćƱĄƒ~{{yyyyv}v}t}u}t}t}u}yF{GCCDBFFD}#M|t}4MpdkhrAvBE EDDEGDDDCCCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~྽խǧơġ̦ӦӟϙǛɛƶݽ㙝ʼnːŊƎ͎͈ȅƅń~ćĆąÄăĭһF| HCCDDDB JBz>ZN`2kJK GACHHCDDDCCCCDCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~ݵέŪéƤǣ͢Ϟϙ̗ʘ̛͗ãн㣧ъ̔ˊĈƋ̉̆DŽŇƇņ‡ćȈϷF| ICEFECECCC|er&L}.QQb;u>}FDDGCCCCDDDDCCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~۽ڼ׹׸նԵմشزׯխԭխիשש֧֦դԣӢӡҠӚϡԦ՜͔ġұ޵ޛ͌ǖʓǏнH~DEDEDFECDFB?@}Va~F| DEGEDEHCCCCCCCCCCCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~޾߽߽߻߹޹޸ްֱٲڱٯڪըӦѩר֧էզԣӢҡҢԚТԣљij靥ϒĖɔœĜH}DEDEDFEC EFEE F8moxcm BzAGIDDGFACCCCCCBBBBBBCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~㻽ݻݹݶܴܴ۳۲ڶർܱ߳ۮڭ٫ثبը֧զԦҤӣѠҤ֜ѡНƜ铚Ǘ͔ƐG}DEDEDDCAGFCEG@HG^:q F IDBDEDCDCCCCCBBBBBBBCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߹߸ߵ޵޵ްڮ֬թҧѧШѩҩԨԧԧӦҤУ΢ҡԛРϣDZﰴڗȗ͐ǑƻGCDDFDDDBF GBDDI?~6U+O?| H JDBB GEABHDDDDDCCBCBCCBCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~⻾޺޹߹߸߸߶඼୴׮׮گۮڭ֩ҩѪԩԩӧҦҤУΡљϘ̥ɮ򖕸ǔǐGCDDEDEGBC FCEEEH=uM^s{DyDIBBHFDDCBCCDDDDDCDDCCCCCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~Ỿ߸߸޷ݶݶܵݵܮڮگۯگڮخ֬իԩըӣϠ͠ΦӦ՘ʜǯӛę³趻ަϛŖy~w|uztzqxpwnvqvyxJEEBHBDDDCCBDDDEHF[gLfC FEBDBDDCCCCDDDDDDDDCCCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~฽ߺ޸޸ݶݷܵܵܰۮ۫٪ש֫իԫԥͨЪөӦϠȝƝŨꨥŗĺݱɥ‹{yu}r|p{o{mykwiweudtiusuHDEBHBDDDCCCDDDE H F!Mx4XCAFEEFDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߾޽߽ߺ޻޹޹ݸݸܶ۵ܮڭܯܯ۬٪اէӬӪӨ˥Ţȵҝްנȓ~}|w~t}s}q|q|o{n{m{mzlzizhwevductgtqtG~DDBGBDDDCCCDDEBF G>x!K~셇?T?CFDBDEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߾޽߽߻ݺݹݸ۸ܷ۶ڵ۳ݯݬڧةت׮ٲ٪ѩ̩ƪô囘ﺿڛ|yvvvwvvtsp}o|lzjzjzizhxgwductbsguorF}DDBFCDDDCCCDDCAAG@;sL`fn&I<{H JFACGEDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߽߼ݼ߹ݹݸݸܷܶ۶ڴگٮۮڬبӦУˢƧű復Ǔ秭ґ~~{wrpsssrqqqo~iyiyhxfveudtdtgtpsF}DBCECDDDCCCDDAEBC H@FK_P\Bx EABCABIGAADDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~໾߷ݸܷܶ۵۶ٴٴ٬ѩϩЩϩϫϬϯҕݵՊąă|xtqqopp~p~o|n|mzl{kzkyiyiwhwgweudsdrhtquG~EBDDCDDDCCCDD@JGBEFAB{er6OAz FFEBDCFHA?DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~Ṿ߹߶ݷݶܶ۵ڵسشزҮ̮˰̼֜ݡȗņĆĄÂÂ}wxz}|zywp}p|p|o{o{o{n{n{kwkwjwiugteseshsuvGGBDCCDDDCCCDDA HGBBEDBD{~cj ;uIHAEEEFDDDBCKDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~߼ݻݻݸٸظطֶնԵӵгʿښ⟟Œăƒ~}{yyxwvttt~q}p|o{nznylxlxjvivgteseshsvyHHBEBCDDDCCCDDDBCDDDFF={*O2OJ EABEGEBDDBDDAADDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~޿ܾܿټֻԻԿ׽ԺϺοۭ͛͡ʘćÄÆƆ…}|{{{zwwvxvut~r|o{ozkvjvithueterergsqvG~DDDFCDDDCCCDDDDCCDDDDL3n.PBqDCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~紴̝ȒᠥŔŒŎƇ€ˆ}|{{yxwvq}q|p{p{o{p|o|p}iuiuguetdsdscsgtsvG~DDDFCDDDCCCDDDDDCDDDDCH D}VfisJFDDDEDDCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~鲯ʛŕڕ‹NjLJŁ~{{yxvusss~sp}o|m{m{m|n|gwgweveuctbsargtkpG~DDDFCDDDCCCDDDDDDCDDDEEAB{dpD[?vFEEEEDDCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~٥žƖ«頻Ĕ̉ˈɈLJҹǹ„~~}{zywvtssssrq~o~n|l|l{jxgwevdt`p]n\mamquG~DDDFCDDDCCCDDDDDDCCDEH?ED @xs}-PBzEDGEEDDCCCBCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~㮰ΠÚÙɜʛꪯΕ͎͍̋ˈDžćĈĈł}|{{yyxwwtssm|n}o~p~p~o~n|m|ixhwgveudscscsfrsxG~DDDFCDDDCCCDDDDDCCBDDEEDD C'L|alCqGGDEBDDCCCCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE~鶺֞˜ǘ͖ΗǷ욝ƐnjȆÉȉȈLJňňÄ~~}{{{{yzxxwwutq~p~o~o}lzjxhwguhugugueseqeqeohpejG~DDDFCDDDCCCDDDDDCBBDDDGBBK B*Pn~@\!M|EEGDDCCDDDDCBCCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCDCE E޿߿ݸ̜ęɠЛʝƽ͢ÑƏȋˆÄ†~}}|{{{vvuts~r~q}q}mylxjwiwivhuguguererdrdrbpao`o_o\lZkZjYjXiWhTg]iN` D}ACEGFICCDDDDDCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDE E}RQnOQy7GlPXu}AR~aihnSWz븷ΨџЙΙ͑뱷ٓ›ȑčƍȇĄʊƈDž…~}~|{{{zvutsss~o|o|kxkwiwiwhwgvfufuerdrdrdqcpao`n^n\l[kZjYjXiWhTg]hO^ AtALGBEDEDDDDDDCDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEE}rqFtHz#Kr,Ir紵ҪȦǦˣϚ͚ϖΔʟԫܤ֓ƕǔȓȐȌȉƉƆĆÅă}|{{zyttts~p}o|o|o|lzkyixhxfvfuetdsfserercqbpap`p^nYjYjWhTgSfQfNeYfy#KB{ EEEEFGFEEEEEEEDDEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEDCD~nlFwNfoC[DsサѴͪǥšƠǜǛƟϞЛΘ̠ӦؠӒĒÓĒĐōċ‰†…}}|{{{zyu~r}q|q{p{oznynxkwkwiwivhuftftereqepdocnbn`l`l_k`k^k]j[iZhYhXg^gXbAr>wH EEEDEEEEEEDDDDEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE D!Ipi @mpEukv$EpٽɯéƩ˩Ϩϣ̠ɥˣǠġơʠ˛ǖ}}|{yyyx~ryqxqxpwowoumumukqlrjpjoiohnhngnbi`h`g^g]g]f]f`g[\}Aj GzJFGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGDx1Nx}JZ2OvW[߽߽߼޼޹޹޸޷޷ݶݵܷܵݶݶݵܴ۴۳۳۱گٯڭ٬٬٫٫٪֫իժըըէԧԧԧԦԦӦԥӣӦιǓÒ̅˂ɌȎȌɋɋɋɌɌɌɌɋɊʊʊʋɋɌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍȌɍɋƑ橭֗ǫڸvvEPm3Gf8Kp>jq@} B|FZ*It G~DxCl[]MUz9Il5HlBQy*Ht>o*Gx?QcfDQ,IBv?iޒ]gIUr*Kz2g>S@W6oK D%Klo%GsEnaj;Ou8Msbl-I{6d^cpq-I{Dr[dY]#GvI~ZdmxDz"I]iBoJA@Fz׫~5Oy&GqpvASv햙5M{9rGap4V EI^l\`8T}EG AMZ4QAq`l昙&H{C JVkI{C>\k3Hq|O@ A%G{Dz#LGzJIEdGxADapgh.Fo[j"KHC}G[>xG AsEFIcKBJ\i&Elz#Fv FBLcI|>|"MozG{B FtBrGEcllr6MtQZCA PzUd?Tv怄GXw3No*IqCmrw~KX{RvhnꬵۓтFUpGXu1Nn,LlV]vyꚢjsL[|7Mk8Mn*Dh1GnZbyӘsy`fvxHW{0Jq1Is1It^h.Q C@E\谯Үӻ䴶ӱ궵㯲ѧɱܾKCL䮵ڌ]]}FPo5IkAe1MuenICCal=PvdjKGC|{DYHA~>rw A{F|H\4Nv6Ryfrs}pyWa Dt8j,Rly8O{F|Cx^jmp8Lz?p 8l"Ezafcl8V$K'Fphk.GmGSxz}nsLV/YVVv>RBr0IvU[dk-Is8j=q1Uivyv.L|ByF{Θin4Kp1Kp5Px%Gq%Dq0K~U{YWr*It HC? ?~P\/Fi7Ij=I`1JuJFBJ^GyBGGWb7Lxz@]KZ=QychΊ[hGC E6mK^~1M{Ep툒(L8pH~~>nAMhxUa,HtJW7R G?zOZDu?~ D(K=S%Eo`ebdvt>Pr@m0L~vyC]?} E ?svyB}DAau"FsLWqwEu'M>|>ucmL GD9nWh~"Gs7TjxիݍZcDwByJ+Okv[^FRyUYѱֳڥit1^.Mr8UCACv`bDP}?R|Űݨy.O.i&Jetni~*>S=Tz={O>>u&Lu#Gg/Iicd㍒Gzz@rktFFF3Vņ7NzIY8]A|HI~I}CC?:h*K GAKDx*IpvE HE M,K|?oq|B{I!Gs!J~AD?v.Ly!Gz'JJGM=ZFyCscm_fszsHLGK HDIfq뉏D}H D7Scn8mHDB Dzfufp} H#GzE EI2K>vGu6clzTh=uD~+Kr{ FEBYj9fKH ?y{GyADGjo=zK@,O0V@ABxE[Bv2OG~BF{I{BEI~xV] ChKDFKcNb>w2TF9z"KB~?KC`HHJI\kH?{ J H?{F{drhs ?rFs2T?}>z Cv1Q ;hu~)TBA Ay`k@m.MzoxAx By#KvPCIgoJE9t@u5O]fBv#M|F{J?}0QDyJF]k]jFZ)QE AAYE]CAEx KAF[ft"OHEy BxG}[jMDA\jIxCFF\ F}D K_o-P@yx(L ?~*M%ID$PivBDDzu$OMICAC$OguK EvIN?xJZ[fvGIJ?uE|FJ>|D!Mn|H|G IE=}?zUbGZ6n-VH@"MCv?pHbnYjID+N{9pM)L>zFzv FzIB~N^@~ DEv!Hp&LwO]Bx K>zI?7SCu FGeoVa%Iy*Gm4Hh:Id{rxI CG~F}FKex߻߽ỿ߽㚢XjB>yGwL}?}GGBH]iIyDI~ޒNY&NAE D~GE#J~ECJy%QB|BKGE{qw#I}HDsiy EHGnsLWHByYlEEXk-Fs B}J(R@~Czkk Fy J D} AyFI]g$JtbmK}DG}GG@FxH{F D]j:Q?T*TBA2S[k EF]kF{GEJCF#OE9yHHV7Ig6Ij.Gg-Fg5IlCMrRx@gEn"FjH GC}C!Lgl#JDGuKvCEGqHEH|ZkDFan"GwI&RI E B{*IxF EJa#Dk"ICHzk}FEGF~D D^i(EjknN=}G*K~WjEE[kJ}@FJCFF FIYeEFFE_EB~ms\i ECF4O}3j&PEw EIG E#IE CJ}?|DCygmI CG~$KwBD6O}EDI}[lED`j Hx?{H%J EHqwA FLW]^_%G FCjz|K?FECD]iS]1JuhuBDB{WiCD\lG{DHICF&N@ E}-QFDC\i DtP[ID GF]]k C D^mFzG D|ICFZhAE#NG|D"MLD Fdl}C|EHy$JwF|J]jNEDHFJF CILF]jC}EJkx%IxFEEFIoxPhFA@Y#IwDM_iGz EFvIb HD&HcqAY#MBFLlrFDerG}EDYjV` Fvpx"J{DF C{`n D D]lF|H>|kyIBF|JEF#MB~F|JE F^hJ}ECJ^GvF}AtenICH HEJ~E CICu'N~IGE1U"Gw%H'J}!L GFG[QgH?4R9O|@A2SGyKC]kG~ CEuzEsu9WCK?tRZ:r1PG~GEYj(L}&HvjtBzJBv|4UD GO_CxCG\g#J C?z1T@zD O{xGCHF|;M^h8S>~MA|yEq"KBv[f$OCG~ FG H~B @H^h!Dq1Kq7P>wEC>S;pgh}F\i*IlGzKFK/K}8ocl G@LWierDvGZ&LFEEYE{AB&J}G}GJak*MICozBtH ELafhrr!GHF-P GJG\w}>uAD1U󡠽/QCwBx9T遉%LA >vKD E{IGF|1Iv/Hp&JAMF_is{Pieq=k]f FDLTf'IqBkpy.Nz>v"J/L|F{GF"GvI~ED`k?sBHVc @tC{%J]h|=Px7Km#ExFCy CzBB4TjwE}B>x-Rii]]|doEy#LGJ]雚Z\D~ @E%KF CL*KD~Bs9Mt!Do[`1Hq|gm BA?wmz%Cp0GvK`?|A@}bq荍{v-PDFKr}DyFLbp쉊FLn]kIDEIGBD}^g&LD ?w;VcoCjXcG}CBL^oq"CcP\Yb@n0N%Dm}}.N}E~Bv*IoCnC{Gxgn"FsDxHxovai&HxBsAo,Iw4Ly+Hs#Dn&Hs1N|>S}#Cl"Fx?UGwB@{%KycnK}DyD{J~7R{S_XbN[IUv3Fchf_mFu@sAv1M}8Nz4Ku'Aj{DtjwCv?u AvBWұߤt{CSz4HlIPp~ ?wA"N8VƬ׭[kJ>}0R]d2N,KBr*IsV_djfk[c,Kn+Mteo"GsBwArS[mkqtwyR[_fBVzI\{2Mm_j~폍U[~kp앚ho:Ot*Il%Gj3NpQ\oxX\}ck(InDs1S]ffs3V Bj(KlE^/Mh\fJ[&Hp*Hp8Nr;Lnlk榯K[EXmszxY^v}}V]jqZ`KlQZ|.Hl">e@No򆄮8hIHyHUuox|ꪮΔ↍nn᎔kldmGE/Gn4Io(LAv/Lv ^jclakfnꍡՄˀˀDžÊĄ–ͺajFEAwESz'IzFv^b0V#NAyDr^])K|!I~5M{cmFD:P}궿mrji*GqJA~#KxMWy5Ov!GqGu-MDw9m-M~9Qzz}⅌chYmODyHzM{.Oz3Mw3Ju+Jt&Jt#Gr%GsDr\cZiFEAy!Fp >wF5Nu䗣quA~C@G{1Hj;pEExemGE.MyX`F|EyDT~GpGB!KwDT|8Nq꒚Yd ;g8atv@VDu&HoJx@zA|Iy륯ktBoD =vT^XhD FBv]c*I~!Eygi;TI~CqDHELM[#M%QG~fmHE!Gp%J|>}HTbIuED*O|!Iw@mov3KqEz>w!IyHzFK+O邑M@ @zYdPcG EBuۉAwBC}ڿCFBF~\hA~CKdmGE&JrCvCAWg-NCEATM[@pr{~,S G BrKBLTdMAAJ{dsLCAxILGӉ㌊zuEFCGfsA}BLcmG EDm KCEapEXDFX]t|ArH~BzDGyH~? G`ngDIDwICD{;y DDxڀgnjnᏍFBBG~`jFAJ}bmGE.L|BZCF]j[dFGdf@V >s!MBxF&HvKDF_m>vJG|GDH~+MIFt񐈝ጕ􌍫咑"V J HI^fK>xK}bmFD'Jz]i?{FXeckG}Him$LDJ&H'J1LyJEC\lB| C!G|HG%K"IA}Gvz慄st>cCC*NksK F"Jyۻ޽ⴻݻ߽dmI E0P|asCH[k]fJG{dm涼G~@AC_ H~Bz(Jw緽繽޷ܨսH{BFYi O @{Ev AvEEx屼޽嵻᳷尼߶嵺ݹ㷻߽뮫޹K>z!M޺imPQgMhH>EwgqG} F}Fq𔎱gaAMjBPp@Pt"@f5Kqgkir1Nr*Jj5Nn.Ij0JnBj9P}ZebjF EGpவMc F FMd޿kuH~>r_nel.Mn&Fk3Ks=O}5M|G\lv2S ECD{}J]%Jtw{挑\\}wt[f*Kj5LiESt6Kq)FlY`˩q|GI6T乾㶹}Y^},FdGRt'Cf9dh$Fq.Kx'IsWc틏Y_Bd?V(LHz@XGyBF\jr~J?tL]K MBx⁇IY}#InFk.Lu$Gs=Sw|옚ln'Df7Kk7Ln'Ej5Ms*Hr;Scp퀂`i2Mv]e󁄰KY!EmYanxGY9Rymu4Nt1Mu>Q}&Gq@Ys}gp(Ii'Ls*OFv2V{syDT}'Ei3KkESt;Kn'?e8Ks]bꎎ^]}KQnCOl>Nm>Nq6Inbf툇dgnBv0RhmGI!Jukj1B_ES}>wJ EDHU7Gi6Fba_vcm>wFfww{FSs4Np(Ko;T{0LwxFЁ.Lt3Ox(Iu/L|'Fz9o AJpww~?Ru5Nr&Iq$L|D|@|FFzpzy|/KuCn4P{ozۣӀV[>p1iJ]i?Mn7Gigg۰׉UV2]\^KT|+G~"Dw^cP[*IrXb֣Ҩ]a-Dn/]OZ߰TVu(Eh(K{4q S=w1TCgyDFH$L~v~5O @z%PF@WV8Mp}ۭu~3OGJ C6WzFXBT|ݵ|JJK6tScExB H^kEq@nbqGA>{_p3Qu`g'N>DD}t|9ModqY_mpgmam_mdlhnhphndl`g^h%JI D#Gs\j>o8TL_ B}C|D[؍bm?zF @mhmB}A&Itbp DGRdfoHI5m[dfp?yJD{fqL_>rN>{@}E3K}~|6oLEw~.QG|8Nu @xD}HH$L}@[=kdpP@B}s.N>?=|KY7R1s CBE{G[GB B1REyC GWgOYBmZd GO:p$Ny|H>|?w3U~=Y@}H*ImDqAAC|.P8TDudpA D?}6Oz|]f;yMJD|DnA\CJFzᑖzC}F FIyDs0J<|JclafAs-MztMFG}ai@qCz{caȀ}nk{?fAI2uC[/Il_d`g\i[hahdidi`dZ^QZ@U?u E E-Lz.P7jm{}GJFx%Q?}DuimF G$GsXfGK]jemH@(LCw EH+Pkw CuJKDB|?u?R{2QCBFYDsE]Er CKGDEqdp?rE{9^FAHxH~EB#O| BLH LMbBGGF{EDD^|DTv+Egv|IA EtE[HNEqcpGF&HpGsHLG|~pu5LowHJGtxICE C}CzH?|co!N>EXe1h?W3O BHel,Ku>u&P{I}B|Cu6QC~ CoZnA?IbpKB!GpU]Bx1RE|GD{zEHK~lpJI!Iv\iIHlzgnO>|.Q0R;{EG}\lMK CD D@y6WoyFJ I}Ya ItBu@EwG D)M|1O | B{`ns~J CC}G{EB+UJb9U*Ju5Nx.Lu@cV]HF/Rio GDFxYc A~E#Eo(Is AGIYy FHH~/VSID2M|UbokzIOHFC#MHwEF]kjuE|9x>IA?xI{_mJ DHy|%L C GB?xG~&RA[9c KE"Jej C{F,KwJK$V{P^Cm;Nvcf G>xFxgk E E&HqIz EJ_fHFdlamCHExvvC_Fh3Ll8Lj8Ll7Ll6Lm6Lm8LlUFG-M}Ch|肌-Q9p>zGF C @vI\G{E%IuXhC~F1RIEG]mE{ EF#MFCz+HC FZjE|CHzHDG|nw/Nx&En|JEzG)KybpKH)J|H}D H^l"H{DG%MEG~+H|D FZjHBG{GDH{Ta2c%K}\dE~G%Ku*HvFF~ D~?}Gycn CCFz#I~C E]kwy4M5i5PDt@ EelHFJ{&HxDGcl覰N`L ByHFJ:tHZHHDu`hCwG"MBA~Cz`mLDCI|elFGCqG~B D^kK E&QG}HGydlEE&HsH}E Eo|O\HH`k`nDCIwBB1VJALL[4NrotkvFu FAeJGFBt D|K"J{| C~ CGG}D F^kJz FGIzDL(H{D FXjyHBF|GDIyG~? EDH!Gs*IzG EG D#K}cn DBF|%I~CD[jQ_FBFbF{GKpzC~GJIt FGdpEb>z GJorB~FEu^m?AA{gnDCEG|fo D FHw(Hz >|>|Uc(P EDE|CFygm EE GvG}DDcp.O| E FYh\mCKG}uMG}MGHbm7SU_ey IHDu F} JFrF|EGwHDE]kI}GGJ~DH"G}DFUjq ECG}GEHyr{FEIE~DGs"Fx G F}HHG{bmDCG{!I~BDZjDvH E[l$L F C|B~GIft&HxDFszIBE}fkEFDt@{I"KhoEEFF|eo?{D#M~`c0M>|HCv CLE}HFxilEFGw!H} E E_o%LxD FYgZmDBDzG[Fz$Kw7UH BC~}&KBAz*M} H JAp.Q B~>{<\HCD]kGF FKE B|G~CERikzBBF}GEHzioGB CzJLHvBt FGxE F Bu`nDCG{I~CDZj L F F_oCuB F~G}GB+O*GyEG^c'RDF~z~I G?rJEE|ksEDDK[gEAJ-I|FFB]DyJ Gas~FGHxkp DE#M/N CC%Q%Ky?}L[hUkED E}!Dm-M~CyC A&L/N}仼F;pTaJBKjrFK D}umoKC GWcGEIguIDGG?ELSdICIGJH~?y?MLCHyArJG`jKFKdpDD E|"MAINaCpJ?7]!M?D}E^9oOE}Ǿ>qEGjp1T3q,MC}G H{Ꞟ*Q?$OAD FJXdO HHim{Jfv{~Z[t#M?{ H#RJdBC+QlqICIx_hFEL$ItK B~3OzLdHG#L>Pv?R|W[%En=UD?Dwdi\a]i >t0O BvD HfwCX4nE9Wlv?`JDFzF%L}EsF @xdlv{C~@~H}XeCH#L%LELI[=RzA|EMit C}G IJ{>yE"Iy홖!I~AJ^gsqKVz{F~Geo C{BG0Vux(Ef푓}Rc¾ⓚ]fGy DFF BtaiCBBnE{>z@|K^ͳ಺"El-NBy-Im.P?{ =w/M}xz2g 5pG^k鑒WZ+Eo}nwJ BHtu"W9nnupv>k=S0L}D8yBo|ܬޭBWBz7n!Gzcl˪ܶ埫pz*KuEs]i BpAG:O}K G=pgrAuw=|?}]iͳᒗMX*ItF|HFEo*IrI~Hycgkn?s C|,OKZD=x.M~Bq?z"IMXJ~A}@x!Qįݷܩz{HT'HAGBvI ?|;u5Qpx敜3LwKSy)PC F_i{|7Ju>pDY*Jv:jox3Q={IKkx۶ެ(Hw+J}1P2L|$FtmuF{(J~*K|>Sx/Ls @pJ@U^nL >u*G|-IxCm&JtFZ&Ir*Ms~fr&O BzExCpr*L}6R~'LpZa{Q^.L3MCp-Hv.Jv$Go%Gn0KrJY+MtGx!GxFSy'N{K+O|w~-O}"J{oCs&Ft8Jx.Bn4Gpaeou4OC}$I}{|v3Q7PBtAm0KuOo=KiZZx}|4SHrꝥ́eioquwfiv{py[g]jhuvxoqjlbdklfkwx}{jqoq}􍐱pw۶ywŽ㉐mtimfkotx~KZw}uv|y}ջuvv{ݾlo{w}glknmnop[]_dmsiqgoZacirtiiyutptrz|r}lvgnos鉎mr`dhlknqt.PwAWy+Lt{>V1Nx#JyU`N_Bo!Fu,Ku*Gv(G{u{t~Cv4N#M}>qR_jzK`v      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~sxWw %VDѨ 2U(`1VGB0(|-? ۖm'jvv3L!/oϦA7a7*d@7/6+>\ܙ@FJF+R%p/a;=Rbn%&<3OWoB41{QjVAQׯV!|pCPP鍩-KqU#T4!zH#d'XbW Țu-R] u[E8(O#G)T[(C9ጩ! Sy(x |Aғ)_pS/a_P>8!n~#}Բ2 80bʤ aI,SC3-|Wϧ40&8;TGd!rwWoDJQ)d[V!h軐 fbP0[$ k.Ph,'N&hExq`eYXoFЇԽq}R˼cd#\^y.@9.d$2>++. lR 9ɡa7̘A>rB^"\ᷖ- fbHaN σVRZqҌtLAN*I MK>9~cE?ޟQ.ˇ3Vʥx+_鋏%:`|Lh濼 i҈5x+O_(>rMQY\`m=7~( 5>rQ8} -[!#?߰#."d*f:2 ^Xw'DYܹo ?g5DIU'1Rղnx% Q=\y`H#0#,ܠ/TIv;;A'C(0B2AGl:qph 7.?-][AKݜ(9IaLFbg"V53?~51|݃ce3ݲKG@qs )v4;y{#GN6)N$'#oYӨkEubh 3mԱSIvue3x", #Ȣ.4XhbK P"CDQ\ zF )_|y0 2I*:: ^ ~~TAJԈ P E&G׫.M9c,Ĵ|Iv\0X!}5O"h4 =Ѩcm:os*KgbNʭ) (1qL#*+ s>Q:=xaQ !q9aoٸU<օqA@a)F̓k0 .#v#ÁT*c7ѝqpu?pڔ af[rM?8𜉧GhP{>+#; -q̗2Ê @Dyb|XA)7jY,JĠRR)Mx 'TmX+W׽Co`ٔ5ZbJy|Қ pATbŽ3Ŝ)E- #Z'"ZFÉZ8) h\"ahcmA\Uȶܲkv<)ʚNw -<0Iķ?o'FqT\Ԗyqp1^< 528~tv&;.3R!ۨ噦7MVڋ|o>gŃ+:;Q3`Ɓ;HH25 ,]axr81%S(XX)}M޸k_&d 4cBeDIrm,?iff!N BU -$s&MQ\̣2@.p Qqcb_L਍IŘ]Yʫ^Ö-MVrKT! qeKЋ%gȕA6♨ajU!i 9͐"F,^asJB4 Qq1 żu. "3Nsn%2G<T44R$Qa֤7زb+4Thϕj/nw+ciPbP2ȹ=l8୐eDNDQVHw*.mjhA1YܣR䵅EzrYeƐ-|RDOw.| lԛD #H萃^Ը $(;IS,=0DT+F<%# ɉTШJ]^95CME MT3Izwݶqpq^?D"錩V lc0fC ʅ.9gs&x ,\($IeOu &A..JM"H@P*ҴmCM.(sY?хO}ziYY~*# Vg,lP)v<;>woTKwO+Wn!y!PLH:3ɩ1_ꨋb-|RAvD2ԂI ^1ؠ*H#i@>7OCɒBāB5 b rSp-)GR*Y,ډh^+]v;u֭Ip~&_18S4۲`WUǟcx8c$#Ҩ!h:YB/l]{˒Q y(u@dTF PdhqJ<_6Ȕ يnK0uګx[ЃOag<ZA`5pxfbʵ-̠d/:#p}9tBz ]w' 驩|._)c@ЬDNB*QLO2Bu77ҚI[+3TMHa*XG ,/.6"*`_Dd@,+W5>|ݵe c//|k_}=<' 4bp t bF_5})(tk;EbLNP/& YƸmH<=]ÿ;L5ٚ]^h[_+ǠD{pJXF^͟/=n\gш 2qnHh92{ķ෿w'v:<1=U]JVkѐbN+djʮ"{JD ur`߉GO[$"v!%`2I=G >DK4l$Lrީ a4ZAJ5F#N+=iv,4"YHRA&BDGz >ωΔu*A,d)^y oyXZ/l{ŬMוֹyu$ż~)WY'3]MZuANf*ڱ#GKSk֯Z*LEz =5gǧrh^#٠h`$TaX Ø ( Be 0Ő$TĹḷ , =ZvtaQA(e-4}pa:TqJ!~6GaD]:b%'Əի$ JMr3=8X'$PghY+Vu7 #'Н=PVQ +{.x ;6#O8:ܱQ(3q7sp:$oٹ"ޱ}oo} B1ss.aqJ?;bIԵ׼И o7u +fONt'ٚ]O򺠎?+Veg԰@NhRŐk?|{c]ٸܻ'/%ļHH(T CN#zΩ^Hŭt0CΊ1+ m$`rg1HwzTG AfL^#,hD%Z0][ 4 Hq6%k>iT< %H'RGFTR͸&FV.] xˊ%"Ŵu؀ Τ>TjgAۊ&R؂Vh w1E_'/4T+hg2Yʻvl =lj|aX Z,ݮN/h.hHX[ .blYB6)RdE8 11=a 0s| J&cȪ`| OdX7mAWswt j|갠@~Nrf ӣU ٛBiD<Bh[/BfB"(Bk`n1 ȃН:FvDG#ZNRp}pPdc&g3Е? ا /~gfNE^Rf+P$ R:3*WCej/}rlb)^buʗܽȡC''P,Ϭ2jcee;T JCf> - X2*$w\<\&Y*p2C!`i3Bx%v8S۬ @L]}eD).#O1S`OLIA&AQ,ߐl!o.g$u,P(GsިV+Hpb g͇p2-AA-Ui惋ggpq .NaԪEP:DAj; ܿg񉉙R<ޮV2Q޻sĉJn %S$ Ѧd2 (X#L|O,X-cCxFQK CH~j #.cY*SmU+Æ>s,X L]ӖQf7rgr&D5R9hjZ<6|Ɋ˲r~RH:2r4\i "Sڂ*md%L5X(ZI5s/pCW:*C 86_LoA?ZF8D5|4/?4iXGjra6l?g~U[i\ TP<0bE4X >8:GU, S,1reOTxGgH2M@zX^|d(B yР>2%؄ty^fB!fk&|x$w(*?$FJ*)ʑz4 5î;À5v$#1ROL|}A AhJKd#PEZ Gfw'_wU~\"GO?msHn[j3~Nda)kbrVc[^ٮʴI"0z10XgFr~~IZ^p!BR]ğX39!ta9 7O0Z Jf2V㠒e @xeEMwq4dfP SXj\2DȄKS]L49°l#;xoћG-XdDY.zSh2* @m]ǜn|$3mI.NA 6 ;˖pPlS3(G\{E˳ipPUԉʌcFvyN〚f`\\<;6Y/<M%}yox`k+!$>%M7m;zm?17!=?] 5i]y6lGi>a@< Ka:j\8ۃNL 7O{ۛJE@@jV-_Ur\nn 1a+abFt L" .]9obؑΞA⣓6!lHd6|ϤMTA d [Q]sŚJ3 SAV# vJEh͐ƃ]ѭ%Dk=mJXP >޼tG.n%A.i4r^\-q^#CD2v^>6oFK8$#w]f(d80(0lsLÚ* 6BHp &v:-|?:r \L潯}yۍ<>h$ UHB=M 49)SA=yySB ~&p )mWH0-;OKdiWU}ɠQjm -]{n&^acЇBIp{>h+K)~acdܘRn)B;_ ێu>xG_{ߵ쭷nOM;]`/5oاȚ o/rL9'!HGJuL.;57 aNBA {K5LPll VaF s.P>.?xI$IJa҅5GM8KFQha- U5@}`E+ҙxo_/)/gH˶wTn6A,&'.*'i+j㔔3pC J4zb]0 P?Sr'nAb_|J=h4 LAnW"rMYHHmncr8R8a}nF:"S)pTAKU;n? i覞JyDZC1:y9C NP!iqODY6z/ڋ˵v;Rs] ȫQb}B %1qn*`"jJ+NF /*J.WC[ 7Om*`H82#eOwL"j,#%v~[=oUR61QK݅cSK!M j.e/+VlXg70CE_EBgrY"σdu'= ӐYޑ).6rɟOA3rC2nai68ԅ[a }H,_幛A!m,`"HBsR2TdDjEc 1nMZ("Jt_ ErN45D6 C) yw%TEU%Ө>VKKu q:]> U26jQ,6R9 -2Ͱ/4}5ASC%rbG5$+9LV_00PN_~cٕUJ9ԂH0Taf`)q?eb>h*!ؑBW{{#"nxME 1=xHW? s(uWVQ`ޑoD=$SrD)ۅkEkeXF#HxiUx d18Σ~~@<+^ؖϑbHpvCvRfPj;Xe+YUʾ=Z#'v 4D$Y|yH?\fMq-$J7*w冷iT)q E )Ƥ-PӐeҌ/Xx֌7oAڵTV"DP[|! ¬1yLvBu4DN{ҝ٣?khqCBfC~7="U~HȆ{.mW?\5tiR7-®I;ȏ^ndI |}Xĺq +#;&Ơ%c<,%1QB[t:2;^ɧMXS܅Eʹqz=d`z_E"U&7vI2g6 dyL!~z˚ل)Uђ5ٌVǙ'&spyՒ.]atGrAj6kZzlЗI%cA IO* ) M{EhF!/StJi2c[\Fa*rSO}*B"rX} I,C\ qd1>J@)y^13=yZwDPxE.#Bb 3"~ojIb[tΟKUDuqS0OxO1iztG榡B puS fsñvՎJHIJ/ ^@]@ԓh#>a,RAWRf%e$]O]Z;A-:D]Q,`_L0D%S9]Ft1ٞù߉& [o*Y1l9KѸdL,}n.jN";&$xht Zj^l[[jFjבɬ:stDu^9?M]qYm&T#(I(2!z.R}pkV-tݳΦ/k )6Rvh~ '80'"o]o7lÈĩ~Of/0N7N9K2<#LnC#TM;k8Yv=dYWzK|a\x ugA/qtåGZqhcx#1) H!`ZjA^U o0QXcE. 8ȩ@ )+Erk *tZ2лt`oP=ÝSsT3FVA9 W"¸A9Dn‡g+3\~nzzyn RUؙ*2}`۱[b%l@s,U*Uy^*w 5.QSF T,]-Xؕݻ'n/?#_u$R3.n +{Et t V5 0NVk38tU׬FO He  pXur?|7s_{_EMNqFbP'bm>(x,t:.AjIdVNAxYBqQxk 3)2)O/0ЅK@Z~L&:P.hVKt/_d`E/4+w>sTx,_ڹy˚)ц$bX;9)eMUqDiv03=/R@6P4e/ź1K2w+qyJ|)baPcRw Iɡf8 uK6o\\IQ򀗭 zT6!#NࠒA2\@ Ļ ,;&?{c'D\o.$( Qʼ$׾[mB'LB(xo/A)4bK!+A]dv6&vRp(|PW v8hBَ&4Q ē(pH&H#0sb"?$Mi@ᜇrafkz5i$Ef'.dBF]b%J$Vlݱnd_xAB!4` ՜mk.ڕbDt0x$8(y߼Htg@_VC৕R%čǯ@Uڊ8o8\;16p])8x:#yR'ӊQ B2 s:OCN` Fc Hm!Zl'R'pP}Tdc0 [8NgұtY&+] O۳j&Az9}ktC"JUtTaϭYdlQFEQ^Ƞ#4^lgFC2'`(,ښ}]z[2 #`` hc IIXJ X%M @!T'૘)o~`Lŋd s8 !o rx׬J:RF<u^HtkфTJ;IYO SGHR.Z.:q0Hť;͛BSqV%ɋxӗ8hi6Oz,_xq"8uBP?y  2ǛpiXS3KlW'wÇUoBqTNdWo`mLR1ubʓHHD.DJXxVSzLR.wzP; w2:z3"G^|WoDln ?|۟AcT*'2 N2(!6PQӅ A\B7JǝqU(AYBJG#sG.[v]u͚,DAF]%zTvrS WC!& 72فpxjb,;x|?7ޜW@$sox7oHC>Eh >3;׊L2Hh<9޼6(qHԩVhT4X. 1ȄC}=~z-xY )p'&B*&VL)N$![}QDqO`} W %K{sl#Z`N2y(<1r"Ll:g݊9#^˂W Sqj{S;1YT@ QBA)1IK'p=d"=s)o  MN(G{b!vLU&}w[.|%4X6QŇlQrRieF$D[ nPL!#XO]]KNuHIO]qUʠF5P&vi*A-d*ꤷ</uR*J#ט|@r]zmt(Z75Dt(ܻ$뎗=2.ܒȈH^},+b/ ,ƊT2ծ$*$:L _L. Hq\S=3a|‚WwLF%=W.]17E`R!;dq_׮Y7b0Hy GNJ;؎i%xNZ)!ܰ>^ '24"ʯ%tJF7FƌŻ ȏID[Vgtw^ܷs]Cu-+]z8'[H+AcAn4nEIJ9|z[;/,&#o?%CPRٌ햀Z+/>&#s葹RidK= ZX)ifؓ~n1 xk64IF>थpw_XCӌUh taS&#adS.G#CDy"XCX:fN$Zۨ5z`tZ)vwwm޲qhM:0>>2/5qxY0^@84)g<~2ZO/#w #ۄfkhElm~IoD"׵U˯ O QZƦ" !W0@lЯlo5*e*>1aJnbMS!;&twTZ:Uᆁ#RQ'\MCJcѯ|{NW*ޯ^e((3je#a~X-7oIR~h|OFdnU\/ yԯzaҼrnbIDSW'W 4,h\`(odnb5%FV2vMn +(Ìcڟf0 0Sk E#csHtCC׏R?vpfa笸8@x )e᪌?:(ăM7 aB 4dq8(5L4YR'Q#8!C0l9gUWoZP t,.`~jGFגE4`Xi0)t3\.FW$d R X\ )ѓ-v DpQ{}t|#ѓ'coZV']|X0a]f .f$/ lͽh]N/fq6||%-0)XmkH>޴M kI%ua!z+H!x׊0٥xrVTiƥOR! SF;zljr.o6 =zb5y&[[[3UԊ<:(W3Hj##5u$[5l"_4$-n$` C` NQwM5RH<ƉN8K("bSqPϔ.arUU.dMՓwr7A95rRr(|e};?KGJьUmɆmhD*"pL$C/!wYYR9>q7w1 K8دԥ#RcW%pm '>ZDĠMFc-ܽek f^ tHy2<=+$=KBZ7 Zslw#GWdK|~_ou݈T>ԁctaAUDa$#Ĥy 0@c9`><4Hrl )Q)*ZR\de'ƛpߴ3cf% ŒF(>A-FAEaM2BJ~h]ϩ~h$\Rh/pa䊋HjiFᒂJdBB֠Q`e\nv2as{J8Aѐ,>g,#oD _udp$T\P i@J"h+][͇l+Կx+[G6Rǭk0r~܅M)C:rnSIF|i6Oc6ϵ5LFa*Mc#"qu :`N C OU+8I*F{w'ET@^C:uH+W Y# Pyz-qB>@ӌIo| B3)=pbIWP_& ? Q c3*U¨u,rjPhXېE@3l /M[:P!KuH54-|G(ӂ /@ߴ\v;?_y\1(J 6pJS0>(癯v=9 X  |1@\xީ/~ၿr#[n?4Cl^&'q T_KW/D6qp):0ñ( L3@BQE`K,ɵ'ʝ[c4jScXw A ONtUHKEodq Z p!9ɼJARHoOf˱؎†Kխ„Z@(b0 [.#/l^AOaK6"/?!DH{aBocݧDwugod(H̼g5X5#CA/U` FUƱ·O?D7}׽!QKCC nI2_@^b"E%蘈 $b9p=}A&19DE6rB7PKkWw7jnX?DP܃t0nάfr} ҙr_ozdY-z3MKq^K, /83ai,\ H ^:V8%YGplR|/ FLenbDUiKw!4dDQ L6ύOA}EfpqB="|eh,D} 4=:<2uv3X* 쳒(n+' 0ɧЂfr\%03V{i~P"n)V}=Ƕ蒎~O|~oؼi1K6}=c衚DuS3o|;x㣡T__kRi֪X$l#5CKw'.{; ܄8D?xGc5׷U! G7?n~Ԍ䘔yUg ftʸ)"3!if G'Ӈ{d4>;[<~d9T>ͯ% λoZ`lӾ9)E7^j٢_.YkʈhA+5^-bX*yHr8 04¨fbK% Hл25(/,]}r2=5 BLbZf0Gm}d|ø L$3پ4ʖw7llJ$ifQ;i?w "t#f_C;L{SJ! e{2s}Q_ۿt_T͉M t7ǠbS3]Ȥ%Oy;LCBQEGZ˪~ _ e\p.**j~ѯ؅4x0YPD\m|ax5,q:. , |-A1iD@XpI`f >@/BPBtDN=9ɤ@ mX## Yr`(Dm2ޮ%zѦ PBqͤkYRe2$8SI7`6:X<0%zpͨ!AZCJ[v}8>Ұ28B%uuIfJW/kD?Coxi%H:O 'Y`="*%^ŢeCF l ֜jv#3'qJ2bы&ch,pwx=r "NѠ n9Lː^3_m\~%/>{\l2VNi R4-\ŭ%%KWMMRFwQ oOK`U6Aa j&YqWAS않땭RT;].ҩD17Ҹfz֭d}%8z{˖GvDp$ l/KzWԌVP9 WJ_Pќt:4e[P٭KIX8T@ HtAѢۘ+o}pg1I"hv01=3> _#_ <1fYƙ&n# yۛo=pȊaK$bzy4й PY!Ջ[5ygou cU@<_]G|ˣ|sn<=X E }G\ijAuʕ;\Px<= D~8NW;ٗv=Aܠ'׎m"&,a _/>`sSt#JP |f@ =0|X.kV2ɓE{E Tв-n8oU=YhR_?feeI@a~LO&tOL( =ВlѲC)~" T&5B<$N"_C{ggB@ݔ1p*R-BI IիzӈKsLHe/}3O_㳞1d\@ ֭˚͍V>4G!!n/ʉ4zmO|g#p*K w͜=߱,2ETਵ8;G@tbbV LJ@^aQLr׃Q-.9=ٚL'*iwd~("jA=@TX4?=% n̖:]j .[j]/jBffPhxE [^tݸiIOg<(:{k4($):5q s^> RM ).v8vm|j1 BdIp`{kfRl DĊ@@ 9/o\([h9nMt;)TsTG`B5br./Y E<͛G d,rR极["bJ1P?圲Ro >XS?+pُ!ks=r=k<9\Rm8.惋r@,xp'U^tȊؤ&z9^C S \rh(r"2򞦶 9C# dٚϩh) 5ʅl6߷ qGL Xjx5+\jnc=R9#IXRʵ ܲ=F~: 0(ψ3®gx>1h|" fnёlaYV2.T'+_k4bЪzƄrfjUVQHfpֲx.?o˖Ëx1dXQ6sןml(qxzC#3sȼ4RjH8GN%꯽1'nX/H CNJ+(YcvbܙpPN/>YS^8[!@oⴔh ]T\% y+"(I(Bmt2H@AFTuIHjɍk7]՝({m?1ztNtսҹ^{pEЧ@ĨaeD Wx$äVsjPs\gV92g606yVeCêlՋ^x[qqWUcrHHQVC{Z /%LFA#nA,`P֨I@V]= y0V4qĻ|ys!JtB'=XU;S\<GO>0["Z2$yUqF1X fXVY 8tg*j)@N`T o祹5#8aze/DF)ڷ2B @}Y&+'c YZV7,ցi'HH=zkQN#=4ɴA .ɤҎLfR"IgwF<׮ffW$*VXB h jshY7U*MOg ])N!r6?sh!h.+\1 8]SG_d nWz m]רaeLĢH7OVJ9N/ӟ'.rACSzGOBi+'JT0RuDKV`d4q* 5+A|dN#I;0,jP?zB`2)E7u8qzE/%8h_J٪ *EB%2RC~B0H,DG,&gM@5l؂XrW#77pIZ . ,XёN!`˻ (/`,UAT0ԍt$GBssc'Ƨ:Q(0QOɖ6}@!2Gna1j\_fQcG_rδdlt TkO^>ԉ_Wg9;@4" D$3{цM}}K;8Tly6_96:9|ceIs0nf)6~F pqnYhRb_3SD΀9X^ow<={3Ӟ׼vji*|6:x> h1k]bOEr <~ڜv:Y, ;ogT/(ɇ&,XL O1Oڟ6.r^!=ҍ%ZPF=Z;W<Q2Dei/T|%ne>(N.c@c xGB%!l@#}EY2~]ZrFKƐ `/}ss.@o0".~4{' My3݀r?<qL@'@`Oozx"#l?29g:;5ZqON(F*Nŵ^ #RD20}%:bT⺡/<׬[Ep\'Q%BV3#aAOX'?3O<]\ctBwֳHŠGnV- 讕Ύ=SG j!`q{YX$fΚ3ۑp-AČgrUcJ2I-VL0 LC*z%ܙ/Z&rliPc. k5!_Ƞwm g;:ŗ\ =BشxbsSV:U(#q&lWk H~xɽ{ NR^A?i!TDid6jD4<ЛK/bEwJiL :;biy S"ρf˩<F:{)62)'}bM3.|_׭M$1:)J.V" B6@;t:isWn:tgph~E"TVU@vtD뿣3ʸ'MOc^$R³ȼ6M'ퟱ/A5E:cdH>AF%|iGbJ+ Єg&7bu HLzd4U~ȼm*"`+3͏: YCKˢ#SD`l={Y0i1Աzl$Ͻ`@GfPfdywwt # .[/vXR5f0vP@5U V+%uW]uy[O<p72c/g5v (}y@04yoءCVذi ǰ\ٵѣv}Nر$E/!#E% vFhe$ 0p9 hE^\ڃ⼋/^^PGS8J4Nv:}[f2lY  ˜ЅbܒALtk>{H< D c+Kb $}7\zr&l~BHw&9tu8hGYA sARKmܯ k VnEٳDW+NkvZ?ky6n,N<Y7M "ʇg7aœ҄(\墏$aPk 0^"nMwue{ %کCyg ? yhq2SBUJwO=1Zܵct||G׮_1NN?y`,NJZ-u];tpemFpW \q[/$T`Ҥh\A!H"Z \t麸 &Wk0 (8ȐmMbTubv ⋀߸Ո5]}/}Mlfzq~4J:Ugb 1@6 jXSapb=X`p(-]ydz9bn8G R(yҪᴭ-$?׳m\qPT-L\2CN&t rIԸaSBRAr(ytӹƾ"Hdlغhb|bQ:U;d4ФY pO;:urSĒޭ/GxfkÇFѩ=QUkdd1qԄ1c "h,Y*­W]y0E&0P)C5\=[?pW__B$ƅA Y2Бl1M;mǎ"6櫯rHQcNpZ_ SQsphjR 8B0Ξhz<YOGBkTD$1n3~x#) "O*Ϛ"mGYOZ,o_ҟbB""Ќޢth@BF]G'Se9v:m/`r0G/ +򗦐"^b% S C.Dbg$Z9%"}sdHbv.J5tj߷hɍ PŠDocæ5h!2z4wɩB-hXqQ& Tq_8T&t.& -_szŒ\{ъapԌRA+XV-Hg XeβEoʱ$?`$G?'V(4Բy8 oׄ^-3$WksA,NFZ 0vCLg;1WE6p8UpҬ0{n.lګz=pIz24RkgBG9g$jeǥW^wB9 DUEk-DzOfIN8,^0z RF-p^iN3`9&I0YdB §XryO)|hnb_c{! Vvk2_?յq8tM$_\utCaﮣ3a%b [QT#(H(B;TJ'tF | O7݉ެse_u톞 TR`!Acפ-tHi. -[ՕOAw<(Ka…^TF?b<@P"^zs45A r5T"T hpD". k<<9Y"Ztb(9=ᔄp9׼\'A qXI|*Ӄ&ymA~ŚcB#Dyց[!>Гlvrb8zDK &鑢cyǢ[Zu+O)O:~6Xd9׿ .^he {tkcy*ۅoBA`Tk  K8y&fL~kicክ RұӅg_'PuۭBAˎڏm{<)S~$?Q7#B(aW:vlnQxy>y[^xTYщ ~2o:%[n0G B{7/?W+rJZ2/cZZGSj X{l6L͕7M$!H$?/I`- 7 Lwөؚ1B A8(@e)@p|%xcFix$; Ntk`-1Zŭ(w$y2]>f D&ZR 8P%D.NI[ϝF k4ѱ}9_X°yED#!B\%.OP/;}PU .]?ť/nOVMjp s䴏XC2tɪ"!hQ+?Eb/Պ-#mwWp~@b"# `L0LtYQ`$ ;s|L6N!-XDS<܂Sf pIn2F7x䇇>%ܼ/5(C?Ld+ܖ"$]M g?{?L I4MXز jf֦<_o?<  ]7?83Lnƒ'NqRG`!gQ@4f+5Y25tymNc @avp999vjk(jU j0i2 NpMRī(X:~255rP f3TEK2c2fݽKz:{8(0lW[gNrjS=^wDʷPM#Y!A+V+ &"ՇE$MX1{?XLwڈJi/'(ln(j_⏿Ѓ#% ETD*~u#C `]*D"bv  mz9 6,hV }wבr37 o=wڎC3E֎p61wӇ^J8C5~ZfqP3*T/@ h['rjZ`&Mi*Bfm6e xWAJQ,yǤxcD=mP0tBDGV25X%BC堤?2 t w._ډ6HjCʊWW+>;Ҁ\/6R;pG j0cpiZJ /SSbXZ)w> gN=<(咓'h5iJ?sW_0=?>zYdHG4kn+?W^̲ToX"ц3!k#3!;>>\* }]ڏ|lӅx<0ܻJCg;tl!iji"M"=x)߲jes"&%U{P>.4QLu%%0[ឃ( &v}+z/슕kWg{(wtKssy02t2΢U_ˮ|過42Ո&\n6{b,߳$ xœfSu|t%@t( ?s _={BT_4zY@*[p˔>Pz`@l Ol-v*O\z'?񶍛z~#Wc}3)ey;VE ~wn)#uA0]b+¯[eN{׳`/gzqן\[ UYx7LQѫ('&-X^D,tbhOݒb ڹzaDHEJi.DVA"bu膼uִx#;VK% 7-_t68$`@)4P]e';:o'~b޽GFƦ %;IX q& 9</-_vՙ$֤8 ߲ %RI`]A'<h EZ Ʋ᱉*r`^Tjǖv/bFҌVrlGO"ဪP,@܉ oMw'+_JS[]]Eaj4ynHzxH$aAb.`NWD֢s9uZElu;D3myj:JܔGbI)%&3R梖p'DIHiZp%$'6*3QbKf#YĆ4H'YVXr©wuF$=wչ[ (|96Z-z:6fpyj P ? إywė>?1Y)Z8 |)ޠ4A YΌC>E3VDywym`(bGoӨ+ ۱JuiBRpXOdKkx5W.]r jCZ>lZԯ&bgTBl4bee` U? /K(l HZƈ3͉tH 0ndB諒pK~C' ($9% kdX .pKwyy<^HNWk^w hYTm`[[ۓLY "QNrpGJªK>B5tx{zOuplTm7^/ o#Я.bŭ L /閝sk:sG9$,THX PY &&mZIC/r`s04A*(1W O1:HZaA}_f80'd͝0)*z 23&hb"Yzv%?cՃWGZ T6=x!f}=K~+׭4QRΡ>AFcf1eC7.OTCbcm?ضFNΡLvw*xCdVa+E(-s 󊡧ldaÀO"v>QGc7oI-ه pXlaꢚ'?_eq 8K ˼( sv|vH:Ws`E 6ȵf&氓@fwn3"; =ɩrar Z(󼍃/?<G@pR{70duJ=,)+IXa&|/\.?VrAjHzPfL:\Ɲfg6lYC]0tn"t),.~4fRI$0mΉ!3alA"|exԳOٷo\wft&po9aS)͖a@WT#cRաߘ±hGͻNԑ0Cq<*(^^!Eo6o|Њ YZ[h2Ō ժG6o}Ç߿ ]i*lRwb4VKE*d:`GA{߿ٻvFGugy#<ehIJp WKLXc(T=#Itt˞k'B0B3zsH#pшRH#ݕ_^~ݸi4ǠBUc):Ȩ #ω\cs eҩ.ˆoL͸b&`kH(Z -6ES ڂXf21]>rpfxi/ Xo;g IYDvM*E#z7H{ENDyW?q p>ѷuS6V61!;^C\ :=X5~Wwޓ9SRÈ]GšK~׭Y oW q*I*:ʰn*\M' ~c_[: Oh0腡Chn}kX swmdɴP.הZƘz-Ӡa.T =M]XC`N.Su4՞C>7xRP,]xuVJ|*s2_D H^d&r}co7ԏ)1:6D.9jEp?4t62al_nP~(Y{dr+(af 7ώZDB*TxO} onuHS8duVx,!!v"?ЃؒLVwl`7\ߝMHq"/1#sPW fDމL5÷{X4S|`?FmE^gvYrFjFw5$i=rl[ HPM$+WMIxr%xʟEa1xb 7$j{J "FBn e|ᩓO8>;[tvl_ӕ&PX/@2 m-:u_بJO_0)zR3Ûש͆Q8Dlqlg!kr\@'4@kbFD!*Ή#Lau]iRIeݱ,g|Crug3tjwCWjUjyuk;(ZsK z=&Mr3op#5ؖ/A;,q}ip[ݚ&@$cb Ljv@QT"P:uxK_mb.yb .)DEMK8cm>|[Svc0jϭJ[$S0S4EAw7 4ЇQO}pŢiӡ=7rAǾSPU??CiT4"0Ņ~SS< ,|*iqRQrX-o l d4P?Sv>>:XF\͙s$FjXAA)4.枆U`h f$xnE 7>2 !3Q_\#E$.b.J/Xs+mX>(CڇVgiw_ tK`d7{2]ҾDF#AAI-bV1xeԽn7_[֯DhG'nqvJ5]"Š x3mcp5Ө!'<-z2]n?qβ''%Y"5xJ StC2 zSYFh_|xPpT\m &Џ[Zj"dTbޏ#:qb!hDc"AجVJLGoء}{tICmPڏ~RZYGmx5l_FjT넪v pىRԩ,]ڝLE& LE\cW%Q:T TF]p3Շe:"QY ,fXFfdj.@=C o{7jCGuw}cGI%-U rݤoTv P&Li, u}gF" '"lL-O8?a~?1s/3O&]xJ_uxqPPgjhDjSdP(AC"6`kJ~l?=6v-(Mj۠9Ӄp! 3L 3=z=5W8 Ma,)TZ#ƟQT$P9ǜTڻ.֕ e,[2Tm }Ȟ%(I*{$hgWO3aP2n:ZA2M@98bS)葂C՜S4cryGF>ϟu^&G~.z"\yEο{gO{  kbwyʾ%-򆆒:E A\?pgǾnھN7BVNzI*7q~\t!i^.t[yR) ZƂf&R˚zv%n<1`]`%SO:cܶp65)T%&_e褃5ӯā WC_l wW@ܦS%}}]IH""iÆ΂r'3xԛI;h Prb g7G>gRo|Wl `a}^O^ =5E'8Z,N -/D]_):$wjn@^x#4"f;و2毑1q𕆃r< EY-sŐWm_c*0̛\=vY|HHvJsj*Pg IH{vrvoJm̓/-bD諁Lc1 gDF `GF?O>a3>(J-bW%PxXv)|H1WmPpY:{5}@hp=!D4oy>^ǣNYXltqmB”z a_`2[GH9O0 Oz $C譨g`nH+1LWjL3fnDW]9A/#*>1([2 ' h%Ұ4怃1(:rZV2ή4fssRc7u"jНf]=Ξ"hLs0=(|h- *bwӚҁ'Aޢ(ő] s ac=z5vau߯~_6ި}(4"av2`d]\U1z(c[n-4P@RtÆ{؂\kAa`&<'S<^cVծ3(P>p4f-|xQ`e%ر Kɔ=ְf%9Z\Z4ff(#G-*r./صϏjb2f_qT4`g_Ay faF`woovlOW}\baĠkOdŠa12 NC?>x|Pq+m3rp?_uaLC({in"1$BGk )-㔯a;^O?{o]ͤM!&VL0 EeNz_ p+_pX {χb x|8ȫVj*j=)bY-RȔ>$@KFatpa*P#{ҵDdU[LTء hl:>L%bbVs-E,o +H䱳5e[/\wu^<8,֚ x݁ v!)<N2Ӻ+iz(6Ҕy }k]Zx3wIwޱAC# S4Wro` :! 麪KdI71ޠ稖Cw>d Unpl^n&0bk##T }f`)IHP9 a!LI)Cf/ԟ\5X=?bS,/ @WbVBUȄA z'ڂbv yF}}=g'rHD:k7 eI[: P|4X4 i8,%ӓB|+2\!pF+H^ źeJC[Mhrf,uҼGeGE%FC&ZgE-OLS\\ QETg`Z7Iak\6k="H'.B19㎌7w,yB_$Pe>4(N! @`l3UoY5Ƨn?;Cx(b3ODݺLj܇Lz%:۾{&{K_V>;v`2G4h=Sחn5 ؋\;:wB:d0F{cPQ@~A˟2!F?Uq*3'AC6XqdWjXld|~-C˜(ګYV>WBrOg 7/Mr=-VcpyϖCK\xLs{;Xƕ#Hc,ܹLyn6W*Am`T4ͬ*/sPIh3 Eoѓ! ?p$GB if_A|X8)PF񭫗W|yM͠pZBMܓ1sp[5ω_u}Ęp!ʍvspI)H(p ?pP|5_ӧs;NrV"w'IS(8s]Ȑ\ ɠњL}30 ƢUTႈЭ'֜ammM'ln* 5W/SUkz:AǴgǁْK?}I"Cr95P归5=rћ)LrSh4v5clHX΢Rw҇>x[y.Ҏ=ِ 0({t VIᕀq XW^_neƱ18iiʏ ^&D+!9C ~{{]hES; y8aV決Yq/7O* XDK hS%)"hA}wV ԙŠ& .|:񨙄f+Ư,"h: ri]x˚_WEw!p6R*.tѽ+9|篿sWȦWyر?g 0QҬ"6چÄxǏ| 7?Ď; *VpJ6#i+jI !\ R1hڲrH&9CU>a}2WNF%'ϕ|Uf @*%X [/LW9DGÁ/=ȃ,lfn04" mVuλpY& ː=%r`# Ҕ+ck׷n}>1Yj)7tҝE'9FÉ$ؠh%cC^KC*z6;xy4"pd";NǏƦnO?;/AQ1B%. ph٧n{-7=v O(hRozKKxW|VBW,EJHI Ft?%RWd3ԚHXޓM^6^ 7dlwҝ`|4>:V̑ѮO0"=6c?~dΝGoZ808R ]\B9v:D+^(9ꃵKSnHydZuLei(20B~ȃ3炛kN}lb w#]`2$Booy睻Ụeak3\CG71±Q}3gJ\f{Y{Ԝq~Ҭk94DQB'D8Q,-;Ĝg_C ~Yų+\am7%Co'R;|$Zхap@x@]ϜΝ;Lx%φ?D[m6 dX-X"yG%-(@m**݋%̪~L)0y2 Q'ٹ"G:?"DKSWe(mdY7m?~I}" qz/wKF",Ȉfa8ŝ1Ejr,jYzf4AJ_+ Hr_?U(S=cAذc"c CG_B 6=H8Zh'T רDDݝ^94qk+atlw\ k qC.=pΓS$uteY2rSG~h׳癆^C*Ul%=B ƫAvb6t A 9tO#OIFedl)Y#wIZGhǹRt_pYB m ~+ʃ!?5$Պ^Pޕ]{_|w)J`V!Fle*{umH'QDUj# PWx1#3Z?e%##L_”k A[<ٍMk䮈nU`8<$ # aOb[P 8…=b)'I:Xw6ݙ\vsVmpӅҍ[1490J,4zzbo&"yhxr; %?7BˡUw9tjѥr P;:3#E-z:±e.! k˧I/B͂:D#H<ag+ '\;5[SO!DT ZrUz#37{|]\o wK6兗b?_hדU~H=h,\fk?!ineH<5G@y!@&X5Imq*X'%ba{lYLע14`zU){dJ;މsG9`mzhᓇ|waK5 MdH~4#ZhtP= [0PhdXZJ|.jF-ϮM?t:٤l M@,B,kX}Ƿ>0ktXC0YJ=6?YLǪVl9?~y`![޽7ȸr-~Vp~I/,2/ݐkaFN%N$YˣWG-+ؙ8i~S6@R N[]nAp&O֖p.].uajjz⑃'OLTfٰ{/duwggvM"k!FEPYCiH.0/V'*H#3Q(B/da7e bjKm+![ E;b͚]kq}w6ݜ~_yI0 *wW&\yU,vYzPjOM]0EVbx'3XxN$2 ON5 (€g? *<#rNϚO04" (X>QAk tG}fɒ@ V~;kafzxKp4bY,y?<H'QIDI5&,Q7]4Bss8=9/ Dv]stCl*puqѕYwjAhS?ZhR B쎻^~lϟ;w~_9c[Égx~KQ<ә-vA@*x: ASUhߕx19xII.՛ZI #TH#DA 3*Y=D " r"D)ڲohkH !WmJdwOLg4uvA F ZSDP\E;L AlS('2-FgeXPdR7#HQ'*2@3:VB2VCjL!nNm-v,5P))a?f(wzP?eGbׁm}IGQ^P^Ԓie|#>%2ݷ^29_4&JETyN#;v# 3(ߦ)9u2A Rd5ߟZ*SE~G?An&+y<>ѡ|k'\EI 'BD8+ A@@Vjo03`ًBlb㭰7,N ۄ% ,7ARA>MXr\NRRcX=ZblWX氙6)߄f\uGi](ޭ?x}`ʦAYoDIrPI."fFAHr5V}Pd IFY3WoMROrQ-J^YX"$avJ:QJ$=hʼnH "EUcfYN~E 9Y͡dUEmYo dd 1rK=5q>\h{B(|v>9!@)#F#FmJڋ'%RɈ| 7'x6O"M΢crR\qcrRAMi+I,U?J|uuKBz~IB3`yOM${NAa$H )zhS$WCbaF]~~mm<SZH$ % 8TW$WY)qߐ/ҜcwXsBDSz H?$|ߎDGUKkݍKk<~Gk49H pdQӊT`TVux.Cl^M`0ּ\A 0d *jd4d Ĭd4ȭ,FFc B&802l @A ²✶0BS\X3ƅKW+-H $O$.'A +Ibuh}r0}`PL^:$P&5KnэKnH~[@,^%)d2 poVMÒc/9ewì)b"7''`j٠CR'b *sq$2KY:DJ/ CbIedi3,q2@wnJ& `©$Qc&vZrss3T*.j4Y{A UȕlT5x[I;/*E>DV zBf:mrRxc')ɰHXVϘ;c?ةr KC= O3%ۑrE¡8ވFBp8'ӌ+~⍠-@(ZiS27}37 rH6X5LQ4p)*#1.dO#J{7}deJ]HI465HpMUN'G6I'd4Ԗ̙7y sU8: fPJ"P#e H)csɹ"Iu4/ !ɡ^`SCU6!Y7[I 5q/|20՜ o|I™JuY}S o D)VXBPop3 31fB TH='(XF_Ff-|T8L/$9ccEvąHď/޴axS}сഛ].T 0T %Ye{:pNX`A| aLbSl>H1sXoB`[)@y`1o`{ޠo:!2akuJxw-,^ s1 hD!ޅ^E=j\`(P N nGr29 *PHs'3n5%$+e#Au5 >UZ ayUKVM8m9r% ɍ>魭*\z֜>4KJwX"S5-ĩmpS 2w -ŅdU.3kѱZK]R = 3X"tg<ꕻt~PSg!E:4X(B31{7twJiGMAaPxژ@+EoPDXiF-2#N(4)m-CA %Z@1);06 q0.5 М`Bs&L+r[ۛ?Ӌ8szuyi/.6Y# rth!K|p2E+& 7 (_#C H34ʙPZ'fxYO|볢0:j +$`tMv}N<лo0ǢH#?߻cr䠷A,38VUxhR(r䠄IKKa(1 _ mTu\*@9V<\m r'<< h*/<REYTJZy9xԕB G;{&tNA~ys@گ^XX >BAAP-W4 <=@ ±r㌣Xdy'Bp%c%61룦D?~9v֯JGcK[3#5ocrOˋѽ"EF}PHϪe80G GMODCԔ9eE'?I9+wWA*6ϪҮHT ;Ofa[iUTZ\\;m8{)e (RG"wnGWݥl^ i</Զ֡)}}CCAX)x|`|3EeHfDl!LQt\d>2|;YL[ q MMzh_RC98|F-BP$r%JzMS Y#$^:|R`sJ׈}$ho V {VP$8h5F ǗOVU=07Ǧk s|5%$ H⨴Bhq-PdQܺg^ݳi={NF"15PKS,cQ+v *HY.YzE|2FV@A1ʙdlt}hcrY.y[\ wAiDwѮ鉚kKki5J=zaieM.AS~cK$ D9 9k)*QDH`77uwu9 'l.+i|OP ~d-/?7ҶutG`KXz1Yru7,&h}6#F=Ő -| ;Z-a$5Yl<Tbuɪ꓌3R?3Ep^jjX14h hr%rRV4b)kb g6GA^HT(^ֹ]ܲqLU\PdڠuдFIIBPhRaJtD2DsZlB:$(׉"#!oH%=V1?rv13&Jӱ{0.4B<*DnXp)J/ N2Gl!V}<=m)HZA{'=s4y~&hd+ S>B-AjSkII¯]<@8B%6Ȧc$@(Ȍ & X:췈I-+͘^|K'NZXouv>Ȥ=S:;wuvm: r&O.,@u`* u[/!ӵ%N@ N,@ނe[ 1J4R>1d"f%jeEejJ6 aS8c9(xJˡg#y4ēV!tP5El S+ U|PC6N)-3(8&!8r 8W7}1@ӏ%X[VH*DR!)ȈC+t--@Q ifEvN86ӑd'PUX$(ޗIn+蚝vi,wUUN=~fUzB{Ca3,WI);g՟ Z|'ŀMOݴع?nL:3@>@h4RI!xGT^߬&CPQǣ&O%D8e4Cǩ(@iZ̓T@,#n$Jl:@LѤЎ!̦1K]bo3USR;,%̖1}=w 458 y:A'TSn|qT~gt:@|d4B~Zd}<9衸%Q4 \iuZִS ϭ>rB]~Qۍb棠ũi0Z4i FO>y77jjaERGgO{66 @I o~IEE/%rEB?Crz1RNK0-09Woutd^O7).Fl.(q"b :$ VfJp UEόʏAԬXS$aFjyGShdP?U%H9d*9:@IĢ6&U+e0zܶ\g+,v,)ϩ9oIU5Exp̦ɘD0p&"F4GhdPQ)6x|vc*isث&to߮cǎ ,e6ۡGd6#Bjw6/XN.CS~# K{bÊtdȟ[ժR4V>'wF:,DFdET>/YT^T r?}xz@s+D9'oI1"A3u{=!wr,;ɇ:#MgJ "BzW8)-BJR ǥg" C0ϝk8oVK"{-]mCDIGQQ,m F*I4ėĒZzFRk$G +Jb+UKd&4T7! !3zR8I@9I}8ԳNYly(ɶƒ@U@2ר!{z@||d'BH@{`1V/i":v/;l6e{Hmvy,9z7(Ouz6צ~z}6dtkQTC"MJڤ'Hh2PZKKhAtdсQa?rH--Fb#O.GN45>1Z&/fH=J`1-F|PHHYG 5"H ~;PēHcP1TD3`JY+B 7@zֿ~xwW(e'AHs[DDkDck##I@>l%Q픂'^^F^WI HQ?݋ X\mi/.UUM/q{l 74EBSV^Q1mL&0kol'Ӭ6+ `prBޱ}bVu"~ Jм%E&/D`k Qx(;rއ_]Հ"d6 ˁ;RR=dcykɭ[|#] 由 BF@O2fo~sރPK_I/ *&bqт֓¯y?i?=d=ēOsO=}7Nh_p̟MVɃKKT:W^MC gutt=K DRo֦&zliE jpl.5J<>QP{h%|5MN-' @gOlW%DeHI Yyo% |'q EH:*z3є>Mmϯoiel^gnV;DW#4 &)cB=X^zM[3fJlІXDPf_(b^O v4~_Yzցֿ '~{M{Zïv 1 iPj~8alpFý=`_S YQ$?b`_7ȱ) XvD){G/J.q)OJ?k1 Oǧ)5)) 1@l!r2^Drwjϧ Ռ2x!DL;}2:Sܳ=7 EgB^vkʆ>5};[}W/V]VTh.c? ;v%bdIi}?AA[2-v_TzU@S D%ݝ=[w\_"qtԊF"z&'a:3~ G Sfc\AANaXӆrN@|kE*F)pHqTǑ9/qp srLL-+#ǡ{A_ݓqXQ ORV2m@ HZS+W}%^}7nz1[|8A3ǭr/a-AߺV}®Ozͬ| Zw >3`P->?>xi Ѫ?N+'.c+w8VȎ77{Cw]Z;XT@$Pa$,@,B y@1lz) `,3x1-n& P)x:SV_HRֈoP.ϤakeT$ ߥ#f)#W>h(uzMfoAH@H|u>I^( &rz]?Q)ݎcغ:M# 'kF3!%aL[]WSv~籿US ;IJVd b&Afy+2Dh#O8F_J@3__ʡ@\8{58.=;lndMh@|Xws*1 T QC.r!| q8-ISTi) o)=DY :yz֩ y߲(%&]U%lC]CoHFɿ~xe~/%<8"K-Hf|#+峦PpJB;ђz2PhGdB|ˮ/BKl݆D`"Nw?I5^:ۚwC Ɗ03> BD&ܗx{GhaHtA=p. .30X)LN)MP4l&# A0(U1>:ApJ'¿x"I7Ql`ږ偅FyKէ9Ƣ YQ*isT.=.|Μ9Hw :#Z95UWQ9qDSSd4@=;x/ ]KJK' Pxb>eҦ'+Mr E$wh2Vh3W`7" FȠCDTj&*!/G~BQ:'LFSl#2Yua-YIlQ(0/( ED(AzdN}b+q*2G,&fĢjlcypz MWWs߸9޽u'.yIR5𢊅){;#̗#)5yqF0-֣E] sgYY=Qwo|E-˞7ìjjLDqGA٣ŝ#eC%N?\9uf@)MCX|e듰 zCHƆqZ+|&?fb@AzKjt#W&PQhȦ%[۟ ދ6>!!<2%Wo5Umoɍ4M|+=WBY.͑&#ne${0mxd}VҽjQש-kE@ q)%եxIAa-`h S$i_/v=(Ȭł0!*%Yw oV?a~Dߵ!yaUUCaJGL%+շ/1($c咨Zd+މ>YmzNUJ־Qb!FUQ05JiUQMŒA쐪=k[.]ERW>)2֔^Eњc&H$B)3jm*S8!%i:d8 20JdH^Xcr/qf@Sce&AG jfo\TwDO AV,,+\%*)ƥ AbT~CJ=P9C%,$gD6wv4Oftd ~+NH") Hm+d(U5:Jq1طh2"9JSE ꅵ7 ]uEyv"΋Fbӎb؈I(h3頧Iri!~ dwxL<Ɠ1eRB<%הB`*VJLbRt vxIá㈬1?KMO߼sSK)k/!fI[„r?ݓ+qtg??{:ؔ]7!NJk|XX"u1bE:ԑ8+* ؄c?T]#ĥR]F,̊6)}@׿탑W>+~㱒⫯7aBKFVG^YKyr[Y7J#ԑO;D,N7VY$E_e:}pT;߭b*4VOgL?XElDH(KlIg )cԐIDAT Ǿ?z7wg}om&_?}-!Fc##ʻq1tg:C jk# Q?"ܲ/}+&!)\|@VJT xJoˣ_/ʶD^a \`?%F1]N(#r&Y;:B?zM-9JE4y$FȒr.x,ێwtEUUE%^df̝".T&n@j8/E9L G!w`E=cGЕE&璥ՠKDDŽ8OܒrHj5wW̟}Va(a?(Uq?g#RY:3jcog,e5WleK%nW ɆQi$!IW/FɈ>>/ګ9I%|a(QYJ%+#ȼ6•%N>U+WLFH>jh <K~)R kLrqENYjJKyPx΄%A O}utɄ9]> %G O-kb岕,F!V{0Ժܻ^{V͜ZeH 004ꅁ0, >=9 #}R.y0O}PX1$A5JG*(E+:2Wj%pTE;$ڂaS]k,]zrPtS]DQ냚}/ead1ඳ:# ~,(5wY4ÔZڇq.x\7 @ 4h;tI4,KoOD( :H MaL Dua]_0Fu4D"Xpz8 pFRP   9cP<'B:Q*H2#  I=-(FOlǐABD邊 T N BXx,#A,I#o&ԧ2eDyXs)s@lbBh h2L/t#*a嫰(Z*DNĚ'p,xN4gQA(F$@ DHiYlṰKLl#&:~B]s$nN9{TMM3H)F}v$~lJR} q#P @hY6F7bgZf6埼֝3U^|U J̩AZ ˙~̱SgO >a:ٵխ G# C(uޢ[>}vuDP>)gGӞ]:>0G96IW]lr3cvK0ܷ\c릍/C>Œ ZESf͙?w銚R͌Mf]GOַwxߣ-w "S+>L*wvww?O܈ij'( %Lv z*M_wlCFsO8}yJNAUyɢ3V_>iG30}Xgi=|dKWk?-˪*k&L9yb͎t:g#gZM"v޳@-:̜=q [ohI$ }U8>2Dn3X+K[%!Q2L_5CH@ T<3;<ڐ3{0g9^QVq.C"2l;D1;ߘ" ÎHuEÑAo~~euN6#s cX'Գ)Ҹ4KMA't Hb(li@-BGNҌ+q9 - >Gu@T_nlՂonQ>b{)y&K Em=4uS3qA fc=̰VHBkECQ3أh,w{ә'=ƒx7zB]&{=fZP4 eX茛-˱XJ,>zkٯp@Vۉ2f=\0T,&~M(ivDWI=%6N{rW֮/)%PDS'?G9ԾWvD6ZQ5= # ,W.\\6 %{Q 6Y]q؍{cÛr7^­gUUwvi Ǘ4k_ BL@ŗך" &M'z75DEsHgEu肿NBAcbpSsihp"x_p;eB~aA<=ڶLI>Ꮼ<J>ԁG_}qhj>}6ֶ=ΝgN/z7q˪_r92 x׭FGxliuحrkTC' IW.ISKwov~ٓNUO\U[峛;HIJ&G1R y7X`"װ+g_Ӿv(J+RoD+'\`겕 }J8|8ȑ m ؽsg{?|<#6&3U'_Uw葦6o)e t ?zZ3Ǣ gӔ܊e͝_3kNݐ*c{Mgx kk+gM4`_{㢝:~hhZojxlfg']9o:Qg(k~g?yBqW__[^L[[afhhMW^1.4B<֧7oF?~w+g/[1sIݽ燆 ѺPyٹw88 +߼a߾|57m6M7,2SgȽy-{ ?,ޖȮGu-}Mͯ;n^W9.-*H`m?@{9/Yl-S[5ԛ8C-,ʹ}{æOG|ɚJZx4tښ %ıG xD$}{ѪSr4M }3--1Ν7 #o V9pp4nB4a%Rg%uNu?~kV.A7 W5FCaU ";{#8COm8 ;?t¥Ο<˒pvt,\:{~uuN(C0c(Wjtvjh oz9 %M}Z"Woz%) N65{r٦3Xnr]:>>$,nD&~W^ڿ?nG,)qK? Q%01O~MO޾x?vw_EW[xnMAn8}w+uH'ZXZ뀆ͭ2i2 Z4kJEIgN4{N-ќQhL>9zD~'$p$"vh?\ιUEx `1ht7o924쵺ÃjU`P!] &qNÎ{ 7|sw.lV8ܧϜN+ƞ]Ї_yҴ˧͞h7=Ωbr=GY7 >m5@ϵhl_Wo:92:mz iO÷,]/߶p6mX-]>wn9|1?{nOؘ٫<߰ n(lʽEWLůoBmâOE@p,er*+k͟V2tbDYUiե[< aۭF>k8dU?mf-g7; )ǵ7:尚JݕEƼ'OZ>ޜIWΫ+**jǥL`d\poS|žW_Cs]~{#-Qx9NxyO4'$ˠC6Il;Sںiuƻ^+Ď uFg\ng E??o[7k_rjkjk]}{=~ɫ/_nYbs9G>k>|W_ԓN_vhreԉnt:Qxm =޽Vv&H'JQ2W^;zOkˮ\Y] l3tdI&KOaY=Ɂ褺r\=vfjʊqeϙW5g{ Pq/Zcq?[6HU{Q2ooOӑ޾eVVO(hq:ixkrNj}ĶVמPA ,{}fͷpӼ27},ϳZQr|E8w:el (PF5T)k.ݗڧM)_źq:H./HBnÜaxGr ECjN{\(^iڜd,u،veq/}uҍ8!N(.t`dк"6 "!:ܸtYԛXtA'p\ ۗlG~5$(x~n@bOVUznv5 ;mw_|n|n8#甕9K"ʸd w7I7T+,,/9La(%3A,h9-) 2lfS1 ̦Ϫr6s놼dqÌx4PTX4;֪ȏ40tEjE՗>w3#h`#g/o L6R6@ReN7}ˮ6 Be3"؊3gjw d+B;|'N8A:$u+z6ٝKUyERw0knLl Wqsn8}P0!I _E &6";e't19%_!.:P0}zNm=oꟾ~#th0o2|3}q(KMSͷd2]yNŘ Mp;  ?`7H7' 5ILtpͮ[k޿eΖ];=sO,O84&uFS coYN" 836]܉SmS6lȷ "[a;jI+$v< k"Nb@zO~olj{g8BF`'VO`Y>tl:#*bI"quj4ӌ`M*LZrPpYӊo|鿿3la]j-vnlkO+r ͜Uͪ8F[Zo b4:{l~xM-;vQ=P6 &2&ŕFo-_!ouvF Ko õɕ(um499=pO*uP[Qe}S_QKz{{@2,ZϹz`8@psSTذ :o>߯?{g~3?}ٟ~~~JI9no9qt ,!50h\"2]DO!BQTNP@LgOo%!yr`<ZOà98dx{o|__g>c;v:u9>[ j†nl&Be)'h1qnXVb% 8 I|pf %Q"BgӇHL;쓻o|?{bʳd[DQk!O@ 'XPI@*ܾ$cJi$bX UIhݭycEqŘBg#n|o?wO^&x(3X N7l<ۺƐ,x(V%бv8s/ rIT^&.Ka\ |?Ok.(iɲg~ÿǮM}@(Q<1P7IL)٥ g @I >'4n4J$e7_G{uEP2}o`LvuQlʆg/Vڸb2!1L@/L6&J)D H)jGC@ʓ!Pqt&M٬ƒܵ7>}^z_^B0cIU 1BiV`ę+xIq0k\kł8C[) ܪ[l<}hFQٚg0^\+ TsWsm&)~Ɠ J)ǵ $q8) ;(Yafdv6wRjT &flXcru P L`07Ɣ[ݙB#iX4HP+ N $V ̇BV[t&K 7oލ9UVUML ߋPJq}bR #iAH(O,"T:< $$a$2f0-XVxipsΙS:oaҕUϝQ4.V)L1AĐːj/@J+ +NG`KVG!ŘO>|{K?g?Up{P* b 5hҤ05j*UXh\VS0EOFm(r\VW,=Ho>w';@d_"X)uND6$-&ä"4FrCG3 ~KI|,y>ƜJ.GC#yhHX&=_?'~O=矸ڳ|z{'^o3?Oo*2W<b)yD?X9~Պ enl'R{@{45wl=bҥ̝SHǑ9J7Ӷlϓ;I L(E9*MOT^^Щ,| IRE QJ`,Uwe7]2 ^V5xOnr+]:abeK*z@FRђEk(8 ;u/*]l|8 t$eZ| krt`pIRoB[VR޸7Rq>9lB93,fr@IRmmqX<0I INKkcqz3q 7E\b4;QbEB1 * 26H(0)Z֊6|Km~z?y$ǜʱelR}"j@HR1n-h$ٟ{BW0A9(j7 RAT ˨**XL)2@UJPJdz-ÕvX3 ?LG^0ҥT 77"g!٧wdtqͅ~ ǍpY'w+Zh880 8 KQ|`6p W']vsۖE9&9F.'je#1 9{ VE#ىuWΘD@Co<;}s#|HXF;[qx`pT;,4kݮ6.tD$@f*3tbPY ]xmN5iv (Svdᬒwzǽo;JP;Sv\DŽݦ?{>ٹ`Bׄ4\'ytrͤ6IL{$s.5tdx&3+w"Os! H*~nMLf(UG9ŌWN 96 CrB@GfpO]@A>rĂ.^T][Rb F?搣ʖ_fEw89=U6\).!͇'uc+1:-Ȣ"hڝPrUaz#ƛ%E6~Ǟ aMVM PE;Ȱ;cIKNz%JB67)# Js"r1k*KեzCG:°`D""`13Ɂa5 0@A< eTX >R] J0#۱σIMs(_JޞP3"7"A[`R,%2v^)o(:A%/h#q5(xDyDuMzQXf]Y3 -FL%  ^$U[h&;YcA M@F*h` `VV*XT΁MYtkGHz &} <*;Ǘ ņG |Վ)_2  &  02K1VÉCq}Ō=` R vun4@;DB.o]1o Y46n?7Xw|I'(.D0yԴOԺ^C-H*QfΨvo=T 8%"M8W^?7SgЄ^\, 3Ӕs,WMnM4c{䑭as4lOs4+/n+ pm6JRcwBƀ 6Srr)a aYvFt/Y, NljvP#?/\@ 6=p!i)c/+Ax=~FYrFc[X'_> DЃ-F<p\QJnZ1?Qؒ16Dc0?N B #b0bqx[ADCrW'bC,'[SE.Wg,GxL뮙=Ƽ^%tbIR ܚgJu@KC7 3ŅwmkF8릐BaEr8l_hXd_nD6~@a{M7 aŔ}E DQ8Tl@!ᆁh:7wjfRn7^eIN&vP٦Ce"乡~p"zU {`B 伡9ו3iyb^݇Xs\6q ]'6 #Ɨʸqg8b }ڿ$D<CnPh`7 G@P?/rx._$["]оbxHxб>\T$cPš13fKgo6eg^k87߷Ϙ{O(Ex"Q|xv8LtU58L@LLJa$X:L7 n=AO0ldYN!uub52 ׺c>Gl|uh8gn ?{lwˬ˖+D a*!lit)*o_"֙,둞'hz(I=Pq-y H̚M݌@7n )1H8m>j._?bPb V_>Leh&z6 7b(eq̊"J 6%nw2oY_x޲@/|lo>i[Sg M0FX>镣,r:V.]`D(@ʍpkW8`yzip0mJ[& é{}x?;vc=mv&^(ȒnJG/rGO7B`0!7ƦsUxN$d=Q,Lj!VNd0k ;fb -Y*ЩyjgRn{betm|UK?4wNӖcq7[64v C YtqC>幣GX}KV&1 eRU2fP7 Cʚwx4~~'Q8dQ ^&k%+15.NASX(ΡtQxv{GNu/r\l!( @QZ:5BBLg?p` [L`g LsͱO*Iڕ(_WZֽ0\7@% ɦçbQCq\; 77Y[ñO_>/|{;&ok3݌'?uѽs}^jzpl]1ԇ?teP}stPOg b7nڰedž=kSZUPxͫs]yS= M imO<2MGQ 2'8`hZݘ {N?r. Yڮgzn9kg=^Dc~o>s$_jj?珆z:::cA%O|᙭<#.y_NK t(v"úSLS"r<0gc~]gv g>&?nE.@5/Z̶&p`(kln,gݾ@^r|#s1G"ѥĤD9XĎOQΨ)tjiM>+=oh秷- _Ms.lc2 qUQSZSDXE/_8vL8O3eE5+U=$1"!0h<5OM,7gz559unX}g_ylaAMeuł,vuCQp0wWG65ű$0+<9gΛ:vhm>f{A\ kJw\͝~*!m/#̷Ρؖ\;ig{nG,w`.O[.[sm+KQ=2m? D'|tg޸-U0OС7_/~Pz !8@Օ}lپ 5Lܜ s/5 pC A. S0?8o}v򄺩ˮn*YhsMxl[5-b)„W!G!%Ჱ^0#^i#1tȃ-:P˝ktEj*iNF&H e/*ɋ$ z `oF.JBR|d$mIWvL ewnZԘ."Cm^F{ɀ,8m R" XKD,ztŚA H vl>"xAI>ieeEAZn"K%X2" ,,v"a :}>AԌ#) 4 N8}|SG4B?)WV9kfմ^0 1y>҉p#6pSKγgZa?0,ZVW^I>~ȔX|xeP*5ڋ;w~.Vp_R7arkƳ E?+?3sr>f{H܊bgOu5lmi Liey.^4inpO:qc(,ΚpF@E/r~o-:/H֐ $M՘6{ 2dBcM!J|""ҬO " N„ .J<A=_@hD%L~-K@mؕRyjf]x)]4+{h}P{,%ь<"eu&r661l0Qn% ~TsŒ AE0GxN2<"`X Z&[a*,6A,[`6LY#XB5*5偐a,hYnP%̚`>b4aPq:kx&@@aEX-"Et$d{Zn#v",,e,T)BĪ0+&n"΍ÍqW Ups2a\#t pahV`@5p?#RjB"|6cN+ [31L=Aɇg*,k@lPlt)8L;}A kdP ɓ2FDSPJpyMHT76<]-2`ЀHCFQ|V;3l;(âKDMV3Ei2kCZL)"aey9I|8`#Ђ8=JqyAJFQ;@ Q/e`ۆ.rTQ?n: !4@ 1cґ2 {`4 L뚋v6pǢ+wLAMu!S:֪ob C^SFbj=8c5B$`XR8bqk$ۊY8$(-8\.,uN1g(R)&( wJ\hh)W2@*Czt 8{)1(<$B$K4CqW^*BOJ3T @\Iv^8Cx仲ڬ"Z|ϯK-r}łrdO~ U%nK8) XїRk\EYY_jȽXqX8~Sp'E ǬW$AH1bm+V/ UIS?8r3H_(4S>*y,WPi3?Pʖ*gIN<\kpNˀDA7a {;:>@ҞpIg(a@䘕HtͭCoX,."Ǚ/v'H8گl?xɬ}Fv6, /uDQwxU l[_AȬXnU1JaǨ>JLG1T0+O&K5B:ZnevYfrha=֭+B!Ťr*M3!'^nFS- 4jN2k2i\4$20TM(񪠞555i”#TDH-YKj3RɆxwthO PW_0Yڢl9Qj2TmR;ibQkqZCrP䡑QCpjlw[` vq5dl&T,T3G ASk@N:5܋SmJ"ͩ_L/ҙXh8 Гn/wFxaIpdKՈ̮fdܲݢ < #="TY$6U,lZ'RjN3k\j BPPdD.+#'ͳdybmȦ wv~7n|X}%?˪&{>$-;4$;*b(Q[.![[j`dgolUG/ח\'hJs"|LdLp:ymcGښ$̐]"dAKcNF K^4O'= MuQR"˷r|r2b%c D٘5k@}+bsRΒM,c$ !evw~cr~L,2바 AҊ!WOFXc`&y?xPƢhHd!}ԄKPaT3a K5 U PBW&#QLM.wF `MK c o"хLR, C[EƦPbJIMMT6)Y[ f%"OIGl%DSǨ}Bڦ^#l77ϬpJkwxʴ6KWH*M lO`/.W_TOhZ &su.d)QMM';JtՂOFi9jj^uԄ˒y˯TZ=hXAo:݋rQH"#jS0-Vf()t 0Ã<87[Fu%ݕ6 {d c>7Km3212BڳUM[jBk;zdD/gSԡŪX طh QdPi ʡj#Uʠ1\Emd♜ofMhyY1rl_yzd75;Mjn G"f*NY^G")(+DR%t$x 8ȂaG1NfG 1Ȳs&H2jkT3#?VO1Ĺ2( dm;MWcF$b~ " 72$y9ACbג׃f2qY=0∑Nߎ+%k4I>Y命F r@3&mSyM@-%MhIa!0Dɺ="B[zQOTUf0.#}u>JipwN"\V0@IY[T6 jE8P7$̪XC_3{v1x1te * "KBH.e-!lǭl|VlA>y!,Y2"e+/Frgw*/ /g\YA1#EJ|YXRI r޼)ϑ;y>㳡22iP+P9-`lsdtzhv'Pæv0-BseaJ)"㵗HJj5C//Iߋp%|W?+zf+ijđ uYY9ĩ/ G?.\!K׌޵ Vԩvg㳟[ ܇x24A:80>#?\J -|zAkEHW9}2# *  ZTc^|XYM¤{/DrQI&Y@R. # ڌ9J'LA %;di?2Z"rmBTS~7^au ILGA[:U ?qHФaVԦ(W!aQMSѺLRABiypì^zC{[G7l9ũL짟U5v&1&2KyC0Sօ<#ZW*ζ|7=2(8 Os{^ml8)8Wl.Qgܡ ȃ/DNQWџM=q`SWOҳȱbԅ&Z,5Snf[#G6>xn9-l܇*rD_S/M i\V0fR@\:Q3Ei;u]X y|Q4qeQY3+1s#m۾4wNk}c*W ,(LusF&Hš]C;&ܹ\s3 Ψ_09* q)8bSG/|v6dAs8CNDvm# Ke;MP>=Qg B3O ;X0>SW)AE{:S3+| Mg+¦#QsSG{XQU\Yj Q(c͇e4NF{# &mȷ*@?p:r(|lQkŦ4a 1l@*@-m!IGD/"J7q+q~/0W +>_Ol䚴HOGWCgSYT.^jM, (m`J 4̻p|a; I*28R6؝.J}W7b^P#yTS>b(ANAHM CýkYFՄ.!R<>xr@ Ėc=}v|NQ~ @yɬYt&)cJ*J8n,5Y  gd5a{0p(#50PꐔARaE~ܱ$xѼ0EҀ0o ,4&([c8EݜK֮(m z3~{#k/xo_>;nysݧ:;Y9 uR)v .a*SJQU >#g=E '_ۚz͎"dryb2ڤ$uDKH!*|]tF C3o \Ps5<"5x#.,.h#l6h<M2*9JHnk~Y} a/Է>;ROICsh/7Cd _4 2%3oլ6 }^q闠U+D"&P`VG OyH4LrA&?dGZdœHѡx/*'ɐɒ7MΧDԠYY{$F6x–ΐ6]Ԓ5 QRO"4KK \)˺l\E%m29eUȹ)?B.v`^ [~Gy`}(K9㖪,Hukl@';B`f87mep`{tf sؙ_BGf@8D)3+s Y^Yŀh*#XveHJd jZP߈T@&3cs[ tFc3xH/&a!k!ig7TBfZւWj;Tfe#}[tD"m,lz9a㡾Ws 3熏/]U盻h6o >,"yk{&OSU2һN=i+AJ  :;yN+mcdׄzEZ$H d"ơ~Re_S|"ܐA\")SL/u@.ɵLiÄ,&Z3]oDWZ:mBh" =nRmihGdv'qhVYb+2+ee.s( >r7-!Aäp$Uϩ'u0C)7i!1FMD)#Z, 5aԶ f#R^gP8fry[k?|w\Di,;_rjEq-zؼpc5n|)'lJ,Vhjv1v׸{1hPÊ$&x2(]{煇KY /qV`/"k 4!NE'6.^)Xʠ ԤW&!}ҠgIe;dg__J*uB%L?`q,$'j1",$>=Mék.2 kp!.! P\Mه`"u6oٽ3/*I7Y3^{풫ΞOMV)W֛`抉l:sh#0} y\ =ou@ɒ4J0tU0 >(F P,_QG5* jrf[eF փT ؏z ܜ(*w.?5mr`ؒ$RRM{5Ӣ3QegG{K ̨LD&H)3sг%/)CaȆ N:efifGNCJ(#";[d* ? ǎ%.r6 ˎ)RMaX` Je=<1 gkGv5V_iMX6fi@>P8{y.YQe5]j(c֯\Y}]>+.T$,UKҋX* (j(̬H"G lNWϖ!r%l,$Zȯk*'0bw:=( ֍VU`QDS؊STʾ? Q|"iJ.SGыPP豁v#~]RN+v8 `$&heq\h զ$5UG&crC;;ZslEK| qG;u2g*n+#e=c&C>ZzӒJ"3^QSI2YE=.fFa'$-! VRxj]҃C5֐5EI1}0*NCªOPM,v6O-BXr{j1&plY$U,P7 bBaf`;E576m*=z8${in Tq8vR[ssgr!j1#?i!0"IKz[}*gn D@Ê:OBy6.I*x4s#RNxSKQ{։o,b0FVd&YWh Tdj7[ɨ3&ju)ʔYu%]|^ >TpHì'Yt<I9J,)J['ZNtC/QcI5j-7\MtˈI!zzUSFMVB/J3Hz={.N^/Wϒ-c>XpȲ劑@'p(X旌H`8K&)Jhd$5h-0S6)P]!x# .m:!8M$sP{{;$6N\Y]4>Q%]9"*n8 M - vm'M-0igtjh.o8lm<|WQmLA0-D+kP'RA-"8%))XK$,չ4Z#Is8i 'pf" ޤ2N<+ZXtH-HK"12.XZʼ1KQ>R Ō3̨%[{I"SF(ߋA`(-X)G g: ua0#I["cݹ4-XuearcYѕXxM:ЇSP!q PHr,V/)aIw,+f}<ñ>Q ,F6t:@)3'FJBeʠNORK;ڌq*İbQg (7'@ MF'd \+險\q~*Q<64e;7EjNЁjpBlP,q,>3v<& ݮefȎ ʌs!Ax$8@e尲T(L-V'Zew7J BhD PYQ2Id{-4!2q eGگLVYJbDnEE$ Yaj|Q<fTU1$#'<0&+""j~PlGܗ $F0;o =aB{`tZӒ7]_0@4cͭ>ߏYjen;ͯR`UŬ-aTVxf3'<C3H<+=6G˜:?B  \o-CY $:QBDƁv[Wg5SiQX*mBL=uӵ+LNlte2N((Xf:0Wl,0v^}u{c+`!8FP=to 7pepzxA ( z,F, b]IŜFԽOnM胸-Goh"EQ= Jl ?3X]=6?1qՇRݸ8X#dʼnDȁfӁ"ܡdppvOFt kE@4þ}{Σ1m׭"*( \xKp8:E=LWL}oCc@?+3&YBqO,ovJ4"߽46t>1qJke`@s#)0wwgFDF"&lp[ 0y4D0@3Co4 Ej$aa|"wLvG ԖcL!9jҼ,?iB>SaTY&oݵgdiB8M}8O^uAY3niVY=D@ R(|5[ `u !hFH,ى8ekfϙ'J0bSPVW|m"y;m8g|Vp4H$fV͜1c'@|}( fHcOn'N綻!C3|x6449Y5 Qb|A ϙNgBz篟jh[pf{ło|ckm6lђb.;ƦƁ kG#DVˈY p4]i'M`).W#i08B(KpXM{v=Z?4 p=%.Snyٴ5[^&>%v8q7Ou7ŒpO#G+Wl믞B*2)7<ԺΡmMS _o{ɾE嵫.[v]s|{;]*Kޱ6ۼ)lBn+,-;s:7 -x8ص̖뷜HzkY4cr&B8GoC\gBѸs_yn;`؆7hJ7=(Y6;֔46͋*_cZޙ7m|`<W4Їb;wU'O 3Aq]Dbq:r 'BC%yCE鋴m\eס})eU9&7eK̟xqa>}L_6WULԱKoٲX;LgJ}ꮵC Z0 tuv؍rCwH}}|wޜ˖)rGNuƒ}'j&hwGcY^9^prk׮[73 uvCompObj uObjInfoCONTENTS vCONTENTSV30 Oh+'00 <H h t  @Primary Care/Ambulatory Care/Family Medicine Pharmacy ResidencyASHP Normal.dotm 2      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~                           ! " # $ % & ' ( ) + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i k l m n o p q r s t u v w x y z { | } ~  `HFӿӿӟPӿӿPP߷`0߷ӟ@PӯPӯPӟӯӯ@0ӏϷ ӟ`Pӟ Ϸӿ0P0ӏ調ʿʿʏp@@@@@@@@@@@`ʟʿʿϷ調ʿP@ @`ʯ 調ʯ`0@ӿ調ʟPʯppߪ`ӟ Ϫ@@@@@@@@@@@@@@@@ PϷӯ調` @pʯʿ調ʿʿ PʟʿPʏʿ@ʿ ʟ0ʏpӏ0ʟ``ӟ@`pPϷߪPʟʯ ppʟϪ00 ʿ0@ 0調ʯp@@Pʯ`ӯ@ʿ`@ӟPpP調`調P`ʟӿϪʟpϪPʟӯ@ʿp``ʿӿp@@@@ @@@`Pʏʯ ʏϪ@@p`ʯʯ@0@`ʟʿʏP0'$%'$%'$%'$%@`@@pʯʿʿʿʿʿʿʿʿʿ@0`'$%'$%'$%'$%'$% '$%調ʿP ʯ'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%P'$%'$%'$%'$% '$%ʟϪp ʟ'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%@'$%'$%`'$%'$%@'$% '$%'$%'$%00Ϫʏ0@ʟ'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%0'$%'$%'$%'$%0調ʟ` Pʏ'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%P'$%'$%@'$%P'$%'$%調0Ϗ0Ϫʟ`0 Pʿ0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%P'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%ߪ00ʿʏ@@@@pʟʿߏp'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%@'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%0'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%調pʿ調ʿʿʿʿʿp'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%0'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%ߪʏ@Pʯ'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`Ϗ'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%@'$%'$%`'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%P'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$% '$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%@'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%`'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%P'$%'$%'$%'$%'$%'$% '$%0`@`ߜpp'$%'$%'$%'$%'$%'$%'$%P'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$% '$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%@'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$% '$% '$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%0'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%0'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$% '$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$% '$%'$%'$%'$%'$% '$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$% '$%'$%'$%'$%'$%'$% '$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%p'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$% '$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%@'$%'$%'$%'$%@'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$% '$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%P'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%p'$%@'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%`'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%`'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%P'$%`'$%'$%'$%'$%'$%'$%'$% '$%`'$%'$%`'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%P'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%0'$%'$%'$%'$%'$%'$%@P'$%`'$%'$%'$%'$%'$%'$%`'$%P'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%p'$% '$%'$%`'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%@'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%0'$%'$% '$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%`'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%`'$%`'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%@'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%`'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%Ϝ '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$% '$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%@'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%`'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%0'$% '$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%`'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%0'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%@'$% '$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%P'$%'$%'$%'$%'$%'$%'$%p'$%'$% '$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%`'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%@'$%'$%'$%'$%'$%`ߜ'$%'$%'$%'$%'$%'$%'$% '$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%`'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%@'$%@'$%@'$%p'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%@'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%P'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%000'$%@'$%'$%'$%'$%'$%'$%'$%@'$%@'$%@'$%@'$%@'$%@'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%P'$%'$%'$%'$%'$%'$%'$%@'$%@'$%@'$%@'$%@'$%@'$% '$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%PP'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$% 00'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%`'$%'$%'$%'$%'$%'$%P'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%Ϗ`Ϝ '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%P'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%`'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%@p 0'$%P'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%p'$%'$%'$%`'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%P'$%'$%0'$%'$%'$%'$%'$%0'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%P'$%'$%0'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%0'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$% '$%'$%'$%'$%`'$%'$%'$%'$%p'$%'$%'$%'$%'$%p'$%`'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%@'$%0'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%`'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%P'$%'$%0'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$% '$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%00@`0Ϗ`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%p'$%P'$%0'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%`'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%`'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%0'$%`'$%0'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%`@0'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%p`0'$% '$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%@'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%0'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%0 `0`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%@'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%@'$%`'$%'$%'$%'$%'$%@'$%@'$%p'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%@'$%@'$%'$%'$%'$%`'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%@'$%@'$%'$%'$%'$%`'$%@'$%P'$%'$%'$%'$%'$%P'$%@'$%@'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%@'$%@'$%p'$%'$%'$%'$%'$%`'$%@'$%@'$%p'$%'$%'$%'$%'$%p'$%@'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%@'$%@'$%p'$%'$%'$%'$%'$%p'$%@'$%@'$%P'$%'$%'$%'$%'$%`'$%@'$%@'$%p'$%'$%'$%'$%'$%p'$%@'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%@'$%@'$%'$%'$%'$%`'$%@'$%P'$%'$%'$%'$%'$%p'$%@'$%@'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0llpl@l@ll`0 plplllllll`lߜP0@p`00 lPlllllllllllߜ@Ϗ'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%ߏllllllllllllll`llϏp'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%ώlllllllllllllllll`lϏ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plllllllllllllllllll`l`߂ l`lllllllllllllllllllplߏ`plllllllllllllllllllllllߏp0ll lllllllllllllllllllllll`@ lllllllllllllllll@ll@ll@lllς@lllllllllllllllllllllll ll` llllllllllllllllllll@ll@lllllll`lllllllllllllllllllllllll`llϏp lllllllllllllpllll lllPll@llllPlllllll@lllll l`ll0llllllllllllllllllllllllll0l`llς`lllllllPl@llll@llll@lPllllllllllllll@l@lplllllllllllllllllllllllllllll0ll`0lllllll@l@l lllll`ll@l@lllll`llllllllll l0ll@llllllllllllllllllllllllllllll lpl`lllllll@l@lll`l llll@l@lllll0llllllllllllς ll`lllllllllllllllllllllllllllllll0ll߂llll@lpll@ll0llllPll lPlll@ll`l@ll lPlll@lllPllPlllpl@ll l@lll@llPlpll@ll@llPl ll@llllPl@l@l@l@l@lll@lll`l llPlll0ll0llll`l ll@llll@lll@lplllll@lllPl ll@lPlll`l0ll0lll@l@l@lll@l@l@lll@lll`l@ll lPlll@llll0ll0lpllplpl@llll0ll@lplll@ll lPll@lllllll`l0ll0l`lll@lplPll@llll@ll lPlll@lll`l ll@llll@ll l@lpll@lpl@lpll@ll l`lllll@l@l@l@l@lplplpllPl0ll0l`lll`l0ll0lpll@l@l@lll@l@l@lll@lllPlll@llplpll@ll lPlll@l@l0ll l@l@l@ll`l0ll0lPlllpl0ll0l`llpl@ll0ll`llll@ll lPlll0lllllllllll0l@lll lllllllllllllllllllllllllllllllPllllll@lPll0l@lll0lll l@l0llllllll@l@l0lllPlllllll0l0lllllll l@l@lll0llll@lllllllllll@l@lll`ll0ll l@llll@l@lllllll@l@llll`ll0l@lll0llll@l@l0lllll0lll@l@l0llllllll`lll@l@l@ll@l`ll lpll@ll0l@l@l@lll@l@l@llllllll0l@l@lll0llllpl0ll0l@l0llll@l@llll0llPll0llll0lll@l@lll`lll`l lllplll0l@l@llll@llll0l llllPllplllllllll@l@l ll0llll l@l@l llll@ll@l@ll0l@l0lllllll@l0lll0l@lpl@lll l@l@l llllpll lpllPll0ll@l@l@lll@l@l@lllll`lll@l@l ll0ll@l@l`ll l@l@lllll@l@l0ll l@l@l@llll0l@l@lllll lpll`llll@ll`ll@l ll lll0ll l@l@lll`ll lllllllllll@ @ll lllllllllllllllllllllllllllllll lllllllllllPll`ll`lll lllll0llPlllllll lllllllpll0lllll@lllllll`lll0lll@llll`llllllPlllll`llllPlllll0lllllll0lllllPllllllpll0llllPlllll@l@llllll lll`ll0llll0llllPl@l@lllpllllPl0ll`ll`lll`llllllll0lllll@lll@lllllPllll@llllPll`llllllllll@lllllll lll0llll0l@l llllllPlllll@lllllpllPllpll@l@lllllllllllll0llllllll@lll0llpl@l0llll0lllllllllllllllPlPll llllllllllllllllllllllllllllllll`lllllllllll@l`llllll lllllllllllllplll`llllllll`lllPllll l0lll0lllllll0l lllllllllllllllll0lllll@l@llllllll`lllllll@lll@l@lll@l@lllPll lllll@lll lll lll@llll`lll@l@lll@lll0l`llll@llllplll`llllll@l@llllllll@lllllll l@lll@llllllllllllllll@llllllplllllllllllllllll@lP`lllllllllllllllllllllllllllllllllllPllllll@l@llllllllllPlllPllll ll`lll`llllllll l@lllllllllllPl@llll`lll@l l lllllllllllll@l@lllllllll lllllll@l@lll`lllPlllplllplllplllpllll@lll`lll`l@l@llll@llll0ll@ll@llll@l@llpl@l@llllll@llllllllllpl@l@llllllllllll@lll@lllplllllllllllllllllPlςP pll`lllllllllllllllllllllllllllllllll`llllll@lllllllll llllplllpllllllllPlllll@l@llllplllllllpllllllllllllllll`lllllll@lllllPlll@l@llll@lll`lllllllll@l@llllll`ll llllllllllllllllllllllll@l@lll@l`lllllllllpll@llllllllll@ll@llll@l@llpl@l@lllPllll`lll@lllllPlllllllllll@l@l@llllllpllllll`lll@llllllllllllllPllllllllllllll l@@ll0lllllllllllllllllllllllllllllllllllllll@llllllll@lllll@lllll@llllllllll@l@lll`ll l llllllllll`lllllllllllllllllll@l ll0lll@l0lll@l@llll@lllllllllll@l@llll@lll@lll lllllllllllll`lllllllll@lll@l0ll@llll l0ll`lll0l@ll@llllllllll@ll@llllpllllll@l@ll@ll@lll@l@lll@lllll@llllllllllll@l@llllll@lll@lll@l@lll@lll llllllllllll lllllllllllllllllllllllllllllllllllllllllllllllll llllll@llllllll@lllll@llllllll l lllll@l@lplllll0lllllllllllllllplllllll@llll lllll@l@llll@lllllllllll@l@llll`lllll@lllllPl@lll@l@llllllllll@l@llllllllll@ll@llllllllll ll@l@ll@lll llll@lllll@ll@l@llllll@llllllll@lll@lllllllllllllllllllllllllllllllllllllllllllllllllllllllll@llllllllll@lllllllPlll l llllllll@l@lpllllllllllllllllll0lllllllPlllll0lllll@l@llll`lll0llllllll@l@llll0lll@llllll@lll`llll@llll@llPlll@l@llllllll`ll@ll@lllll@lllll@ll@l@llllll0llll@llllllll@l@llllllplllll llll@ll0l l0llllllllllllllllllllllllllllllllllllllllllllllllllllllll@llllllllllllllll@lll0llllPlllllll@l@ll l0lplllllllllll llPllllllllllllllllll@l llllllPlllPlllllll@lllllllllll lllll`lllPll@l l lllpll@l@l@llllllllll@ll@lllll`llPlll@l@l@llllllll@lllllllPl@l@llllllll`llllll@lllllllllllllllllllllll0lpllplllllllllllllllllllllllllllllllllllllll@llllllllll lllllPll`ll0llll0ll`lllll@l@lllllllllllll0lllPllllllllllllllllllllll@lllll@lllllllllllllllllllllllll llll`lll@lplll`l lll@ll`lll@lll llll@ll l@lllllllllPlll@ll@llll l0ll@l@lpllPllllllll@lllll@ll`lll@l@llllll0llllllllll@lllllllPlll@lllllllllllllllllllllll`llllllllllllllllllllllllllllllllllll@lllll@llllllll lpllll`llllllll0ll0llllpllllllllllll@l@lllllllllll`ll lllll@llPllll`llll`llllllllll`lllll0lll0lll`lll`l@ll`lllllPlllll0ll@llllplllllllllllll`lllll0lll@l llllll0llll@llllpllllll@l@lllllll ll@lllllll@llllPlPllll llllllllll@ll lllll`lll@ll@lllll@ll@ll0lllll@ll0llllllllll`lPllpllplll`lllll0ll@lllll lll@l@llll llllllllPlllll0llllllllllPlPl@l@lllll`llllplllllllllllllllllllllllllllll llll0llllllllllllllllllllllllllllllllllllllll@llllllll@llllll@llllllpllllll llll@lllll@l@ll@lll@l@lPllllllllllllllllllll llllll`lllllll@llllll llllll llll@lll lllllllll`llllll lllllllll0lllll@lllll lllll@lll@llllll@llll@lll`l llll`llllll`ll@lllll0llllllPllllllllllllllllll@ll@lllll ll l@l@lplll@l l llllllplllllll llll0lll lllllllll`llllll ll@l@llllllllll@lllllllllllll llll0ll@lll@llllll@lllllllllllllllllllllllllllll0llllllllplllllllllllllllllllllllllllllllllllll0llllllllllllllllplll@l@l@lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllPlll@l@l0lll0ll@l@llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll@llllllllPlllpllpl@l@llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll l@l@l@lplllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll`lllllllPl@l@lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll@llll0lllll`llPlll0lll0lll@l@lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll@llllllllplll lllllll ll@l@llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll`lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllPlllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll@lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllPllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll0lll@lllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll@llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll`llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll0lllPlllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllPlll`llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll`llllllllllllllllllllllllllllllllllllllllllllllllllllllllll0lll`lllllllllllllllllllllllllllllllllllllllllllllllllllllllll lllllllllllllllllllllllllllllllllllllllllllllllllll@llll lllllllllllllllllllllllllllllllllllllllllllllllllllllllllll@llllllllllllllllllllllllllllllllllllllllPl@l@l@l@lllllllllllplllll0llllll'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%P'$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%@'$%'$%'$%'$%'$%'$%@'$%`'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%P'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%0'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%0'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%0'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%0'$%'$%'$%0'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%p'$%`'$%'$%'$%'$%'$%'$%`'$%P'$%'$%'$%'$%'$%'$%p'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%`'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$% '$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%0'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%'$%`'$%P'$%'$%'$%'$%'$%'$% '$%'$%'$%'$%'$%'$%'$%'$%`'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%p'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%`'$%'$%'$%'$%'$%'$%'$%'$%@'$%'$%'$%'$%'$%'$%@'$%@'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%P'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%'$%:ҎKQK5 (beM[c>pO<ݼaˇ5qo~3g&N/􆢙7ܿf˛;uv^|rӳ>~Žu.H7aD"ݽSxX&P*ωH[ :p䙵75nF-l :<CƂE3/=-Iڞt"…"|G>(3;wngί}ۏ<}@wt˒  vj<{KvS <%%>c;O %Rq]w$=FҶ`|#4vopaHaě6YOAOByZ^ε'9woL\HƇ_aaْ jUop{0(Z4gm-B$*A3-] Nr+/U͵돟k~|q`󱛮\lɬyބ=M.+aue̚Pf3a 4w9Æͻ  'aBXZ;kί7'{_T!$ Ѵ3xSN6DE/'tG7]rVϞUR]3mfmu儞.Y^:y⍷/.*.W>evr%WZtoX c ϟjĕ7]6iҹ%tzuw'U(3SN+S݃--Y{-7Y2ϙt[W7G떭o\ZthJϟ@!W\bçrh: 0H6Lɹ뮜zh4E*e}׽N%n6Vf[`oo/vՍ/u$sζtEP~n.\\AE8|:CO/5&O6ɞm?2u̞;I\~b4B5^87;tiՄ&`/cSX‹:L#w[5im^{҅˪LqC{0fڕMrif`(>;&9E쭭C{2>}WOέP8snmqQE'v>{Z53/$H;-z˚k?W7[4"& L?~^+k["FWSX8yڏtͪ%K[tżr/'=^9?Z>a&TVLV2ib+9;~eA|ëBE9vWWKKӹvdg6g`a蹧_ڹum8~ÑmtbXܟkܱhN-͝14כj;]C} C=sݍMӦk'/.84|kUe,Z\+yyʲ`g5_9iR9J"["/lw,Y񻮾l>d@w|/E"O=K[[zۚ9W3$#1'^1́}؇f*Ap-5kӦ7^z +tc83>veUQ-r`5 "̙oy'@/.CfӀ [zj'5#a[j]]fd;o {k#"]%L&ӼAJ1P<D:M7 b JM R`Hq)x DuE[s`grZ5,E4voFk,PҨ5 Ӥ7Х+vuzxqzS[$s_/^o/8d0rCg:bdr`,)rWo8rlKJaE4g CY52aԙɟ[g,gTysGEZ Z cAHrq<4oشcw[kwيEn⡢׋OW.,8٪7g2 667nĀEq+zO P,rYDc`A+hƮ@ߠ겑sQ kAjD#;<ܹ̏%Ve EA4{NM++J(l).̷X];+/:uρ)&d W]7}rXLaZfUVy'X犥 ꐒ, `7_{dWys,uRrF%6ۃ`{ƓqzaƖffG,c @ rι[nNkjK]߻;߉?no_߿j݆ 3{KUku'li0cUuet9+=?~/@H&g-]^iڐo4Jc{ ~.{yVXy݂9Waj7rR0s3.n}iSPect̚P3IRjC}Qn$D8 n#A R]n +n&Ҟ-W>n'đ7>&͝[g_ۖp9E0| uT#ј &WNb#wʔC'R`h[&FSxϭKw ~CӧW(5@HEB?ƃol}Gn~}{}"G9*ۜ F+1noj D eb"}Y..%,I6:/ $Q>(~Tj)#n@$` kf(u.YR+nT O9ZDI{ˤ|r0-h?[[Ӗ"LY=)g@}ˏl}e֜)g@1sz(B=Bk9wF>.DB=6`nC'q0(_0>zțx<|yۣ>X!z70%yB"ief']'DaǏ_L5P)D ح& 4Cؕ4M@ B:09oɄ)*}X;A#c7g=|pv);uVVqxh_eRqʈac(?>c:Dt50R GjC_Νžg# r2 Vf;:e* n鰿to~KnP4V@Fց؂&p(UiP(?77*#V#C>;U -X< a8JLԜ% \MOEө`%:@}HU[@!,١y1 &tOzxܞ _?=WӠGݑ`<0l2`GbT !s& FLf(M| ^xX- Xw?Ȏl&$өTT_$ǃP҅UD*h9%K4٪`Z |hl8HH&*DP< 8JNGoh%_E~ӧ;:M`t O,/۝9ڨ/ &m.:pH4E[[y(s 03t_,cg;3w9wɆݦ)̂pJ((<ױ)(5H:{([1Дa㹋]ZZ+I{LBS =ObjT; Nв~uONe=7~e˚n}˯7y>QkU8XfSzۡT0!!e銶ƝΡA3W?/۴f-g4| Eb L^Ix4&%=xӝ}YJD57Vҹ\ZƢs]Cp.ViTNsJ)~/D.mwe4ȍPh α`Ξ;rCG?KkQsbQ;zGƒ7У .yrdHΡ"eف ar#oz}ao4JZg6oκnIa+I [Ҡb77_H&F,F WO=ʖ'XKo̓w,[ IP%XwbȧIx,7~e*3g<;_7: Oq~S^2R"u VhFri]XنmؕT6kuuuߠiTB1 =Ő=|` D`4ϼ*Y= B{%ˠOL&}HM[&N(V;~W =RꝌaX^sٶ_u(ηvi"Q:nLx>q-VZH^P?5rou3+rtÒHuOP(RE֧_Ϡ'- ޜW@RCZ .+>^}FL(~`K,\dMUHOI[ [&4nޫWXCmGC{ tyA62´;\"[٧: XH &2JY5K.B/ڞϨCq؈94MUGloPV)f 헴C3A)@׌P;d mQ1҈ ~KG%¥̂_?QW}G>{j'9txns6gAC+A"" _d"_X$sdCNZ守"Y<A2G$-BR w=:qTr!|;zxώw Ӹ 53z>:]heqt96r zwQ\J}\! c}c1j6~aErUvH::Eݫ+SfcE>#Kt8HzQ#tYֲ?}_:rS74U(D^>6͚ ⅧhxuZso:}AՄpMf͙U 008ݤCNVJh8^~e,wo*MұXړ,i,t45]t{B7.(N ɅNhTL8cY,N>n!S+7혛"|(? ;WtUGc5JYMD/UeȎ3ˈg?nafo`F{u ͨ!G.=zob f@R>#4:aaTb b@zBa>h"+^lZ,dѵ3"Q PmȐ^2rƭs~tYAot>w8 WjOwtij_TB9ҳ Ϗp-I*gS곖$KE+h+;G~۹󝭵g/oiVMب셰/(+*bqMec=JO^TY]ڒ )%@17j˪9HWRuZgmK?ѫ7??[~[gl~Wٷ|߳Va^rHh`Ќ̭!PYUBhn>[y7^=G9ZQݻ˗M1 dA?owﴷm R!jr;_y~Q4$fh O4Oy~X+>e2QȲdyà=.]i#w䀎)% ;yiʌ4͙@fPU9{eB:Be2r+UYXʘ28ᳩ*oQ:VrYdvhzd*=D(Gvf3y*&T['i0pocݱ}gTbo}WݺO#=9:fi>p.tc[( ϟxC$+t`RΔ'ĶLl! {佪jv^#=ŭ'OG5OW>}oez:Ȏ L!G ]\^hb# +s;q A&uPV& 4?~s W8\?=|90$F5TRL`sWc"-Bަ{'>-зo8zo?#Jb_3y24',FHd&XIEU0g Cèl[>eGN/:8e@pE< Gyv >W)_Goy: R>-p(VFW8Q$~ճ).5٤D(,tS*uS9iҭF[Z514<6&.+o49SAYw |^;@P vNK9Nm0:oJ(^2 ,cQ6"uNjޕīu[Q6Fptyi[9uXh8Yp~+?ڿ𢹅(^Z_P>oS!"j/k"Ngi SKpRkؒ*=̍&-EHQXsm.kYwECM mYty'(FL $S'_&`1ע&7Htk?2RDnQYyjm-ȥ j9JQӇu eXȭcty#g;9)_sׇÌ͖WHkTϓ(JBRORdw1ߓeKo*r1|'/NY]lH  6*؞}O8-lCjdPx0r c2Ic<7d7GH2hcL  8ğ =Gx 2̭Y?_tTon|46"0;n4FE^eK0^A}oܴ9 iɦLJq,ph~ uاVO U:;aBUNMj1i>'Տ$6kSkmߋ̙NrK81.V)$ݼXb g2gy+A:՚W'cT;4xo峟s>qy|i8/yGLZ|ɑ;jڎ۶lt2QS:b._r4 *@Hձފ锗ٽ4$ZO*kܴLPS}'d2OQ֠+:ǔ=z'Qm[;ER -] d5)7MvbPbe=)|j0:_fI|~Yy`$dkV~j}LZ?֑'УbnKk[Otҕ9騵8M#Qr@,LMͨޒJWM߮::z^a,B߱~ekxEKƓ'B C*[8%Ǎ4)*'U-&}Ġy՟{><qh?SɘN=$e7V JE[f54֦ 5S~".m%ܷH9w{{ƅ=), X\YI{APY(.f̣q|>GD*|SLBd%!5ֱ*v #-輀X'U38[pMZPRRCPclM#[7#E07Y! "]YiӦ׭jw"rcXDra2J|:RCPze]J( w&pq-j  %+" B&]EA0ieSZOڒ@a;!!i03ϱ&+(h%K& .?KC-;SW ,$. +i'Ťؗ43+fX&3sҫ7Mj/ r@k <4Dz½qF8;>92 fy}YYYdK7uw bpxͫTq]l>1yN2u/g%`1G,|p8~ Urm,gJBɰCdFXmdHA[2s˸%$%5dE|Vd h ⴂ*D#vd׭o]2mt3z:sϝ:GX&yP,/ORDb NB'˗6'8I F@zKa (cz3>}u$_C d)ORG`ZTqe3^PӐUMN@ *=YyQBtH1JLҟHTkP%HR'?@(a1Q5Y?W5@9DKբ$dstorJ'Ҡ:#6]5 vyMC&d9e:I$@6$qh pQ|bSeɗCqo^ xiPU4eRY#b,>*-&V 12=vLވg㤂!>RNhȶ7@02X]ZV80].EBeW1Ǧ5|,%s9KT9od4{=LQ ]tFr }̗XN8,AaWM%Q~8N6KN :1EVxv\eP擙v_󨸜I.d͂Uo勣4`Cv%c4TETG|3F">?K.lXjq[,yQR$޸t JJ\\7Ҡ_γTx=h;g%q/D-+'0j]'dqȺ+rY:1R G#}ft j;KjDWa+-4-zTwѹJȟ:( xsSIidIٶ@0LpqW[p vO<=t匿sgdFݮի(Fy[xP75M- /;+$zE$xl2s/aA`ed>D tIL2&7M&'Q:_(c?u>{8@_gW:2-mM+6Bh⨥{p8ɎsCC٬&[ ]z?^^b/>N;WU9{v3޽cX!hjB?xC[^{q8/A'SZ='n69 \=7`;7ߦf ~gu}k 0/x۷ZH rdUbIqTؒptT h1[E/xDzM` }67#o<^1tkol.Wo\>c;t"Dj. p?6޺|ƌ*:7!Bwo<ك>5ZU%9Kuqzj2it]d*ܪ5+?MȽm܆{|gF(}Ǧ|w̘u3P3c[虺 9V52PcUykSXIGYB-saj2}a\5u԰|$!]̅6@"93w{V]4#0lےEЋy1W,}32sRF9D`5+/EwܷK[[`+frl֙W,_{] ECEKKE:*#{zk<mh9:»޼0:yBp`)k E>v?GP5ȆU[Rb,gX@$`MӬ,ZMS|E9fmyb\r,5S "'l:C"T`b \/~[FI.dͤ%$z'-FkA6IVL7ɽ}N}WK9m37m\d҉;r"M= #RoNW3*'#JYhɰ5KNjIr3et4q *{4T:88ДetMXZT4ePxt t,>\K@iu=o^|T&EтٳZk;w.1D{wVh(v{r?>(|g{A.]1 1*}-p"N_őxfcqLql8wK-<R14bS䒹hйz_Vqϯ+c>*P%GTkZuhkT|MMnEKN4Mvg~W!/8D%6ny$H% y-ojRWp4H 2/d&=tR1i08^M=_"5꧄Vl¸Ȱ݄=;N@6 ~ >nޢs* ѝ;x%S3T~K묥Ww=psR[ښ {Qj>,lGŖh@{; E*³f)u}m~f;x,Mh!,8!RWO'[Z(j.a &$)UkUΘ"{ $(ut84Mp{[y v()GG^DOE.L?|S20 ~ a'X*'\)s.3ojJ}v2d';14:MVnuCgckϹKg 2Ǡg3I,>rC/n~豊E6.m>y,^"k@Ov(d}15`8~iܙ+W5WWzF e1-?( %6'ܺPME3ZϪ?Mbu`ă"2z֯fly5(=_Y`~Źic'2ignZB<@===;(`SVο__sy+t\>ؑwmE[ճfVauP1GG6?N:sBF](ʀiɌt\R=7ǭΊ뗐]wc 4+OAfi˓;UMK͞6-`T*l2Z"O{sCFćf5kUs#G߾įpk׮[k{ @_z bM3ӑҸHhU@ygm^2$Xu=yR穷#дͨwY->`2cIWoؽcGkqZfh]q jh$50ZGOOw<6BCΔ:{ي9a!w'.YsYzKi ex$ V"zuHTxA4 xá.g]$%CW*sE*-)8C9ZhvN!f$YChdg($ei {c dy]K=d4Ll!ɽ}2M;{r̞ &:{Ȃ3 IW!$,ΜC@nR6FޙjApSW|vE'Knt#;jt@ yBc,:3zoܶ+ ΃tirY3Z8jRGʑ6@qfV\B uHځ$O,I֠pP@`YX4!9d ~zˆsu$K>lDn`A275caduAXlRII0xmXZ|>Y EILGI1>Y_&Džr|X9pBP*%SL7K(́we8v0vL61G`@bf Is.2%_ې9?!p?l}z4ꭨ$ӋiH3F[npt.sĉ t *Xe1+RB yYNc~[JݩZcaڑ~k|Xö  CKU^g뱸RHgObm H nƘhL*gR0P[Z%)2!I)JnK)Cnv ՉRA5K5CtUg:aPp) #"犊% -AA32 [: L/wf葶_9MV䢪(?Q+`"!)|E}ΘCQd$_c(~?|᏾|_#GgXQI6#U1R A!H7lQs4<6'\CƿAV!4 ·@IxE VSuɄCh0./*U``X\ YU9F}Y/93ꔑc׸#?$M&T@z[B/"R c ?KDuÞll<ۼB.1yjɷ.(VEs!L It_ѴC|Ci_`TfiiLu< 4yDC9ye2SpB*ĉad֥x3QxCUpb5eYE+Dұ< eh t6>MTp7@U PX wA%u, #SdL-v8˫=0 wOk%ǜQmATDE\@Uަc5`2BAE/M Z /1 8$ ŕ\\[HaPaAI)'՘7+F4^03.\2B>%pIhHJlB*`d7OA!D09@ n.L0v%%i@^ H X6P1bQ0ڔ$?6HML{64Uܟe:"M{[c]ɿt锵J˺5*U1땚A2(4^!̲kfl9IJ\|&eds6I\PQq!'Gh*/O3(CP,:L,#BAȁd7%w3@-!%;.\qyF12Sd,}Sdr87#)2g`q0i{F{ 2Vdg!L21p4#RQR)kfmdxk Xk W4M^`Z}OO7lIDnN~V_>O9xFUOSŵ6/`^V/(S/]m.W5)2fzC_{N޷>SS!Vȓ+]^-e\{wTZVTb}Xs˯.kmZג6|B( Xuʍq2寉1YaĮŠ>}S-GOHTzd&-»ޚWKf⎵sȹvʕN|ܲQ5y/Z>QO޹:}3YWROm%6/|*MJLH֯.Oɏ͍6?aN3qLFfdw^?nBM^_)vXIꩋ?7I#$JIxXx^bD&̠l KGcǯO-‚R]_+]z𷻞INZm9(dx/^涺aٌ$%eHյ \_ \׃ɲ! N3":IO]mKp͙\͗?!mɷ{㯯+p]g*AWK2+[+*h ɄKH+p}~+p]?tE';%YK3=ywom7t&iTA2'/W'dɸiIENDB`'UDd ' 0  # AbT7Sܳ!mTnwT7Sܳ!mPNG  IHDRa~sRGB pHYsodT IDATx^{ŕ/ @(xtCNp4ݫ_O'Q͚I,h2k tOҭ9h&@@]eֲzzy9o=UU{iǏE@PE@PFA3"ʡ("("T"("( ԆFPE@PE@ E@PE@PB@ jC ("("U"("(@C!Nñk|Լ6("(@"pAlٱg ÏJx^GmE@PE@h<pL|mPF vF;k(6("(@C!G5Mvݛ'/՛biS"("4JPk4MkmX$5 )]PE@P*JPk4ovئ u~ly-("(@WB@ j F֝S45t}j 6("(@C!رk܌V("(@A@ jCy~Kn_A[PxZ"("( rj'ԵW v>շ|JNKRPE@P %mM/3zY8Z"("(MIm>'k+9͊WE@PԂFU6/Zz5-("(]% 9tذ,]ԿbςUE@PFyˎ=S윚^geyF*"("PZ(;}'#MS*E@PEK"a\e̷E] g8*GE@PE@(Abht-Y !UE@PE;!5h4UיMc"("t ӣ>۹`Bǎ}ؗQ:י9MR^gm<|>gg쌩Gw5o e9WiVԴ"("t7 }wVCs#Ul>笆--՛^eJ>WֲOږ"("(͈@]*mIXB;ji4o U[nX*S{ h("(@#"P3 )ݶsVCJ9ebm.noޙ]ӳ>sG]v錬iyE@PE@P# {3M"7W_6p5W eJ2LJsoy9-("(j羃-< _ ;`惇 =?¾g̈6wVaiVS3rH,+>("(@wCpQCL7n55+Dp8={vYEC/kGcV:r,HjC\ԿF nTVF_CPE@PE(ܽՐE1GO,ャBr{yzNhlLRdx ע?چ"("(@a7$hkPC.קy/aH\Ͼ*7[!3 'ʧ("(@(|7 >b%󚁔 yxs;]7|[[gm3C > Qza@&("(@-^y;&enZv0O[EG_>yVoz irҞE@PE@|Nq#]Ghf#ϮZyQ}$穐S~ӎ{c0&7,xƔ2"("terTH|N3&7}H:<􏜧W hW,&Xjaq{S"("tur5|[ 9R&-'7=ؒO?Xݿs>kc>2\(ۊ4>jW|?E@PE@P|"!uH+m2F~6VrCS3%iF&gh sۓ ĖINi 9 U{4g>/~/D-S`AɅ#`0UE@PE@(Lc庥!U`egW]ؿwG ZTZJNe[PE@P-[-z?qţzuY2Y*蚔P3zaiPUMYI_er6K*KӐV"z =#c}Րt;U)"("=6>0SM|{ۂosϬ:J!W_6pC?iq8:۱F-O,K͠Qh6wڵw4*"k:aۺu>{wf qMZ5rԨ-Y2#`X 'E$k?to(5]vӱ7ܸg}}w3L:u־FwR¿ЧO>._u)<ƍqĉOq{{ϻk+Zzo6E&-[{t6@|?źww/5~{^t6-?ʈ| I, ܴr[wO2o}n3AMOߋ `ceGv*R0?-ML9G,:g:cI]>~=x>s،QlD['?0wqDXOg"|6VI$yAj>s=H2Ȳ̘Ƿ6q17d"/D@E/\;f҄1*ZHYbxaŐtֱ#'MLE<7)IF& J/Z .*F!9$8L&]y2QV* FJf$,egl!ҿ3bZ.MA}Ʀ2Y~9a\a ֮}[ ~}BTcDP+Md$tБB1-?/VY#LZ|Z!{\*U!B!&Ǟ;cFA[܅ݭi} SL:'C1hQ|"C5kn3|Kta5/IcV3SSeog~ޒ]U H!?n57_*-#ڒ WБ5O-_}{cϮ\ZI;uU+V!$%d3bsR,d !ABV}аeZ7g7^XspkTprb->gzҨ'˝gY<ߧ3)@(IpCI}y11MZimg$,ƚ@',c}v<֝G{?lբ#̇/_4hF :žf*SJPU!2hۤɫ\L^(_S}^Y7C5-u'"IP~I޵ o~ܞ$rSET||i8|ScRN9ؤv8~Ǣ($qur!L>ѬHʂ\;nz hD{i7Mv(W՘\ȼO|2c3v=d7JPR <2>6ݾƈ2M{~0I-،sʞo d=W58aB$w}04,6\} KI#ruaz꘵Bnݺ>]5B\+k%I{Gv+Zm=~"u"=-0i v[i|.i]2koM l+5k7z=ouڤ.wOyv+2=V 1+j?,e8u!_)#12&$ u։ P*-KsqWrJZV*J* 6OK7ɌbztBl҆!mIc{iaNP_5XY ON! y-?=~yΘs*%$Ϥy8lQW82yI>v519x ib%qxz`C1'6cH ,%_M><؉F? oL]GۆI\@A Z2._Nwc<ɟcMķd͟uG߸[C/7B!ST [_zsug.^?}aRzgW-?pxS=O> <τ!>,6[wޔSi}V(h7m3c$c(r@R䙧36&i„6g|&󘍃I;iؿniR&WHqxߝJ+p'΂XAg\Ԃ`^1Cs9KB/s^!!}`'RnIcl1:ˤ`^Ɣ2Ȕzɞ YBF\No["dHYmF!I5}{{[˿_YG,$g+6;eo>uȡ+&VZȟy+F+O)AB-%ES>8 7c7% %mKZXbAʈ%6f5*N^S3YHK=O3Q䒔rk'-ThVȲ+[NDs2U2d3<&c^乐KH-T13:ggY]|)0"yM!Wr ł+GS6;x)J@p gI[gǸDb.e{g0mƟWrbRIPEʑ;i8UcKI5$3Q8ihYN\P=+W _*c}jp`)#%b~H߹/ԋ+W@Ⳍq_#iA_|io/؝gbZژWB|y}H5r"v7\0 \X?> Ľ;s(tl<"/]ĸ {ڰ Izɝs?dL ,><4rqVZ=Mѿ3zm,ލޛų 0ޞ>9|]B*sS0ħ?A?ny!.!E!lUߦM` iGX|iF\<,llY#bf] 8E?)9 EJ1IGsx4 Ii;L+KgܹϾb޸/!#,jd?GXظ1/=e/H;pwϩoo7HLc R{֩';6{!d'%H!ܪL:`1틯\*j;9#& >}*߇]cOlN]=ez;Ip!évٳM7_Ɲi{$kߨ=ZL3򛅒38*>`wO# ~֞ʂu&?||!+{J}K* y}uy!bQ6A;OB5%:vYd *i22'*6]o.Nz8-7> 9롈[¤ 6":y^_- 4=d/)x ? wov[_f,pR!uּm >9ޗC6Hk>;^ Iw0u_}Wuq ]NCҰ_Đ0W"F޹*s}pZ5'EY hzk=aߘ-c`}c˻HοȖB! M(X,f5qS\qSZz&!,ھ]kG 2*VHE "g)Țb.6j1)Jb_rMRrGl.,mI~yR.ܺ MDiniMSE`Pq)( }biǒ5Ec]*~0^>AZ$a? ;:yA@?AM`?9j]1RϜH[WigH+28BcjjNP'J~MNF  ۿ9c UREDʝ?w˦E4R"nI(o8:a 62E9~ l.1/,e'R /*[ B2LL_pL im^R0D fJjkIe=I y=jb@?oc">I'6O\AQ:"mn|ˆ&B7RA>!XOc{TE^|W{OI-БϢ0!fO(A11}.LV gYr 1UiE- mc-o BRMpf2q(Y1-ZkMZ`7X!XR!ғCĂ}'`ѽUW=% BԓCeſݵaz.uFJjEmzgA3rjCR5L_ &yRNU^̳>?@6 uc?ip+g1< +Ww.'ij\RS} gZKQ8pO2Ap-~I/< },'Uaȏ4i\u'bD,as:J¯ `QkZw?TO]AM`+oEmձjݦφd*hW4=xə LK%#OU2\ĦSt?B,/(_HP:/zˋ)7`e*W>G~yp / I* ?q*qLBXU^RE"1HKS`"Id }mC}}B&q V `Qk#>Zw\.V˕FPrD_9F=z7[~DA˓n+K_^5w!C2UDwm$FMk Giw'BJ南V<韒nHa]@ ݅ʐSܑ 2t>˦ Uvl:eMdEFp[g[=V?0/v% GnT_W(sL(;,żxn08pQklBomdqʅ^bs(^ԿZ:oMgW,zٯmU7)xq XOD_֟3=YLQb,*Y74y]u`e('+ \}˺YT#+φn?\gPHlH|HQ&V|N({!k XGw|ގ>)Mm6؈8g9,8>gJ>p$s?bDZ$IO"zP&  B&SlbUP߶K`ȪQ]12Ftk5A9|HQ@޴c%Tol>Z+?]/#c\1ߑ֬Q^djq8')d_k$I'漤߾ =Bk^qɚ1d{MܒB Pj'>,EY7`XaG]#: *+!g>KMYs+}r 뀤yxNu>L\D^Ƭкc7ۗZe1r-SWj K?52?X\~QO7 /6ȱf^9PHWL\m5x*l(OWff;G!<_4yFI!S <ƁuHY&|efu droo͋/miw'zͷ_j́FϦerf 6$%ohݱo^>j0+R jfwη ]_wjSgW.͚3zvGMZWhpU6< `X'Wcڶ< MW2ʂhBd+BGyUEaJІ_\T4_n̊݌+ ͜΂_dcngfYK+k3,#W B}}w6'tTkcc1iׄ|dG0"W a6ҝ:B -is]u\f}NǏeGj]88n$߲|^{XVF 4/9E֫//^:Ր4Ow>l-1,P~.#_i}+^ivZ:hMD$[D}ZbD;J?,;Gj&aŎ]޾4tWvҼYYdg0cIq9Ƒk-\n?fm8:|Lu??sW7$:YYhӜڜ/9Hڋϔ ߢup5ر9 |:Q;J^p36+d^kC/[VbtK6dy iWfI5v=ʕNP_\֬対u q67;Mk7΂*i)қ@MW^=mDgS+"("ЌNP4_,drzmc'H&]u|-;v!,}{oXU ~I9FOS`A6y'=[Io1%kh}1#νs#r܌TeVE@P@HZQoµӄ0>9+_]ƘN&;un~g$)9ݭ-YT|q Y}=wiV?Sim73t)=VE@PE TD T sU-yEzAʗZff9g <{b_LIWE@PEH;cP3C4Bhga8xbU ,`:+,b&n iG䕋SE@PEQ [@yVkFPb%N b*uwZg!<_rFG-YFX*"(@"TTs~3bi$0j_ӆjwT v"V;#G:18uLy-("(@wGYf {<>KCG.3j=}&o="("( 5on%č QJ堋1i~gW;(ae]mn.D={𣏪n9#=?ozV}^P>줘_"#PSxX-E?LJjM_wgϹc\[S. }kVjz|դ|6g^{/{MOch._KGqXN?n:`Ʒv^Ϟ.vV\!?mK;+/¿&EYW_$sĒ] k#o#} xG,(Jo=?3EYlUU &^cw-Au}0jH8\]>l"BÛ2_ ԅCG/̟ȏ7@VP'W~qHuH դJC?EN噍k-VRPD`+맢1@(*"@f *K[wnٽa(>睳=F~G=I5g<2lIM1pKVE.,;os7JVmGPFE; ;'qKPA a:o ! H揟Y0E,7+JYqjN?y\9_lb:Ǣ@|&fcx˅By Yi{kĵ w 9k,l23]9 C葅:c2flRn[XM{yN |^I;bh7"><#⍘dn\Y[fKߓ昍2&_d1q׍X`\^Kܱ{YquےB^]O>s~Ƒ4p0GXd`Vd89o"+BcKl򝌙CXg5cPY_"'s+7AvJhg:[ƕi{<ߑ0G>C#}?U7?A`C9{OlK˼u qUɜsu׭oq~grN`'R!:Ӭm3MH/%GڸʼEMvu__.nrIH?6a:w׏mT:c= Ztqe@~N2]Vw${%m}.F5=`fβ翽 oo]y9gS*gB7svisR@M&"ljsUa|CG֒l}. #\wن`IëCAR8,Hxߘ4v|nn,Ϟ&!#76=cb8.X:hyW s 33&O|,!Gs6#X%ת7(5<-w(k7)2z O=O `1EJ?4SSa.(mH\nj_ڟ|qٯޘ&D<4ʊ)ONZ@d}}"s#}X'0;*+J`ʸ!uvk1>B~uɌ7 ){ݍ)\ʈ RMD_~0o#}Dd<+cI8"g˺s9ed߉]/`y[2=k れ+;~NY,ßkco#k1Dw3DO2nƸ>1<K~w;$&{>66vZ gBbe!1i7$#魁!tWߞnObQ{֡^qUC@*d͂E$FִdƧbi,u)dX 6)^$e2Y?vkc82m_78x>7 yKa#L g+t嘏9V"@fRwje:hqp&Yk1uY1]_02N([94oق+v4'k?nA}ߝ˼3ndfW_, 117cM/beb^2XCp&sn|,w%aM0F\)c?,wl1̼rc-Y֑[:eN*s@p#,!uv)y^'O,n8~=Oټ'I[&zml#Ƅ~q3\++rҰy5W=z]|OYͲ([C|Cg1&6X}u.]7|{\||jwed\DS'sU`\γ`Ղ/ K6sb܃/[b]Eˉ[ 9ӿCBY0gp9V R #D;o8FW tq@T<=d cu& ĊM~Rw5e!L2PN(jY2828*)mo o/KNi EX>&28BcѰ=ĉes{"D6Gxؖ/v$ 2,(m)sbf41no\c=uI$Ӈ,H֧/K@)R:}n}kKi'uI=K_dy;j:%88-m[@OVp= PdLIiؤcHwhCYZL@G~"W[BrdY%ӟ1a̗p 睓:qzT3xeMKL,z[TOH +ͺ mMb d#Y]\@XKDvܪ`p{9tE!z]#JM~_>}B\m$#Gɣe3' Y YNB(yzn UY,f~HeNA6Jn[yĺXwᤀ6|.|Oy\J}}+zo2N$S蛽ΙcM*t.4瘏I{ɳe*# yn֏1z! *Y>M&XTL8C\+XXk_i%~|Vև Q_*ǮjZZXT+Vy;+s"H:댽6<.{c*ķ Ǜ*Y뭦IBڇ2v#V#lV B(\ D%ԓfmeN ^QrGN1H~OˈOA^*caґk^ Gn!, Q  M}+Z0gBVw| Os ['pS<"%_i/fއ^Rb۪\=P*z T '>..VrBZ_n?m  <"" [턪y|LjR,kO5UDNa@*>!\~:PⳔ]g,N20qk QI闲`ʲL@9u,VVqHT#AZ2>7<.3B%V|B^{Gi}3X\C UWl=b,؇cD+A)7CƶT9Ud γ@ʑ6ZWXY*'a/z*9Z 8V$5=!Xr2!7>TȺY֚F,Icza9KF)c[$ٷelpTZLq(8zWsb,n!(E<51戜2a * ?|7#*&e1)QB `b#Ksi'k<:?v-J0'n2f>9IAw$X%&R}"T'+&RH_Xػ3' V1' QNywEu?e+sޕ쁸/z#1 :s[PP|Y$54<'IEV/J8TNвVjbEżs7^$BRKq X󿿫_QJ%DFg!'`yaHҔ O.eTeQrv$ҔwuR.f,B q13?ʹ1 N%SI9%8|ˌ+{L9կE<!mJxzY!qpfEa^93E)nl$yF1UEP( !x⼌NElY& o- 1i2a݀':"bPl!'y޺ɁJ|ǽB"ic$8L,d^0^1 re3fG\kB$#Q Ybf}UHi&(]9\l ATPCړyO6[ΐUMHߥ(`tiɼb\ZX<|ןdB:"%L^be\cM9H/mibܱŖrJ;I2)0w7}mk|R:F"7F\Kd89y2{Z1WݬD''WU!(RYXZ+&o.r$."ȏ7t>LdƋ|y!~4@yaaK.j /~j kR$E1Cʿ! * T"gwcc.Hz:/sE>6ƛ$щwi/&[*W0mXo.ɉL73M'el!S'd-4x1Dv1ҞdIcXEyƶ2f4sfwnj~Ӈ$!I` GE~Q`nE5XǎR.i9P% Uby(Er ʍY'碽Cȳs΅#{O8:eEՌ'ϊwh#5J5J=` ^]d^ G~z="zOOd&WMRiIV>wIF~ƂʭL(2N$m b(ɂ׍ #iid<+I;N%7FHB($ %9=Q6ȒWiN{DPD%ʚYdɋ68&DO@n-ʮ4W>wI# sRŮ|1f1W6* ${O> 3}K{i&~'{V(pJ}" mL0ǯIwLe-c#zZ,ZnyRq$Zdr1Bc6'D۵isSڊqe.|挎 LYR#)N]s?Ou6|elOsY=7ex<;i'lFuKrNso>oڏY羛bL]]KljNg~sfJ[ 1"IOOmr#UcHW'd;YdO,+W1Q ԪnӔ(}Ӯ5O~#AR!o:Zq@j*"4byTw„RկR35Y(8>}eD~|HUc@S8=RAZBPtr^%R*`m"-j}+batH9.ʡYl6E@j&;4B|'e]0@>Xݣf HzZ}P?|p-JJ`i"@B>UTYJP+wk;Kn߈h/#ɝI"m8b[b`*"4s_,QZr|6y7 *qTV+j92Ö#֪("(@:TD yoygE@PE@(T: e%/f_n32*"(@s PZ}+ҮlSʐ{cJR)"("Gf.h%LG,j=-[UPE@Pj@M Tr֮ݧ%Oo"("U9A 㮝{ŐK:*W%W8k"("P,u!tAo(v Jkb1E@PE>ԍ4 :iJS֢("(@}A_sxӴkE@PE@h JP84FQM,w}iz?}JPE@P%O>?ªo;=z@N@kZ) "("h*?iCT_z)9jP("(6 GPE]+߸WoHd96o:E@PE@4,AcbU튃' RXĴ"("4#MAPX9_[Sjd}JYE@PE@hvGʑ> ,KJTE@PjhJ]W270AE@PE@h& .|]%w6~ZMi)"("P]Q+^nS4+Q%}톘~E ֣("(@!e :C=TE@PE@h6H"("tvn*"(",(AmR9E@PE@&%HjS!,ޘ6wy+V޽{w5jL}B,XƏSZ$YnoZZ"("(XPm_poy^S׷Vh;"("425'[lܒ%@Y쳓$l[nvنݿŏ/6 OO++"("9A}tAбvVC87n\Hx){!XHډ!iu"("tjJPX.z,l5 _Gp/O`aMDrWg=S=Jdc2"("435%S,.`>+gl d=3 r]?ߧ!4hF<.x47'ʮ("(@,5%!kb(+  2O#6q'.v]vmKe6K?"("(̈́@*d DO#ͱr+ 3IP6Lw[𵓖 V6-("(@"P3"^B@cEw8w;PjnE5D!x;}KWE@PEY A%Q;LDg%l#JSC)wK8'Yү,Iφf V5SE@PE@HB&5c4D}~_a{{NuիAdK#v=P$*G.E@PE@P j%=%hmR@E6H0VQȠW)-ȯ/t\k9E@PE@Pӎ?^?Ьa L"C,XƏ@C6Eu={?*x䨑kߞ[$\\V("(@"P:A{Í{#l!b R$鏩2E$B+_?VD Wv"("(D#~ DRΓu $jUE@PEJPCy; BZ!"("(͈@iYz_o–5T-%[#m)"(@# PA Y;%Ma+*[ @}NolK)%GPE@PR*VNnDCֈXRV5"a r2 Ooɤ2*"("PDC zR'!p(Փۙ:ZS>憪$3zlYC`"d Ԭ)bbh"(" Rj:*"("4?7?,E@PE@Pz!^k"("(^PE@PE@h(6p0"("(JPu("("4JPj8TE@PE@P%:E@PE@P E`FMl.IENDB`{$$If!vh5"#v":V l t065"yt}3{$$If!vh5"#v":V l t065"yt}3$$If!vh5#v:V l t065ayt}3{$$If!vh5"#v":V l t065"yt}3DyK $http://www.dmaa.org/definition.htmlyK Hhttp://www.dmaa.org/definition.html1Table kSummaryInformation( DocumentSummaryInformation88CompObjyMicrosoft Office Word@@5@`_?@`_?H`(՜.+,D՜.+,p, hp  ASHPK( @Primary Care/Ambulatory Care/Family Medicine Pharmacy Residency Title 8@ _PID_HLINKSAy:$http://www.dmaa.org/definition.html  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH DA`D Default Paragraph FontRi@R  Table Normal4 l4a (k (No List jj h Table Grid7:V0pS@p hBody Text Indent 3) G08p1$^p`aJh4 @4 Footer  !.)@!.  Page NumberRR@2R <Body Text Indent 2hdx^hHBH  Balloon TextCJOJQJ^JaJB'QB 2WComment ReferenceCJaJ<b< 2W Comment TextCJaJ@jab@ 2WComment Subject5\>@> l!b Footnote TextCJaJ@&@@ l!bFootnote ReferenceH*ZYZ  Document Map-D M CJOJQJ^JaJ6U@6 n3 Hyperlink >*B*phb/b _sDefault 7$8$H$-B*CJOJQJ^J_HaJmH phsH tH PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]  ^ %%%( )2;C6GUK~QUX^h@q*tz{NdH|w] 8D\}'\,28=YAFHLOTXX]jptxȎTƟݣ7$  L~B#3(-93<sHdTZj`$hrvJMORVX[]_acefikmoprtuwy{}~  !"$&(. b=bb"=).3c9e?KC_JNEU#Y[[^dp5wO~6Q!==xq/P %]!(-4:?@BFtKS$Y_gQmqx|cǎQۣ s/<N =os $(.5x<BKS [dlz~ǂ\hKLNPQSTUWYZ\^`bdghjlnqsvxz|    #%')*+,-02Wiii::X !(!!8@0(  B S  ?G$LZdZ\|TTTT<dll$$D$Nَq$=dD$ddTڏڏڏ ;cL;cNN@BACEDF,,,lVV[[jbnbnbccc#i#i0m@BACEDFB9*urn:schemas-microsoft-com:office:smarttagscountry-region8D*urn:schemas-microsoft-com:office:smarttagsdate=E*urn:schemas-microsoft-com:office:smarttags PlaceName=F*urn:schemas-microsoft-com:office:smarttags PlaceType9G*urn:schemas-microsoft-com:office:smarttagsplace9>*urn:schemas-microsoft-com:office:smarttagsState8?*urn:schemas-microsoft-com:office:smarttagsCity  11151991199920200520062122331459DayMonthYearGFED D D D G?>G?>G9GFEG?>GFEG?>G?>G?>GFEG?>GFED  GFEG?>G?>GFED GFEG?>GFEG?>G?>wtttt}}}}Ƨӧ#3˩CSfvz Йڙws&&#9*999+<2<<<J=Q===oWxW4X:X;XEXwXXXXYYaYgY` `jjkkpprsuzhiikllnoqrtu}@; :!!t"u"""""D#f$j$&$'%'rsgi33333333333xCxCyCyCXIXI{I{IYYZZii"j"jtwt=]^@@@@3j>>??rssugiikllnoqrtu}xCxCyCyCXIXI{I{IYYZZii"j"jtwt=]^@@@@3j>>??0Vrsshiikllnoqrtu1W8a ^+9+xFNS&N?ȂˤS Rq{gN4I3$/ V*b, d+jx~u-|0rqO :Nl qr#)`B AL+5 -ILIW.،S.`~.\IZ0(0ڊ/p3V<44di5N'6~%:X8dnCVq9p%-Y<ڦt=X+mC:v*HzЌpI4-V:#D"kY"*?S[t;^oҀt`,N@gHJG"mqGWM@ryumou<#]9Nrv53zvWUs{4h^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh ^`hH.h ^`hH.h pLp^p`LhH.h @ @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PLP^P`LhH.  ^ `OJQJo(hH@ @ ^@ `OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hHPP^P`OJQJo(hH  ^ `OJQJ^Jo(hHo^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhp^p`OJQJo(hHh@ ^@ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhP^P`OJQJo(hHh ^ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhp^p`OJQJo(hHh@ ^@ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhP^P`OJQJo(hHh ^ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hH  ^ `OJQJo(hH@ @ ^@ `OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hHPP^P`OJQJo(hH  ^ `OJQJ^Jo(hHo^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh8^8`OJQJo(hH^`OJQJ^Jo(hHo ^ `OJQJo(hH ^ `OJQJo(hHx^x`OJQJ^Jo(hHoH^H`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hHh^`OJQJo(hHh  ^ `OJQJ^Jo(hHoh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh  ^ `OJQJ^Jo(hHoh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhp^p`OJQJo(hHh@ ^@ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhP^P`OJQJo(hHh ^ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh ^ `OJQJ^Jo(hHoh ^ `OJQJo(hHhx^x`OJQJo(hHhH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh^`OJQJo(hHh  ^ `OJQJ^Jo(hHoh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhp^p`OJQJo(hHh@ ^@ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhP^P`OJQJo(hHh ^ `OJQJ^Jo(hHoh^`OJQJo(hHhhh^h`OJQJo(hHh88^8`OJQJ^Jo(hHoh^`OJQJo(hHh  ^ `OJQJo(hHh  ^ `OJQJ^Jo(hHohxx^x`OJQJo(hHhHH^H`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh88^8`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJQJo(hHh  ^ `OJQJo(hHhxx^x`OJQJ^Jo(hHohHH^H`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh  ^ `OJQJ^Jo(hHoh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hH  ^ `OJQJo(hHv v ^v `OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hH^`OJQJ^Jo(hHo^`OJQJo(hH^`OJQJo(hHVV^V`OJQJ^Jo(hHo&&^&`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHh^`OJQJo(hHh  ^ `OJQJ^Jo(hHoh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH13zS*?S[WM@rZ0Us{9+xN@g/p3W.t`"mqyuqO"kY9NrvpIS.uW8a|06{l-Y< AL+b, $/ -VCVq9St= -*H~.N4r:i5q44:X8;^u#)N?mCjx11                                                                                                                                                                                                                                                                                                                                                                                                                                                         zB":8b-DY{cKij8hT)#GG9 +ALp{} P~./0M4_4\V2&GN S) j- M8 R o`  SU H\ z & J$ S ^ k ' G  ic `j 6P?LW$k86PPRHyq(IIK 'N_'D;L{`"{'pMO:nD- )nBwF 5 Hf"#FJ)gj<8N"x0A ?A[\c 8FQH1B+Fcfkj @ /` T!a{!4"""/"{5":"Y"I##_#w$H$MK$#%e%%M'%Xc%_&&&Q&;,'z9']d())K)'*Du*.++`+d+,,mA,M, h,}n,-f-,-$l-? .#.Bn.00"0#0M00"6011C41&F1O|2}323{8344!4r%4DZ4g4~4E55k5*85T5Y5\5:o5u5lu5tq677T7^7l78&>8s8v8_9"9px9J :1:3:?:l:O;I;0<$L<Z<j=F>=Q]=S`=Ib=\>?">D>=^>?4?K? g?q?wx?(@K2@VA~]AbA?BiHBICWC%D)D_,Dv|DE.F'|F G)G!,GgGHH?H^UHVwHMI^\I `IzITJKK9|K L~ML(\LL M9EMHMtMR$N1CNQ O)O[5O MO{HPiPlPNQPQR1RkS[S3SH{ST TITYT Uv3UdULgUX%Vj8WKW]W`WFyW{W}W7X)XziXY ;Y?Y~DZsZ6[E[K[V[\\8w\*^]^E>^rH^9_[@_`+`l/`M`a`l`Uavabbl!b/bAb>Wbsb:cdd?#dFdcdbqd e$5e6_eNf1xf{f}fHhh.h5h0sh-uhGiQ1idifi j%jrj9~jk1k7k\OkO lc l l#l0l:>l mm0mFmTmem9nnB"nH*n YnGo/oLo^\o]owoG{o"pqqW q8rQrk_rwr!sQsUSsVs_s zsAt*uu!uy?uOu>Uu|bu<v&vj5v5vmFvYvU ww+w4w7wx0IxXxy9y{y|%{02{K6{D{z{|)|#I|S|_}SD}S}u}=~W  cDHu!'ZcKgbi>mZ/2?IRILlMU'->K7PRYSVf"v;Fef'~)n5NB1;YJWX3[x2ajz34{&IX^t{:R{~E!"r3%Q,v|]^~g%#NX)@W' Z7\/Fl al Q YS[E<ZGqL>PP+^pn%s"I@g L1Vjxn3>Q3v2$&-y.5<R_H039?K9q9:qW.l6kv<`qbiRYd{eY "%&3 :S@TW_q{);22t$7^_knrS7ZZ/W]h3U!XCW7.Z!p rNGo^{O2WZeO]nq;"Y$i6? s|t}=#P$&_cw9RSpwB>2Kx^ _p@~f6m #Rh0zd02I!SP0dh*xC3H(+ &0Ttu& An37:ALdt7q;JLP6mvyj]<?@S~z#D.% `%J?+Nx S Zd~5jHuKL)VY 8>zx?ABfQRUZg s,N_i[v4=;NReyim@VwmU0 )*htl+. :A'u{V_t %6:uGfyA=harz{> \G^dj }lrN|}87 H0tP y<UabJ)/r13V^` #H>L$'X~,s?@`dimShp] FZL]q`.3ENuTY]KAO^]m^fhSwdkmtx&&I\~\7`}a~+Ghyv7L!aqHk0^[aLdsu@X@UnknownAPAUserAburnsjowenScott R. McCreadieG* Times New Roman5Symbol3. * Arial?= * Courier NewG"Albertus Medium5. *aTahoma;WingdingsA BCambria Math"1hJڪ`(HK`(HK4d(( 2QKX ?u2!xx?Primary Care/Ambulatory Care/Family Medicine Pharmacy ResidencyASHP 1                           ! " # $ % & ' ( ) * + , - . / 0